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1 Introduction 
 
1.1 General principles of innate immune responses 
Infection of multicellular organisms by microbial pathogens leads to an inflammatory 
response by the immune system. The innate immune system is thereby the first-line of 
defense against microorganisms, such as bacteria, fungi and viruses, and the main 
contributor to acute inflammation [1]. The system primarily depends on the recognition of 
pathogen associated molecular patterns (PAMPs) and damage associated molecular 
patterns (DAMPs) by innate receptors. PAMPs do not occur in the host and are usually 
molecules essential for the life cycle and viability of a pathogen. Thus, PAMPs are highly 
conserved, making them an ideal target for recognition. Examples include bacterial and viral 
nucleic acids, fungal -glucan and -mannan cell wall components, the bacterial protein 
flagellin, components of the peptidoglycan bacterial cell wall, and lipopolysaccharide (LPS) 
from Gram-negative bacteria. DAMPs, also known as alarmins, are endogenous molecules 
normally found in cells that get released during necrosis and contribute to sterile 
inflammation. Examples include ATP, the cytokine IL1 , uric acid, the calcium-binding, 
cytoplasmic proteins S100A8 and S100A9, and the DNA-binding, protein HMGB1 [2, 3]. The 
germ line-encoded receptors for PAMPs and DAMPs are highly conserved in all multicellular 
organisms and are collectively referred to as pattern-recognition receptors (PRRs) [4]. PRRs 
include membrane bound receptors, such as Toll-like receptors (TLRs) and C (calcium 
dependent)-type lectin receptors (CLRs) as well as cytosolic receptors such as retinoic acid-
inducible gene I (RIG-I)-like receptors (RLRs). PRRs are not only expressed in specialized 
immune cells like macrophages and DCs but also in many other cell types.  
Sensing of PAMPs or DAMPs by PRRs results in transcriptional up-regulation of genes 
encoding for pro-inflammatory cytokines, type I interferons (IFNs), chemokines and 
antimicrobial proteins, as well as many uncharacterized proteins [5]. NLRs e.g. are known to 
additionally regulate interleukin-1ß (IL-1ß) maturation through the activation of caspase-1 [6]. 
These initial, locally restricted, immune responses limit replication and expansion of the 
pathogen (e.g. viruses) and can in turn convert resting dendritic cells (DCs) into potent 
antigen-presenting cells, capable of promoting the expansion and effector differentiation of 
naive pathogen-specific T cells [7, 8]. PRR-induced IFN is also required to promote T cell 
survival and clonal expansion after antigen presentation [9] Moreover, interferon potently 
induces the cytolytic activity of natural killer cells and cytotoxic lymphocytes [10] and plays an 
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important role in promoting B cell differentiation and antibody production [11]. On the other 
hand, PRRs can (directly) function as co-stimulatory molecules for antigen-specific T cell 
responses and participate in the maintenance of T cell memory [12, 13].  
Nucleic acid motifs are the main virus-derived PAMPs to be recognized by the innate 
immune system. Four classes of PRRs have been shown to be involved in the recognition of 
viral nucleic acids by the innate immune system: TLRs, RLRs, NLRs and Cyclic GMP-AMP 
synthase (cGAS) [14, 15]. Viral RNA is sensed by TLR3, TLR7 and TLR8 in the endosomes 
of pDCs and myeloid DCs [16-18] and in the cytosol of many cell types by RLRs [19, 22-24], 
and a subset of NLRs [25, 26]. 
 
1.2 RIG-I-like receptors (RLR) 
RLR proteins are key players of antiviral innate immunity and act by recognizing viral RNA in 
the cytosol. The RLR protein family comprises three members: the retinoic acid-inducible 
gene I (RIG-I) [27], melanoma differentiation-associated gene 5 (MDA5) [28] and laboratory 
of genetics and physiology-2 (LGP2) [29].  
RLRs belong to the superfamily 2 (SF2) helicases/ATPases and share a central ATP-
dependent helicase domain as well as a carboxy (C)-terminal regulatory (RD) domain. In 
addition, RIG-I and MDA5 each bear two amino (N)-terminal caspase-recruitment domains 
(CARDs), which are essential for protein-protein interactions with the downstream signaling 
molecule mitochondrial anti-viral signaling (MAVS) [27, 30].  
Due to a differing affinity for RNA patterns, RIG-I and MDA5 recognize different RNA viruses 
with partial overlap [19]. Activation of RIG-I depends on RNAs of a minimal length of 18 to 20 
bases that carry a triphosphate moiety at the 5’-end and a base-paired region in the range of 
10 to 20 nucleotides in the direct proximity of the free 5’-triphosphate end [31, 32]. RIG-I is 
thus required for innate responses to many ssRNA viruses, such as the negative-stranded 
viruses of the orthomyxoviridae e.g. influenza A and B virus, paramyxoviridae e.g. Newcastle 
disease virus (NDV), Sendai virus (SeV), respiratory syncytial virus (RSV) and measles virus 
and rhabdoviridae e.g. vesicular stomatitis virus (VSV) and rabies virus [20, 24]. Moreover, 
detection of positive-stranded flaviviruses including hepatitis C virus (HCV) and Japanese 
encephalitis virus (JEV) was found to be RIG-I-dependent [33]. In addition, RIG-I can also be 
activated by cytoplasmic DNA after RNA polymerase III-mediated transcription of AT-rich 
DNA into RNA [34, 35].  
MDA5-dependent signaling is induced by long double-stranded RNA (dsRNA), most likely 
involving a complex RNA structure [36]. Up to now however, the structures serving as the 
MDA5 PAMP, are not entirely elucidated. For in vitro studies, the commercially available 
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RNA analog poly (I:C) is widely used as an MDA5 ligand. In vivo, MDA5 is required for 
protection against picornaviruses such as the polio virus, encephalomyocarditis virus 
(EMCV), Theiler’s virus, mengovirus, norovirus and murine hepatitis virus [22, 23, 37]. 
Similarly to RIG-I, MDA5 has also been implicated in DNA virus detection. Vaccinia virus, a 
dsDNA virus of the poxvirus family, activates MDA5 via a yet to be characterized mechanism 
[36].  
Even though LGP2 has significant sequence identity within the helicase domain and RD to 
RIG-I and MDA5 it lacks CARD domains and therefore cannot induce signaling on its own. It 
is supposed to have regulatory functions on RIG-I and MDA5, however the functions of the 
protein in antiviral signaling have remained controversial, as different experimental strategies 
have demonstrated seemingly antithetic biological activities for Lgp2 [38]. 
In addition to the immediate innate immune response, RLR signaling also affects adaptive 
immune responses by driving the maturation of dendritic cells and other antigen presenting 
cells (APCs) in order to induce tailored T-cell responses to viral infection [39, 40]. These 
parameters serve to control cell-mediated defenses and modulate the adaptive immune 
response to virus infection. Thus, the development of RLR-based therapies that trigger 
specific innate immune programs and lead to selective effector gene expression and function 
have a beneficial impact on the control of virus infection and antiviral immune enhancement 
against both chronic and acute viral infections and have already been successfully tested in 
several studies [21, 41, 42]. RLR-induced immune responses can furthermore be exploited 
for anti-tumor therapy approaches. Targeting tumor cells with bifunctional triphosphate RNA 
to induce RLR-mediated immunogenic cell death in these cells in combination with small 
interfering RNA (siRNA) to disrupt tumor-promoting pathways have proven to beneficial in 
several studies on tumor models [43-45]. 
 
1.3 The antiviral receptor protein MAVS 
Upon activation, RIG-I and MDA5 undergo conformational changes and can bind via CARD-
mediated interactions to their shared adaptor protein MAVS, also known as Interferon 
promoter stimulator-1(IPS-1), Caspase recruitment domain (CARD) adaptor inducing IFN-  
(Cardif) and Virus-induced signaling adaptor (VISA) [46-49]. In addition to a single N-terminal 
CARD, the protein bears a proline rich region (PRR) and a C-terminal transmembrane (TM) 
domain. MAVS was initially described as a strictly mitochondrial outer membrane (OM) 
protein with its localization being crucial for signal activation [49]. In a later report, MAVS has 
also been shown to locate to peroxisomes, and both localizations are thought to be 
necessary for an adequate antiviral response [50].  
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Figure 1-1 Illustrations of differential RLR signaling via mitochondria and peroxisomes. Upon 
activation by viral RNA the receptors RIG-I and MDA5, undergo conformational changes and bind to 
MAVS both on mitochondria and peroxisomes. Mitochondrial MAVS initiates antiviral signaling via 
activation of the transcription factor IRF3, leading to a sustained antiviral response with expression of type 
I IFNs and subsequent induction of ISGs via JAK/STAT signaling. Peroxisomal MAVS induces ISGs in an 
IFN-independent manner, induced by activation of IRF3/IRF1 heterodimers. Activation of peroxisomal 
MAVS results in an early and transient antiviral response, supplementing the longer sustained 
mitochondrial mediated antiviral response.  
 
Upon activation by RLRs, mitochondrial MAVS homo-oligomerizes and activates antiviral 
signaling by recruiting various downstream signaling molecules to form a MAVS 
“signalosome” [51]. Association of tumor necrosis factor (TNF) receptor associated factor 
(TRAF) 3 and TRAF6, as well as TRAF family member-associated nuclear factor  B (NF- B) 
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activator (TANK) and TNF receptor 1-asscociated death domain protein (TRADD) lead to the 
phosphorylation of interferon regulatory factor 3 (IRF3) and IRF7 by the TANK binding kinase 
1 (TBK1) and IKK , as well as activation of NF- B to induce type I interferons (IFNs) and 
proinflammatory cytokines (e.g. interleukin 6), respectively. The PRR domain of MAVS 
contains consensus binding sites for various proline-associated immune proteins, such as 
TRAF2, TRAF3 and TRAF6 [47, 52]. The protein has also been shown to interact with FADD 
and RIP1 [53, 54]. Upon virus infection, the CARDs of MAVS form prion-like fibrils which 
convert MAVS into functional aggregates on the mitochondrial membrane, leading to the 
recruitment of E3 ligases TRAF2, TRAF5, and TRAF6 and the activation of IKK and TBK1 
[55]. 
MAVS activation on peroxisomes creates rapid and transient antiviral signaling. Upon 
activation of peroxisomal MAVS, TRAF3 and TRAF6 are recruited to stimulate 
phosphorylation of IRF3 and IRF1. This leads to direct stimulation of ISGs, independent of 
IFN expression [50].  
 
 
Figure 1-2  Mechanisms of MAVS regulation. MAVS is tightly regulated by host cell factors that 
inhibit MAVS signaling by direct protein–protein interactions, by altering mitochondrial properties or 
dynamics, or by post-translational modifications. Positive regulations of MAVS signaling are shown 
in green, negative regulations of MAVS signaling are shown in red.  
 
Several proteins regulate antiviral signaling by direct interaction with MAVS. Following RIG-I, 
but not MDA5 activation, the stimulator of interferon genes (STING) interacts with MAVS at 
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MAMs, facilitating TBK1 recruitment [56, 57]. The nod like receptor 1 (NLRX1) interacts with 
MAVS via its CARD and is postulated to disrupt formation of the signalosome [58]. 
Interestingly, NLRX1 selectively inhibits signaling of mitochondrial MAVS, whereas signaling 
of peroxisomal MAVS is unaffected [50]. The mitochondrial proteins mitofusin 2 (MFN2) and 
translocase of the outer mitochondrial membrane 70 (TOM70) both interact with MAVS to 
inhibit and activate signaling, respectively [59, 60]. The receptor for globular head domain of 
complement component C1q (gC1qR) was shown to translocate to mitochondria to 
negatively regulate signaling via direct interaction with MAVS [61]. The IFN induced protein 
tetratricopeptide repeats 3 (IFIT3) is a positive regulator of MAVS signaling, facilitating 
interactions of TBK1 and MAVS [62].  
Additionally, post-translational modifications play a key role in regulation of MAVS- 
dependent antiviral responses. The proteasomal component PSMA7, poly(rC) binding 
protein 2 (PCBP2), tripartite motive protein 25 (TRIM25), Ndfip1 and the Nedd4-like E3 
ubiquitin ligase AIP4 can stimulate ubiquitination of MAVS and promote proteasomal 
degradation of the protein [63-66]. Phosphorylation of MAVS can both activate and inhibit 
antiviral signaling. Phosphorylation at Thr234 by a yet unknown kinase facilitates binding of 
polo-like kinase 1 (PLK1), thereby blocking interaction with TRAF3. The tyrosine kinase c-Abl 
was identified as a positive regulator of MAVS by direct interaction and phosphorylation [67]. 
An overview of regulation mechanisms of MAVS on the mitochondrial surface is shown in 
Figure 1-2. 
Even though the physiological importance of many of these protein interactions remains to 
be determined, it is now established that upon activation, MAVS forms a signaling scaffold 
whereby the recruitment of TNF-receptor-associated factor (TRAF) 3 leads to the induction of 
IFN-dependent responses whereas the recruitment of TRAF6 leads to the inflammatory 
response [1]. 
 
1.4 Mitochondria 
1.4.1 Structure and morphology of mitochondria 
Mitochondria are double-membrane bound organelles, forming four compartments with 
distinct functions: the outer membrane (OM), intermembrane space (IMS), inner membrane 
(IM) and matrix [68]. The composition of the OM is similar to that of other eukaryotic 
membranes and the presence of porins permits free transportation of metabolites and 
molecules of less than 10 kDa into the inter-membrane space. In contrast, the IM resembles 
prokaryotic membranes in its physiological properties and composition. The protein/lipid ratio 
is significantly higher compared to the OM and the membrane is very rich in cardiolipin (CL), 
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a lipid found also in bacterial membranes. CL is crucial for the proper activity of several IM 
enzymes and responsible for the convolution of the inner membrane into cristae-structures, 
the site of oxidative phosphorylation (OXPHOS). The IMS contains proteins (e.g. cytochrome 
C, DIABLO/Smac), which play a major role in energy homeostasis and apoptosis. The matrix 
is composed of proteins involved in the citric cycle reaction [69]. In addition, it contains a 
circular 16 kb genome (mtDNA) encoding for 13 proteins of the respiratory chain as well as 
for mitochondrial rRNAs and tRNAs. Unlike nuclear genomes, which are inherited equally 
from both parents, the mitochondrial genome is strictly passed on along the maternal line 
[70] . This maternal inheritance pattern of mtDNA is due to its localization in the cytoplasm. 
When an egg is fertilized, the cells of the resulting embryo contain the mtDNA and cytoplasm 
of the egg, not the sperm. As the embryo continues to develop, all of the cells in the resulting 
human contain the cytoplasm and clonal mtDNA of the mother. Therefore, mitochondria-
associated disease mutations are also always inherited maternally. Mutations in mtDNA lead 
to severe neuromuscular diseases mostly due to an impaired bioenergetic status [71].  
Mitochondria form a tubular network throughout the cell. Their ultrastructure and distribution 
is highly dynamic and controlled by a continuous equilibrium of fusion and fission processes 
[72]. In addition, mitochondria are in close contact to the endoplasmic reticulum (ER) 
tethering at multiple contact sites to form specific domains termed mitochondria-ER 
associated membranes (MAMs). MAMs possess distinct biochemical properties and a 
characteristic set of proteins [73] 
 
1.4.2 Function of mitochondria 
Mitochondria are implicated in a variety of cellular functions. In addition to their function in 
aerobic respiration, apoptosis, aging and Ca2+-homeostasis, mitochondria form an integral 
platform for innate immune signaling (Figure 1-3). Furthermore, mitochondria are tightly 
connected to cell cycle control [74] and alterations are observed in aging [75] and disease 
[76]. 
One of the most important functions of mitochondria is the production of energy in form of 
ATP by aerobic respiration. Mitochondrial respiration is composed of two intimately linked 
processes: the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. In a first step 
nutrients (such as glucose, amino acids) are processed to metabolic intermediates (e.g. 
pyruvate, acetyl CoA) that are subsequently metabolized and decarboxylated by eight 
different enzymes in the tricarboxylic acid (TCA) cycle in the mitochondrial matrix. The 
decarboxylation steps are coupled to the transfer of electrons to NAD+ producing NADH. 
During oxidative phosphorylation NADH is oxidized by complex I of the electron transport 
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chain (ETM) and free electrons are passed onto complex II, III and IV to reduce O2 to H2O in 
a series of redox reactions. This electron transfer results in pumping of protons through 
complexes I, III, and IV into the IMS. This creates a temporary form of stored energy, the 
protonmotive force (PMF), which is used by complex V to produce adenosine triphosphate 
(ATP) from adenosine diphosphate (ADP) and phosphate (Pi). Electron transfer through the 
respiratory chain and nutrient oxidation also produces reactive oxygen species (ROS) by 
electron leakage from complex I and III. Electron leakage to oxygen results in the formation 
of two types of superoxides, namely, O2- and H2O- in its anionic form [77]. At high enough 
concentrations ROS can activate the mitochondrial apoptotic machinery, which ultimately 
leads to cell death. However, at low concentrations ROS serve as important signaling 
molecules [78]. 
 
 
Figure 1-3  Overview of mitochondrial functions. Due to continuous fission and fusion 
processes, mitochondria are highly dynamic organelles. Mitochondria fuel cell processes by 
producing ATP through oxidative phosphorylation. The reactive oxygen species (ROS) generated 
as a byproduct of mitochondrial respiration are potent signaling molecules that can modulate 
protein functions. Additionally, the intracellular energy status as well as a variety of cellular stresses 
are detected and, in case of privation, mitochondria can respond with the initiation of cell death. 
Mitochondria play an essential role in antiviral defense and are modulating and are modulated by 
innate antiviral signaling. 
 
Besides their function as the “powerhouse” of the cell, mitochondria are implicated in calcium 
(Ca2+) sensing and signaling. By acting as a second messenger, Ca2+ regulates many 
cellular processes [79]. When transported into mitochondria, Ca2+ stimulates oxidative 
phosphorylation, which then results in faster respiratory chain activity and higher ATP output, 
meeting the cellular ATP demand [52].   
Mitochondria are furthermore able to promote apoptosis [80-83]. Two major pathways, the 
extrinsic and the intrinsic are involved in triggering apoptotic cell death. The extrinsic 
pathway is initiated by the ligation of death receptors (e.g. tumor necrosis factor or Fas ligand 
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receptor) by their cognate ligands, leading to the recruitment of adaptor molecules such as 
FAS-associated death domain protein (FADD) and then caspase 8. This results in the 
dimerization and activation of caspase 8, which can then directly cleave and activate the 
effector caspases 3 and 7, ultimately leading to apoptosis of the cell [84].  
The intrinsic apoptosis pathway can be induced by DNA damage or endoplasmic reticulum 
(ER) stress, which in turn activate B cell lymphoma 2 (BCL-2) homology 3 (BH3)-only 
proteins leading to BCL-2-associated X protein (BAX) and BCL-2 antagonist or killer (BAK) 
activation [81]. BAK and BAX promote mitochondrial outer membrane permeabilization 
(MOMP), leading to the release of proapoptotic molecules, such as cytochrome C and 
SMAC/DIABLO from the mitochondrial intermembrane space [80]. The release ultimately 
initiates activation via the apoptosome and caspase 9 of the effector caspases 3 and 7. Both 
the extrinsic and the intrinsic processes congregate at the activation of downstream effector 
caspase 3, which is responsible for inducing the morphological changes observed in an 
apoptotic cell, such as cell shrinkage, nuclear fragmentation, chromatin condensation and 
membrane blebbing [85]. Crosstalk between the extrinsic and intrinsic pathways occurs 
through caspase 8 cleavage and activation of the BH3-only protein BH3-interacting domain 
death agonist (BID). Activated BID (truncated BID; tBID) is required in some cell types for 
death receptor-induced apoptosis [83].  
 
1.4.3 Mitochondria in antiviral signaling 
Due to the localization of MAVS at the OM, mitochondria serve as signaling platforms for 
antiviral immune responses. In addition, mitochondrial function and morphology are 
intimately linked to antiviral signaling processes [59, 86-89].  
Activation of RLR signaling induces elongation of mitochondria which increases 
mitochondria-ER tethering and facilitates MAVS downstream signaling [90]. This effect is 
mediated by an interaction between MAVS and an effector of the mitochondrial fusion 
machinery mitofusin 1 (MFN1), which is described to positively regulate MAVS-mediated 
signaling [88]. Furthermore, the mitochondrial membrane potential ( m) is crucial for MAVS-
dependent signaling as reduction of m leads to abrogation of antiviral responses. For 
example over-expression of the mitochondrial protein, uncoupling protein-2 (UCP-2) to 
depolarize the membrane, greatly reduced MAVS dependent IFN production [86]. Upon 
activation, MAVS forms multimers on the outer mitochondrial membrane to propagate 
downstream signaling [55]. Loss of m might in turn prevent these structural 
rearrangements of the MAVS [86].  
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m is determined by the electrochemical gradient that forms along the mitochondrial 
membrane. Additionally, it is the driving force behind ATP-production. The m dependence 
therefore also links antiviral signaling to calcium uptake. Furthermore, mitochondrial ROS are 
reportedly involved in the RLR signaling pathway. Increase of mROS production, generated 
through mitochondrial respiration and accumulation of dysfunctional mitochondria, leads to 
enhanced IRF3 activation and IFN expression [91-93]. Ultimately, activation of RLRs also 
initiates pro-apoptotic signaling via mitochondria, independent of type I IFNs [94]. 
Some viruses show evolutionary adaptation to the profound role of mitochondria in antiviral 
signaling. Upon infection hepatitis C virus (HCV) expresses the serine protease NS3/4A and 
induces cleavage of MAVS from the membrane thus dislocating the protein from 
mitochondria. This greatly reduces the ability to induce interferon expression in HCV infected 
cells [95].  
Taken together, mitochondria are playing an important role in host defense and are 
modulating and are also modulated by innate anti viral signaling. 
 
1.5 Peroxisomes 
1.5.1 Biogenesis and morphology of peroxisomes 
Peroxisomes are organelles usually 0.1–1 m in diameter bound by single membranes that 
enclose dense matrices primarily containing metabolic enzymes. Depending on cell type and 
environment, peroxisomes vary significantly in size and function. While usually spherical, 
peroxisomes can change their shape to be elongated with formation of reticular structures 
[96]. In addition, they are able to increase in size and number in coordination with 
morphological changes in other subcellular compartments, including mitochondria [97].  
De novo synthesis of peroxisomes involves vesicular transport of peroxisomal membrane 
proteins from the ER. Peroxisomal membrane proteins (PMPs) insert into the ER and 
assemble into three pre-peroxisomal sub-complexes, which fuse after vesicular budding from 
the ER to form mature peroxisomal organelles [98]. In addition, mature organelles can 
multiply by growth and fission. Fission cycles begin with membrane remodeling and addition 
of vesicular structures from the ER. After elongation, the organelle becomes constricted by a 
yet unknown mechanism [99]. Interestingly, the fission step is regulated by GTPases also 
implicated in mitochondrial fission, namely the Dynamin-Like Protein 1 (DLP1) [100], 
mammalian Fission 1 (hFIS1) [101] and mammalian Mitochondrial Fission Factor (MFF) 
[102]. The molecular basis of peroxisomal biogenesis and protein import is highly dependent 
on the protein family of peroxins and will be described in more detail in section 1.5.3. 
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1.5.2 Function of peroxisomes 
Peroxisomes play a central role in the regulation of metabolic processes in the cell, carrying 
out various oxidative reactions that are tightly regulated to adapt to the changing needs of 
the cell and varying external environments. A major function is the -oxidation of many 
classes of fatty acids including very long, branched-chain, and polyunsaturated fatty acids. 
ß-oxidation is simultaneously present in mitochondria as well as in peroxisomes. However, 
processes are catalyzed by different enzymes and play functionally complementary roles 
[103, 104]. Catalyzing only a limited number of ß-oxidation cycles, peroxisomes act as a 
chain-shortening system in order to prepare medium chain fatty acids from very long chain 
fatty acids (>C20) for subsequent degradation in the mitochondrial ß-oxidation [105]. 
Peroxisomal -oxidation results in generation of H2O2, which is degraded into H2O and O2 by 
the peroxisomal enzyme catalase. Furthermore, peroxisomes play a role in the production of 
bile acids important for the adsorption of fatty acids and fat-soluble vitamins, such as 
vitamins A and K in hepatocytes and bile duct cells [106]. The organelles are additionally 
implicated in the synthesis of phospholipids required by the nervous, immune and 
cardiovascular systems (plasmalogens) and are involved in signaling and the protection of 
cells from damage through reactive oxygen species (ROS) [107]. 
Peroxisomes and mitochondria share common metabolic functions as well as the members 
of their fission machinery, DRP1 and FIS1 [100, 108, 109]. In addition it has been shown that 
active interchange of metabolites, membrane proteins and lipids e.g. through vesicular 
transport between the organelles is possible [110-112]. 
 
1.5.3 Peroxisomal biogenesis disorders 
Peroxisomal biogenesis disorders (PBDs) are a heterogeneous group of diseases affecting 
the formation of functional peroxisomes, clinically characterized by sensorineural hearing 
loss, pigmentary retinal degeneration, multiple organ dysfunction and psychomotor 
impairment. PBDs comprise two clinically distinct subtypes: the Zellweger syndrome 
spectrum (ZSS) disorders and rhizomelic chondrodysplasia punctata (RCDP) type 1 [113]. 
RCDP type 1 is clinically clearly distinct from the ZSS disorders and characterized by 
proximal shortening of the limbs (rhizomelia), multiple punctuate epiphyseal calcification 
(chondrodysplasia punctata), cataracts, facial dysmorphism, microcephaly, small stature, and 
psychomotor retardation [114]. The Zellweger syndrome spectrum (ZSS) consists of three 
overlapping clinical phenotypes: the cerebrohepatorenal syndrome or Zellweger syndrome 
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(ZS), neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD). ZS 
classically presents with severe hypotonia and characteristic craniofacial features including a 
large anterior fontanel, a prominent forehead, shallow orbital ridges, epicanthal folds, a high 
arched palate, a broad nasal bridge and a small nose with anteverted nares. Ocular 
abnormalities such as cataracts, glaucoma and corneal clouding are common and in some 
cases patients show seizures, renal cysts and hepatic dysfunction, evident as neonatal 
jaundice and elevation in liver function tests. Infants with the most severe ZS presentation 
are most likely to die within the first year of life [115]. The clinical course of patients with the 
NALD and IRD presentation is variable and manifests in developmental delay, hypotonia, 
liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. 
Children with NALD may reach their teens, while patients with the IRD presentation may 
reach adulthood [116]. 
The PBDs are autosomal recessive disorders and can be caused by a defect in any of the 14 
different peroxin (PEX) genes described in humans. These PEX genes encode for proteins 
named peroxins that are involved in various stages of peroxisomal protein import and/or the 
biogenesis of peroxisomes [106] (Figure 1-4).. Mutations in PEX7 exclusively cause RCDP 
type 1 whereas mutations in the remaining 13 PEX genes manifest in ZSS.  
 
 
Figure 1-4  Import machinery for peroxisomal protein import. Schematic presentation of the 
human import machinery for peroxisomal matrix and membrane proteins indicating the different 
roles of the 13 different peroxins, the cargo protein is depicted as “C”. For detailed description see 
text.  
The transport of proteins to the peroxisomal matrix or membrane is highly selective and 
mediated by specific import sequences known as peroxisomal targeting sequences (PTSs). 
Peroxisomal proteins destined for the matrix contain a C-terminal peroxisomal targeting 
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sequence PTS1 [117] or, with less frequency, an internal peroxisomal targeting sequence 
PTS2 [118] and are recognized by cytoplasmic PEX5 and PEX7, respectively (Figure 1-4A). 
PEX5 is expressed as a long (PEX5L) and a short (PEX5S) isoform. Both variants can bind 
PTS1 proteins and direct these to the peroxisomal membrane. In addition, PEX5L contains a 
PEX7-binding domain required for binding and shuttling of matrix protein-loaded PEX7 to the 
peroxisomal membrane [119]. After docking to PEX13 and PEX14, cargo proteins are 
translocated into the lumen and shuttling proteins are released from the membrane for 
another transportation cycle [120]. A similar but less characterized cycle has been proposed 
for the transport and membrane incorporation of peroxisomal membrane proteins (Figure 
1-4B). Proteins destined for the peroxisomal membrane contain specific internal targeting 
sequences, recognized by the cytosolic shuttling protein PEX19 [121]. PEX3 is one of the 
earliest membrane proteins found in peroxisomal membranes. However, incorporation 
mechanism is independent of PEX19 [122].  
Due to their distinct functions in peroxisomal import and biogenesis, mutations in PEX genes 
result in particular phenotypes. Mutations in the PEX1, PEX2, PEX5, PEX6, PEX10, PEX12, 
PEX13, PEX14 and PEX26 genes typically affect only the import of peroxisomal matrix 
proteins and cells of patients with aberrations in these genes usually contain peroxisomal 
membrane remnants. Due to the involvement of PEX3, PEX16 and PEX19 in the transport 
and incorporation of peroxisomal membrane proteins, mutations in these genes affect the 
import of both peroxisomal matrix and membrane proteins. Consequently, cells with defects 
in these genes are completely devoid of any peroxisomal structures.  
 
1.5.4 Peroxisomes during viral infection 
Due to the localization of MAVS in the peroxisomal membrane, the organelle is a platform for 
antiviral signaling, initiating an early and IFN-loop independent response via expression of 
ISGs. In addition, activation of peroxisomal MAVS signaling is accompanied by 
morphological changes of the organelle, leading to the aggregation of peroxisomes and the 
formation of peroxisomal tubules. Some viruses, such as vesicular stomatitis virus (VSV), 
interfere with the host cell’s induction of interferon via mitochondrial MAVS by viral proteins 
[123]. Consistent with this shut down of the mitochondrial interferon induction pathway, the 
remaining cellular antiviral response to VSV was found to be mediated mainly by 
peroxisomal MAVS [50].  
Furthermore, a number of viruses exploit peroxisomes during infection. The Nef protein, 
expressed by human immunodeficiency virus (HIV), interacts with the peroxisomal acyl-CoA 
thioesterase 8 (ACOT8). Interestingly, this interaction results in down-regulation of CD4 in 
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HIV-infected cells [124] and enhanced enzymatic activity of ACOT8 [125]. However, the 
impact of this effect is yet unknown. The nonstructural influenza virus A protein 1 (NS1) binds 
to peroxisomal 17-b-hydroxysteroid dehydrogenase 4 (17b-HSD4), an enzyme involved in 
oxidation of cholesterol and long- chain branched fatty acids. This interaction potentially 
leads to inhibition of the enzyme, since overexpression of 17b-HSD4 results in reduced 
expression of influenza proteins, impaired viral assembly and budding [126]  
 
1.6 Screening approaches to identify organelle-associated proteins with implication 
in RLR signaling 
Two complementary but distinct approaches can be defined in proteomics. Firstly, 
expression proteomics that aims at describing the proteome, defined as the ensemble of all 
proteins expressed, and its dynamic changes upon perturbation, stimulation, or disease 
condition. A second approach represents interaction proteomics that focuses on mapping the 
protein-protein interaction (PPI) network by testing direct pair-wise interaction or by defining 
protein complex composition. In order to investigate RLR signaling, we used SILAC-based 
proteomics as an unbiased approach to study changes in the mitochondrial proteome. 
Furthermore, we performed BRET to investigate PPIs of MAVS with peroxisomal proteins. 
 
1.6.1 Quantitative mass spectrometry via SILAC 
A powerful method to analyze complex protein mixtures is bottom-up proteomics, also 
referred to as shotgun-proteomics. In this approach, proteins are further fractionized into 
peptides and analyzed by mass spectrometry. Peptides in comparison to proteins are easier 
to solubilize and separate, which allows better interpretation by mass spectrometry (MS). 
Identification of only few peptides is generally sufficient to unambiguously identify a protein. 
Shotgun proteomics does not focus on specific sites or proteins of interest and thus offers a 
hypothesis-free and proteome-wide analysis, well suited for screening approaches.  
To systematically capture the transient and spatiotemporal regulated nature of cellular 
immune responses, direct comparison of different physiological states is required.  
Quantitative high-resolution proteomics, such as stable isotope labeling of amino acids in cell 
culture (SILAC) offers the tools to evaluate proteome compositions under changing 
conditions with great sensitivity and thereby allows the characterization of cellular processes 
in an unbiased manner [127].  
SILAC relies on the metabolic incorporation of stable isotopes of amino acids (2H instead of 
H, 13C instead of 12C, or 15N instead of 14N). Incorporation of the heavy amino acid into a 
1 Introduction 
19 
 
peptide leads to a mass shift compared to the peptide containing the light version of the 
amino acid. For labeling of cells, the essential amino acids arginine and lysine are chosen to 
ensure that cells have to incorporate the added, labeled amino acid into their proteome [128]. 
As shown in Figure 1-5, for a standard SILAC experiment two separate cell populations are 
cultured with either labeled or unlabeled amino acids. One of the populations can be 
subjected to a stimulus, whereas the other population remains untreated. The two 
populations are subsequently combined and processed simultaneously. The proteome of the 
sample is extracted and measured by MS/MS analysis. Since both populations are prepared 
simultaneously measurements of the peaks of corresponding peptides can be compared 
directly and abundances can be quantified via their peak intensities. If the SILAC peptide pair 
appears in a one-to-one ratio no difference in the abundance is seen in the proteomes. A 
higher peak intensity of the peptide which contains a heavy amino acid indicates a bigger 
abundance in the designated population [128]. A major advantage of this method is the 
possibility to label all peptides without the need of further chemical modifications. Therefore 
the method is relatively easy to apply as well as compatible with multistage purification 
procedures. However, a prerequisite for SILAC is that the cells of interest tolerate and 
proliferate in the special medium that usually contains dialyzed serum [129].  
Unlike in shotgun proteomics with unlabeled peptides, SILAC allows mixing of two samples 
early in the proteomics workflow and thus makes the quantification independent of variations 
that may be introduced during sample preparation, e.g. cellular fractionation or LC-MS/MS 
analysis, ensuring considerably higher accuracy in measurements.  
SILAC was only developed in recent years [130], but has already become a useful tool to 
study changes in protein abundances, modification patterns or protein-protein interactions in 
the context of immune signaling [131-135] and has additionally been applied in tumor biology 
[136, 137], virology [132, 138], apoptosis [139] and cytoskeleton dynamics [140]. It has also 
been proven to be a valuable method to study changes in subcellular localization of proteins 
[141-143].  
 
1.6.2 Determination of protein-protein-interactions in living cells via BRET 
Virtually every cellular function is dependent on signal transduction cascades. Activation and 
regulation of these processes rely on transient interactions between two or more proteins. 
The method of bioluminescence resonance energy transfer (BRET) allows the in vivo study 
of protein-protein interactions as well as the study of conformational changes within proteins 
or molecular complexes and is thus a powerful tool to study the molecular basis of signaling 
pathways. BRET relies on the non-radiative (dipole-dipole) transfer of energy from a light-
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producing donor enzyme after substrate oxidation to a complementary acceptor fluorophore. 
Since the efficiency of resonance energy transfer is inversely proportional to the sixth power 
of the distance between donor and acceptor dipoles, any changes in the spatial orientation of 
donor and acceptor can be detected at high sensitivity [144]. 
In order to perform BRET experiments expression vectors with genetically encoded 
luciferase donor and fluorescent acceptor proteins, fused to two potential interaction 
partners, respectively, are transfected into cells. Energy transfer between donor to acceptor 
occurs only if the distance between the two is below 10 nm, thus a positive signal indicates 
that the proteins of interest are likely to be interacting with each other, either by direct 
interaction or as part of a complex. The resulting acceptor energy emission can be detected 
and, in proportion to the donor luminescence signal, relates to the BRET ratio. BRET can be 
measured using a luminometer (microplate or single-tube) or scanning spectrometer, with the 
capacity to sequentially or simultaneously detect filtered light of two distinct wavelengths 
[145]. 
The most common BRET techniques are based on Renilla luciferase (hRluc) in combination 
with coelenterazine as a substrate and VENUS, a derivate of the yellow fluorescent protein 
(BRET1) or a DeepBlueC substrate in association with green fluorescent protein (GFP) 
(BRET2). However, due to better quantum yields, the use of VENUS was found to provide 
better BRET signal detection [146], and was applied in our study. The BRET technology is 
most suited for studying protein-protein interactions in living cells where they are expressed 
in a near-physiological environment in the correct cellular compartment. However, due to its 
high distance dependency, variations in BRET ratios can occur in response to changes of 
donor to acceptor proportions or conformational changes of the interacting proteins. Taking 
this fact into consideration, BRET experiments for one protein pair are performed with tags 
either fused to the C-Terminus or the N-terminus, respectively. Additional evidence for 
interaction specificity is commonly provided using a BRET-based saturation assay. The 
BRET technology has been used successfully for a wide range of assay types including 
protein-protein interactions [147], functional assays on G-protein coupled receptors (GPCR) 
[148], and receptor oligomerization as well as protease activity assays in living cells [149] 
.  
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1.6.3 Objectives and aims 
Up to now, diseases caused by viral infections remain a challenging global health issue. 
Innate immunity is the first line of defense against these viral infections. A hallmark of 
antiviral innate immune responses is the production of type I IFN and pro-inflammatory 
cytokines. These molecules do not only rapidly contain viral infection by inhibiting viral 
replication and assembly but also play a crucial role in activating the adaptive immune 
system to eradicate the virus. RIG-I-like receptors (RLRs) are essential for the detection of 
cytoplasmic viral RNA of many human pathogenic viruses, such as hepatitis C virus, 
influenza A virus, norovirus or dengue virus. The adaptor protein MAVS coordinates the 
signals from activated RLRs and is crucial for the initiation of the antiviral signaling cascade. 
Due to its location in the outer mitochondrial membrane as well as in the membrane of 
peroxisomes studies focusing on MAVS hypothesized that the surfaces of mitochondria and 
peroxisomes act as signaling platforms for antiviral immune responses and postulated an 
intricate bi-directional interplay between mitochondrial and peroxisomal organelle-function 
and antiviral signaling. In the literature, many details of the interplay between organelle 
function and MAVS mediated signaling have already been elucidated [59, 60, 86, 88, 150, 
151]. However, many aspects of the interplay between mitochondria, peroxisomes and 
antiviral signaling are still unknown or a matter of debate. The presented dissertation 
therefore focused on the following scientific questions:  
a) Is it possible to identify and characterize new candidate proteins with implication in 
antiviral signaling using quantitative shotgun proteomic analyses of mitochondria after 
stimulation of RLR signaling? 
b) Does RLR signaling influence mitochondrial respiration and the mitochondria-
mediated production of reactive oxygen species? 
c) Is it possible to identify peroxisomal protein interaction partners of MAVS, utilizing a 
BRET-based approach to screen a peroxisomal protein library? 
d) Is it possible to elucidate the potential role of peroxisomes in RLR-mediated signaling, 
using a cell culture model deficient of functional peroxisomes? 
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2 Material and Methods 
 
2.1 Material 
2.1.1 Technical equipment 
1-ml Luer Lock Gas-Tight Syringe SGE Supelco (Bellefonte, USA) 
Alpha Imager HP Alpha Innotech (San Leandro, CA, USA) 
Cell homogenizer Isobiotech (Heidelberg, DE) 
Cell incubator Heraeus (Hanau, DE) 
CELLview glass bottom dish  Greiner bio-one (Frickenhausen, DE) 
Centrifuge 5415 R Eppendorf (Hamburg, DE) 
Centrifuge Sepatech Omnifuge Heraeus (Hanau, DE) 
FACS Calibur BD Biosciences (Heidelberg, DE) 
FluoroMax-P Fluorimeter Horiba Jobin Yvon (Unterhaching, DE) 
Freedom Evo 200 Workstation Tecan (Männedorf, CH) 
GE Ettan LC System GE Healthcare (Munich, DE) 
Ice machine Ziegra (Isernhagen, DE) 
Inolab benchtop pH meter 720 WTW (Darmstadt, DE) 
Lamin Air Flow (HB 2448) Heraeus (Hanau, DE) 
LTQ-Orbitrap Thermo Fischer Scientific (Schwerte, DE) 
LUMIstar OPTIMA BMG (Ortenberg, DE) 
MidiMACS Miltenyi Biotec (Bergisch Gladbach, DE) 
Microscope Zeiss (Jena, DE) 
Multiplate Reader Mithras LB 940 Berthold Technologies (Bad Wildbach, DE) 
NanoLC system Agilent (Waldbronn, DE) 
NanoPhotometer Implen (Munich, DE) 
Nucleofector 96-well Shuttle  Lonza Inc (Walkersville, USA) 
Power Pac 200 voltage device Biorad (München, DE) 
Scale LP 6209 Sartorius (Göttingen, DE) 
Scale SBC 21 Scaltec Instruments (Heiligenstadt, DE) 
SF96 Analyzer Seahorse Biosciences (North Billerica, USA) 
Thermocycler T3 Biometra (Göttingen, DE) 
Trans-Blot SD Semi-Dry Transfer Cell Biorad (Munich, DE) 
Shaking device Janke & Kunkel (Staufen, DE) 
 
2.1.2 Kits 
Annexin V apoptosis detection kit BD Biosciences (San Diego, CA, USA) 
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Cell Line Nucleofector Kit (100 RCT)  Lonza, (Cologne, Germany) 
Human IL6 ELISA Set BD Biosciences (San Diego, CA, USA) 
Human IP-10 ELISA Set BD Biosciences (San Diego, CA, USA) 
JETQUICK Plasmid Spin Kit Genomed (Löhne, DE) 
MACS mitochondria isolation Kit Miltenyi (Bergisch Gladbach, DE) 
MegaShortscript T7 Kit Fa. Ambion (Darmstadt, DE) 
Mitochondria Stressor Kit Seahorse Biosciences (Massachusetts, USA)
 
2.1.3 Chemicals 
ELISA  
Bovine serum albumin (BSA) Roth (Karlsruhe, DE) 
Polyoxyethylen(20)-Sorbitan-Monolaurat Roth (Karlsruhe, DE) 
 
SDS-Polyacrylamide gel electrophoresis and western blot 
Ammoniumpersulfate (APS) Sigma-Aldrich (Steinheim, DE) 
Blotting paper Schleicher & Schuell (Dassel, DE) 
Bromphenol blue Roth (Karlsruhe, DE) 
Enhanced chemiluminescence detection 
system (ECL) Amersham (Little Chalfont, GB) 
Ethylenediaminetetraacetic acid (EDTA) Roth (Karlsruhe, DE) 
Glycine Roth (Karlsruhe, DE) 
Methanol Merck (Darmstadt, DE) 
-Mercaptoethanol Biorad (München, DE) 
Milk powder Roth (Karlsruhe, DE) 
Sodium chloride   Roth (Karlsruhe, DE) 
Sodium dodecyl sulfate Roth (Karlsruhe, DE) 
Nitrocellulose membrane 
Amersham (Little Chalfont, GB) 
Prestained protein molecular weight 
marker plus Fermentas (St. Leon-Roth, DE) 
Rotiphoresis Gel 30 (37,5:1) Roth (Karlsruhe, DE) 
Tetramethylethylendiamine (TEMED) Roth (Karlsruhe, DE) 
Tris hydroxymethylaminomethan (TRIS) Roth (Karlsruhe, DE) 
TRIS hydrochloride Roth (Karlsruhe, DE) 
 
2    Material and Methods 
24 
 
Transfection reagents  
Genejuice Merck Chemicals (Darmstadt, DE) 
Lipofectamine 2000 Invitrogen (Carlsbad, CA, USA) 
Lipofectamine RNAiMax Invitrogen (Carlsbad, CA, USA) 
 
DNA gel electrophoresis  
Agarose Sigma-Aldrich (Steinheim, DE) 
Ethidium bromide Sigma-Aldrich (Steinheim, DE) 
Formamide Sigma-Aldrich (Steinheim, DE) 
GeneRuler DNA Ladder Mix Fermentas (St. Leon-Roth, DE) 
Urea Roth (Karlsruhe, DE) 
Rotiphoresis gel 40 Roth (Karlsruhe, DE) 
Tris-Borat-EDTA (TBE) Sigma-Aldrich (Steinheim, DE) 
 
Cell culture  
SILAC amino acids Pierce Bioscience (Bonn, DE) 
Aqua ad injectabilia Braun (Melsungen, DE) 
Calcium chloride Sigma-Aldrich (Steinheim, DE) 
Ciprofloxacin Stada (Bad Homburg, DE) 
Dulbecco's Modified Eagle Medium 
(DMEM) Sigma-Aldrich (Steinheim, DE) 
Dulbecco's Modified Eagle Medium 
(DMEM), no phenol red Sigma-Aldrich (Steinheim, DE) 
Dulbecco's Modified Eagle Medium 
(DMEM), suitable for SILAC Sigma-Aldrich (Steinheim, DE) 
Fetal calf serum GibcoBRL (Paisley, GB) 
Fetal calf serum, dialyzed GibcoBRL (Paisley, GB) 
Hoechst 33342 fluorescent stain Pierce Bioscience  (Bonn, DE) 
L-Glutamine PAA (Linz, A) 
MCDB 153 Sigma-Aldrich (Steinheim, DE) 
Opti-MEM Invitrogen (Carlsbad, CA, USA) 
Phosphate-buffered saline (PBS) PAA (Linz, A) 
Streptomycin PAA (Linz, A) 
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Trypan blue Sigma-Aldrich (Steinheim, DE) 
XF assay medium Seahorse Bioscience (North Billerica, USA) 
 
Cell lysis  
Glycerol Roth (Karlsruhe, DE) 
Nonidet P-40 Fluka Biochemika (Buchs, CH) 
Phenylmethylsulfonylfluoride (PMSF) Fluka Biochemika (Buchs, CH) 
Protease inhibitor cocktail for  
mammalian cells Sigma-Aldrich (Steinheim, DE) 
Sodium orthovanadate Sigma-Aldrich (Steinheim, DE) 
 
TLR-agonists and cytokines  
CpG Invivogen (San Diego, USA) 
dAdT Invivogen (San Diego, USA) 
IFN-ß Sigma-Aldrich (Steinheim, DE) 
Poly (I:C) , HMW Invivogen (San Diego, USA) 
 
Enzymes  
Calf intestine alkaline phosphatase, CIAP Fermentas (St. Leon-Roth, DE) 
Desoxyribonucleotide Fermentas (St. Leon-Roth, DE) 
Lys C Promega (Münster, DE) 
Pfu-polymerase Fermentas (St. Leon-Roth, DE) 
RNase-inhibitor Fermentas (St. Leon-Roth, DE) 
Trypsin, sequencing grade Roche (Mannheim, DE) 
 
2.1.4 Antibodies 
alexa fluor 488 goat anti mouse Mol.Probe (Darmstadt, DE) 
alexa fluor 488 goat anti rabbit Mol.Probe (Darmstadt, DE) 
alexa fluor 568 goat anti mouse Mol.Probe (Darmstadt, DE) 
alexa fluor 568 goat anti rabbit Mol.Probe (Darmstadt, DE) 
Ms mAb- anti-ß-Actin, HRP-linked Santa Cruz (Santa Cruz, USA) 
Rat mAb-anti-MAVS  Dr. Elisabeth Kremmer (Helmholtz Zentrum München, DE) 
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Rb pAb- anti-COXIV Abcam (Cambridge, UK) 
Rb pAb- anti-HSP60 Santa Cruz (Santa Cruz, USA) 
Rb pAb-anti-Cytochrome C Cell Signaling (Detroit, USA) 
Rb pAb-anti-TOM40 (H-300) Santa Cruz (Santa Cruz, USA) 
 
2.1.5 Viral strains 
Infection assays were performed with Sendai virus (SeV) cantell strain, obtained from 
Charles River Laboratories, and vesicular stomatitis virus (VSV) Indiana strain, generously 
provided by Prof. Dr. Anne Krug (LMU München). 
 
2.1.6 Cell lines 
The human melanoma cell line 1205Lu cell line [152] was used for the investigation of 
changes in the mitochondrial proteome and mitochondrial respiration rates upon stimulation 
of RLR signaling. The cells were kindly provided by Dr. Robert Besch (LMU München).  
Human fibroblasts extracted from patients with Zellweger syndrome were generously 
provided by Prof. Ania Muntau (LMU München). The PEX3-deficient cell line was described 
by Muntau et al.  [153]. 
 
2.1.7 Software 
Adobe Creative Suite Adobe Systems (San Jose,USA) 
FlowJo Tree Star FlowJo (Ashland, USA) 
GraphPad GraphPad Software Inc. 
(California, USA) 
Microsoft Office Microsoft (Redmont, USA) 
MaxQuant Max Planck Institute (Munich, 
DE) 
Perseus 
Max Planck Institute (Munich, 
DE) 
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2.2 Molecular biology methods 
2.2.1 Polymerase chain reaction 
Polymerase chain reaction (PCR) is a method to amplify a defined part of an extracted DNA 
sample. To define this part, two specific primers are needed that flank the region of interest, 
one upstream and one downstream primer. The general range of a primer is 15-30 bases, 
and the guanosine and cytosine amount should be 40-60%. The maximum size of the DNA 
fragment, which can be amplified with a standard PCR, is 10.000 bases. A PCR consists of 
several cycles. After each cycle the amount of amplified DNA is doubled. 
The PCR method was used for the amplification of specific cDNA fragments. The 
polymerase PfuUltra (Fermentas) was used to prevent mutations. This enzyme has a 3’ to 5’ 
exonuclease activity and thereby provides a higher fidelity than normal polymerases.  
 
The composition of a standard PCR 50 l reaction mix is shown below: 
 
PCR  
As required DNA (100 pg to 500 pg) 
5 l 10x PfuUltra II Reaction Buffer 
1 l dNTP mix 10 mM  
1 l upstream primer 10 M  
1 l downstream primer 10 M 
1.25 U/50 l PfuUltra DNA polymerase 
As required     Nuclease-free H2O 
 
Standard PCR cycling conditions: 
 
Function  Duration Temperature 
Initial DNA denaturation 5 min 95°C 
DNA denaturation  20 sec 95°C 
Primer annealing  20 sec 65°C      30 cycles 
Primer extension  15 s 72°C 
Final extension  3 min 72°C 
End    4°C 
 
2.2.2 Gel electrophoresis 
DNA fragments were separated in a length-dependent manner by gel electrophoresis. For 
separation, a 1-2% agarose gel (1-2% agarose in 100ml 1x TAE) was used. After boiling the 
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agarose was cooled down, 0.003% ethidium bromide was added, and the gel was poured. 
While cooling down, the gel forms a crosslinked polymer allowing the separation of DNA 
fragments according to their size. The DNA samples were supplemented with 1x DNA 
loading dye and loaded onto the gel. Due to the negative charge of DNA, molecules move 
from the negative pole to the positive pole when an electric field is applied. The DNA 
fragments of different sizes are separated at 100 V for 30 min. For size determination a 1 kb 
DNA Ladder (Fermentas - GeneRuler™) was used. 
 
2.2.3 Purification of PCR products via gel extraction 
The JETQuick Gel Extraction Kit was used to re-isolate double-stranded DNA fragments out 
of gel-slices after separation and purification of PCR samples by gel electrophoresis. The kit 
purifies DNA fragments of a length from 40 bp up to 20 kb. The DNA adsorbs to the silica-
membrane of the JETQuick spin column in high-salt buffer while contaminants pass through 
the column. JETQuick gel extraction was done according to manufacturer`s protocol. 
 
2.2.4 Digestion of DNA with restriction enzymes 
For analytical purposes 0.2-2 g of DNA were digested with 1 U of one or two restriction 
endonucleases in an appropriate 1× buffer. Restriction digests were carried out for 1 hour at 
37°C. After digestion samples were separated by gel electrophoresis and extracted via gel 
extraction kit or directly purified by JETQuick PCR Purification Kit. DNA amounts were 
determined by photometric measurement. 
 
2.2.5 Isolation of plasmid DNA 
For plasmid DNA purification bacteria were grown on LB-plates, containing antibiotics for 
selection, and isolated clones were picked and cultivated in 2 ml LB-medium under antibiotic 
selection for 16 h at 37°C. Bacteria were harvested by centrifugation at 12,000 g for 2 
minutes and plasmid DNA purification was performed with the GenJET™ Plasmid Miniprep 
Kit according to the manufacturer’s protocol.  
2.2.6 RNA purification 
Total RNA was isolated from 1 x 105 - 2 x 106 cells using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. 
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2.2.7 cDNA synthesis 
First-strand cDNA was generated from 1 g of total RNA using Oligo(dT) primer and murine 
leukemia virus reverse transcriptase.  
The following reagents were subsequently added and the reaction mix was incubated at 
42°C for 60min, then at 70°C for 10min. 
 
The composition of a standard 20 l reaction mix is shown below: 
PCR  
4 l 5x reverse transcriptase buffer 
0.5 l RiboLock RNase Inhibitor 
2 l dNTP mix 10 mM 
2 l 
RevertAid H Minus Reverse Transcriptase 
10000U 
 Nuclease-free H2O 
 
Standard conditions for reverse transcription: 
 
Function  Duration Temperature 
Reverse transcription 60 min 42°C 
Enzyme inactivation 10 min 70°C 
End    4°C 
 
2.2.8 Quantitative real-time polymerase chain reaction 
Quantitative real-time polymerase chain reaction (qRT-PCR) was used to quantify the 
relative amount of specific mRNAs in samples. Relative gene expression of each gene was 
calculated as the ratio of gene of interest mRNA and hypoxanthine 
phosphoribosyltransferase (HPRT) mRNA, both determined in the same sample. qRT-PCR 
was performed with the LightCycler 480 instrument. For specific primers and probes see 8.2.  
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For all runs the standard Roche protocol for mono color hydrolysis probes with 45 
amplification cycles was used according to the following protocol: 
 
Volume Reagent 
1 l cDNA 
5 l 2x Kappa Probe Fast mastermix 
0.2 l upstream primer (100 M) 
0.2 l downstream primer (100 M) 
0.1 l fluorescent hydrolysis probe 
3.5 l nuclease-free H2O 
 
2.2.9 Molecular cloning 
Molecular cloning is a technique to integrate selected DNA sequences into a vector for 
amplification in bacteria. In order to get the vector and the integrated sequence amplified, the 
cloning vector must carry an origin of replication. Additionally, one or more prokaryotic 
antibiotic resistance genes are needed for selection. Molecular cloning was carried out using 
the Gateway recombination system [154], which is based on the site-specific recombination 
system found to be used by phage  to integrate its DNA in the E. coli chromosome. Both 
organisms have specific recombination sites called attP in phage  site and attB in E. coli. 
The integration process is catalyzed by 2 enzymes: the phage  encoded protein Int 
(integrase) and the E. coli protein IHF (integration host factor). Upon integration, the 
recombination between attB and attP sites (BP reaction) generate attL and attR sites that 
flank the integrated DNA fragment. The process is reversible and the excision is again 
catalyzed by Int and IHF in combination with the protein Xis. The attL and attR sites 
surrounding the inserted DNA recombine specifically during the excision event to reform attP 
and attB sites (LR reaction) (Figure 2-1). The method is advantageous to transfer DNA 
sequences back and forth between a common intermediate clone (the entry clone) and a 
variety of different destination vectors.  
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Figure 2-1 General Gateway cloning scheme. This diagram presents a schematic representation 
of the standard Gateway reactions, identifying the different plasmid types found in the BP (A) and LR 
reactions (B) along with the relevant selection markers.
 
For the cloning process attB sequences were attached to the sequence of interest via PCR 
amplification using PCR primers with incorporated attB sequences. In order to generate the 
entry clones, 50fmol of the PCR product was combined with 150 ng of the donor vector 
(pDONR™), containing attP sites and Gateway clonase enzyme. After incubation at 25°C for 
18h, 2 g of proteinase K was added to inactivate the BP-clonase and incubated for 15 min 
at 37°C. The entry clone was amplified by transformation into chemically competent E.coli 
Dh5  using kanamycine as a selection marker and the integration of the PCR product was 
confirmed by DNA sequencing through an external provider (Eurofins Genomics). 
In order to produce expression vectors, 100 ng of the entry clone was combined with 150 ng 
of the destination vector (pENTR™) and 2 l of LR-clonase. The reaction was incubated for 
18 h at 25°C and the recombination reaction was stopped with 2 g proteinase K for 15 min 
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at 37°C. The entry clone was amplified by transformation into chemically competent E.coli 
Dh5  using ampicillin as a selection marker and the correct size of the expression vectors 
were analyzed by restriction enzyme digestion. 
 
BP reaction  
pDONR™ (150 ng/ l) 1 l 
PCR product (50 fmol *) X l                 25°C/ 18h 
H20 2 l 
BP clonase 1 l 
Proteinase K 2 l                  37°C/ 15 min 
 
LR reaction  
pENTR™ (150 ng/ l) 1 l 
Entry clone (100ng) X l                  25°C/ 18 h 
H20 2 l 
LR clonase 1 l 
Proteinase K 2 l                   37°C/ 15 min 
 
2.3 Biochemical methods 
2.3.1 SDS-polyacrylamide gel electrophoresis (PAGE) analysis 
Separation of proteins by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was performed using 10 % separation and a 5 % stacking gels and 1x running buffer. 
For denaturation, the protein samples were diluted in the appropriate volume of 6x Laemmli 
sample buffer and heated to 95°C for 5 min. Electrophoresis was performed setting the 
power supply to 30 mA per gel with SDS-PAGE running buffer. The run was stopped when 
the dye front was 2 to 3 mm away from the bottom edge of the gel. The PageRuler 
“Prestained Protein Ladder” (Invitrogen) was used as a marker for protein sizes. 
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Buffer Composition 
4x Separation buffer 3 M Tris (pH 8.5), 0.4% SDS 
4x Stacking buffer 0.5 M Tris (pH 6.8), 0.4% SDS
10% Separation gel
2.5 ml H20, 2.5 ml separation buffer,  
5 ml acrylamide, 50 l 10% APS, 5 l 
TEMED
5% Stacking gel
2.5 ml H20, 1 ml separation buffer,  
500 l acrylamide, 40 l 10% APS,  
4 l TEMED
1x Running buffer 3.02 g Tris, 14.4 g glycine, 1 g SDS  in 1l ddH20
 
2.3.2 Western blot analysis 
After electrophoresis, proteins were transferred from the gel to a PVDF membrane, pore size 
0.45 m, using a wet blotting system and western blot transfer buffer. The wet transfer was 
performed setting the power supply to a voltage of 100 volt for 50 min. 
After plotting the membranes were washed in TBS-T buffer and blocked for 1 h at room 
temperature in blocking buffer. Subsequently the membranes were incubated for 2 h with 
the primary antibody, washed again and incubated with a HRP-conjugated secondary 
antibody for 1 h at room temperature. Membranes were washed 3 times for 10 min after 
incubation with each antibody. The HRP-reaction was visualized using the ECL-Plus 
chemiluminescence kit (Amersham BioScience) and the alpha imager HP-system. 
 
Buffer Composition 
TBS-T
10 mM Tris/base pH 7.5, 0.1 M NaCl, 
100 mM gylcine, 1 mM EDTA, 0.1% 
Tween 20
Western blot transfer buffer 10 mM Tris (pH 6.8), 0.4% SDS, 100 mM gylcine
Blocking buffer TBS-T, 5% fat free dry milk
Antibody buffer TBS-T, 5% BSA, 0.05% NaN3
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2.4 Immunological methods 
2.4.1 Virus infection assay 
Cell lines were plated in 48-well plates at a density of 5 x 104 cells per well and incubated 
over night. The next day the serum-containing medium was removed and the cells were 
infected with vesicular stomatitis virus (VSV) in serum-free medium at a multiplicity of 
infection (MOI) of 0.5 or Sendai virus at 40 U per ml diluted in Opti-MEM. After 1 h of 
incubation, extracellular virus was removed by washing with PBS and serum-containing 
DMEM medium. Cells were harvested at the given time points after the infection. 
2.4.2 TCID50 assay (tissue culture infectious dose 50%) 
This endpoint dilution assay is performed to quantify the unknown amount of infectious virus 
particles in a sample by comparison with a virus stock of known concentration. This assay is 
only possible for viruses that cause cytopathic effects (CPE) in the cell line used to perform 
the assay and defines to which degree the virus containing sample needs to be diluted to 
cause 50% of all cells in the assay to die.  
For the quantification of the TCID50 for VSV, 1x104 1205Lu cells were seeded into a 96-well 
plate to adhere over night. After adherence, a wild-type VSV stock solution with a starting 
concentration of 107 MOI/ml was diluted 1:10 in 150 l Opti-MEM in a separate plate with 96-
well format. Cells were washed in 100 l PBS per well and 100 l of virus dilutions were 
transferred onto the cell-containing 96-well plate. After 1 h of incubation, cells were washed 
in 100 l PBS per well and 100 l of culture medium was added. The samples were 
incubated at 37°C and monitored daily for CPE by microscopy over a period of one week. 
Wells containing living and dead cells were recorded and TCID50 values were calculated 
using a Reed-Muench calculator [155]. 
 
2.4.3 Enzyme-linked immunosorbent assay (ELISA) 
To measure the amount of IP10 and IL6 in the supernatant of cells, a ”sandwich” ELISA for 
IP10 and IL6 (BD Biosciences ,San Diego, CA, USA) was performed according to the 
manufacturer’s protocol.  
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2.4.4 Detection of apoptosis and cell death by flow cytometry using staining with 
annexin V and propidium iodide
Propidium iodide (PI) can be used in conjunction with annexin V to determine if cells are 
viable, apoptotic, or necrotic through differences in plasma membrane integrity and 
permeability. In viable cells, phosphatidylserine (PS) is located on the cytoplasmic surface of 
the cell membrane. However, in the early stages of apoptosis, PS is flipped from the inner to 
the outer leaflet of the membrane, exposing PS to the external cellular environment where it 
can be detected. Staining with fluorescein isothiocyanate (FITC) conjugated to annexin V, a 
calcium-dependent phospholipid-binding protein, provides a quick and reliable detection 
assay for studying the externalization of phosphatidylserine. Additionally, in late apoptotic 
and necrotic cells, the integrity of the plasma and nuclear membranes decreases, allowing PI 
to pass through the membranes, intercalate into nucleic acids, resulting in a red fluorescent 
signal [156]. 
For annexin-FITC and PI staining, cells were harvested and washed once in PBS and once 
in 1x binding buffer, respectively. The cells were resuspended in 1x binding buffer at a 
concentration of 5x106 cells per ml. 5 l of annexin V were added per 100 l cell suspension 
and incubated for 30 min on ice protected from light. The cells were washed in 1x binding 
buffer and resuspended in 200 l 1x binding buffer. 1 l of propidium iodide was added per 
sample and cells were analyzed by flow cytometry. 
 
2.5 Cell culture and cell fractionation 
2.5.1 General cell culture conditions 
All cell lines were cultivated at 37°C, 95% humidity and with a supplementation of 5% CO2. 
All experiments were performed under sterile conditions. When cells reached a confluency of 
approximately 80%, the medium was removed and cells were washed with PBS. Cells were 
detached by trypsin supplemented with 0.5% EDTA and diluted to the desired concentration 
in complete growth medium. For experimental procedures, cells were counted with a 
Neubauer hemocytometer. The viability of cells was determined using trypan blue, a dye 
selectively staining dead cells. In viable cells this stain is excluded, due to an intact 
membrane potential in these cells.  
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2.5.2 Transfection of cells with siRNA and expression plasmids  
For knockdown experiments via small-interfering RNA (siRNA), 5x104 cells were cultivated in 
24-well-plates in 200 l DMEM. Per well 10 pmol of siRNA and 1 l Lipofectamine RNAiMax 
were diluted in 25 l Opti-MEM each, and incubated separately for 5 min. The reagents were 
then mixed and incubated for another 20 min before they were transferred to the supernatant 
of the cells. siRNAs were transfected twice in a 24 h interval and knock-down efficiencies 
were controlled 24 h after the second transfection. 
For over-expression assays 5 x 104 cells were cultivated over night in 24-well-plates in 200 l 
DMEM. Per well 100 ng plasmid DNA and 0.5 l gene juice transfection reagent were diluted 
in 50 l Opti-MEM. After 20 min the complex of DNA and transfection reagent was added 
directly to the supernatant of cultured cells. Plasmids encoded GFP-fusion proteins which 
allowed verification of transfection efficiency 24 hours post transfection via immuno-
fluorescence. 
 
2.5.3 Purification and subfractionation of mitochondria 
For the isolation of mitochondria, a cell homogenizer (Isobiotec, Germany) was combined 
with 1-ml Luer Lock Gas-Tight syringes to mechanically rupture the cell membranes. The 
homogenizer was pre-cooled on ice to ensure cooling of the samples during the isolation. 
Before the isolation start, a 10 mm tungsten carbide ball was inserted and the homogenizer 
was equilibrated with isolation buffer (PBS supplemented with protease inhibitor cocktail for 
mammalian cell (Sigma-Aldrich)). 5 x 106 1205Lu cells were resuspended in 1 ml of isolation 
buffer and passed three times through the system. To recover the whole homogenate, the 
system was rinsed once with 1 ml of isolation buffer. The pooled homogenate was cleared 
from cell debris and nuclei by centrifugation (800×g, 5 min at 4 C) and the supernatant was 
collected to further purify mitochondria. 
 
2.5.3.1 Mitochondria purification via differential centrifugation 
To obtain a crude mitochondrial fraction the cleared homogenate was centrifuged at 9000×g 
(10 min at 4 C) and the mitochondria-containing pellet was resuspended in 50 l of isolation 
buffer. 
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2.5.3.2 Mitochondria purification via magnetic cell sorting 
The Mitochondria Isolation Kit (Miltenyi Biotech) was used to isolate intact mitochondria from 
1205Lu cells. This kit is based on the MACS (Magnetic Cell Separation) technology to isolate 
mitochondria from human cell lines and tissue. Two homogenates of 5x106 cells were 
prepared according to the protocol described in 2.5.3. The cell lysate was incubated with a 
monoclonal anti-TOM22 antibody covalently coupled to magnetic MicroBeads for 1 h under 
shaking conditions in separation buffer according to manufacturer’s protocol. This antibody 
specifically binds to the translocase of outer mitochondria membrane 22 (TOM22) of human 
mitochondria. The labeled cell lysate was loaded onto a midi-MACS column and placed in 
the magnetic field of a MACS separator. Labeled mitochondria were retained in the column, 
whereas unlabeled cell components were washed out as the column emptied by gravity. 
After removing the column from the magnetic field, the magnetically retained mitochondria 
were eluted with 1 ml separation buffer. The eluate was centrifuged at 13.000 x g and 
washed twice in 100 l PBS. At the end the mitochondria-containing pellet was resuspended 
in 50 l PBS. All steps were carried out at 4°C, buffers and solutions were kept on ice. 
 
2.5.3.3 Isolation of the outer mitochondrial membrane 
Mitochondria isolated from 8 x 107 1205LU cells via MACS according to the protocol 
described in 2.5.3.2 were pooled in 1ml PBS. After centrifugation (9000 g; 10 min; 4°C) the 
mitochondrial fraction was resuspended in 1 ml hypotonic buffer (20mM KPO4 supplemented 
with 0,2% BSA), causing swelling of the organelles and rupture of the outer mitochondrial 
membrane. After incubation on ice for 20 min, 2 M sucrose in 20 mM KPO4 was added to a 
final concentration of 0.75 M sucrose to achieve hypertonic conditions. The sample was 
incubated for additional 10 min. Ruptured Mitochondria were subsequently pelleted by 
centrifugation (16,000 g; 30 min; 4°C). After resuspension in 1 ml hypotonic buffer, the outer 
membrane was separated from mitoplasts by dounce homogenization. The sample was 
incubated with a monoclonal anti-TOM22 antibody covalently coupled to magnetic 
MicroBeads for 1 h under shaking conditions in 10 ml separation buffer (Mitochondria 
Isolation Kit (Miltenyi Biotech). The labeled mitochondrial fraction was loaded onto a midi-
MACS column and placed in the magnetic field of a MACS separator to recover the crude 
outer membrane. Antibody-labeled outer mitochondrial membrane was retained in the 
column, whereas unlabeled components were washed out as the column emptied by gravity. 
After removing the column from the magnetic field, the magnetically retained outer 
mitochondrial membrane was eluted in 1 ml separation buffer The eluate was centrifuged at 
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13.000 x g and washed twice in 100 l PBS and the pellet was subsequently resuspended in 
50 l PBS. All steps were carried out at 4°C, buffers and solutions were kept on ice. 
 
2.5.3.4 Proteolytic digestion of mitochondrial surface proteins 
Mitochondria isolated from 1x107 1205LU by MACS separation as described above were 
washed three times in PBS and resuspended in buffer A (20mM Hepes, 100 mM NaCl, 2 mM 
MgCl2 – pH7.4). The protein concentration of the sample was determined by Bradford assay. 
20 g Trypsin per 1 mg mitochondrial protein was added and incubated for 15 min on ice. 
Reaction was stopped with 1 mM PMSF (5 min, on ice). The sample was centrifuged at 
13.000 x g for 10 min to separate digested peptides from the remaining organelle. After 
centrifugation, the peptide-containing supernatant was collected ant immediately stored at 
-80°C. The mitochondrial pellet was washed twice in 100 l PBS supplemented with protease 
inhibitor cocktail (Sigma Aldrich) and was resuspended in 50 l PBS for western blot 
analysis. 
 
2.5.4 Immunofluorescence imaging by confocal microscopy 
For immunofluorescence imaging 5 x 104 1205Lu cells were cultivated on 12 m glass cover 
slips and fixed with 4% paraformaldehyde for 15 min at 37°C. Samples were carefully 
washed three times in PBS and permeabilization was performed using 0.2% Triton-X-100 for 
10 min at RT. Subsequently, samples were treated with blocking buffer (2% BSA in PBS-T) 
for 1 h at RT. The samples were incubated with the primary antibody (1 g/ml dilution in 
blocking buffer). After 3 washing steps in PBS-T (10 min; RT), the samples were incubated in 
fluorescently-labeled secondary antibody (1 g/ml dilution in blocking buffer). To stain DNA, 
samples were incubated with the DNA binding dye Hoechst 33342 (5 M) or DAPI (3 M), 
respectively, for 1 min at RT. 
For life cell imaging, 5 x 104 HEK cells or 1205Lu cells, respectively, were seeded into a 
CELLview glass bottom 4-compartment dish (Greiner bio-one) for adhesion over night. HEK 
cells were transfected with a VENUS-containing plasmid according to the protocol described 
in 2.5.2 and analyzed 12-24 h post-transfection. 1205Lu cells were infected with transgenic, 
GFP-bearing, VSVwt or VSV-M51R according to the protocol described in 2.4.1 and 
analyzed 8 h post infection. To stain DNA, samples were incubated with the DNA binding dye 
Hoechst 33342 (5 M) or DAPI (3 M), respectively, for 1 min at RT. 
Results were imaged using a Leica TCS SP5 confocal microscope. If not otherwise 
indicated, all steps were carried out at room temperature  
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2.5.5 Visualization of mitochondria via MitoTracker CMXRos staining 
In order to stain mitochondria, the cells were washed in PBS and incubated with 100nM 
MitoTracker CMXRos (Molecular Probes) in pre-warmed DMEM for 30 min at 37°C. Prior to 
fixation, the cells were washed twice in PBS. Mitochondrial distribution was assessed by 
confocal microscopy as described in 2.5.4.  
 
2.5.6 Quantification of mitochondrial ROS via MitoSOXTM Red 
MitoSOX™ Red (Thermo Fisher scientific) permeates live cells and selectively targets 
mitochondria where it is oxidized by superoxide but not by other reactive oxygen species 
(ROS) and reactive nitrogen species (RNS). The oxidized product is in turn highly fluorescent 
upon binding to nucleic acid. Due to its high selectivity for mitochondrial ROS, the dye is 
suitable for visualization and quantification of intracellular mROS levels. 
1205Lu cells were seeded into a 24 well plate or glass bottom dish, respectively, at a density 
of 105 cells per well and incubated over night for attachment. MitoSOX™ Red was added to a 
final concentration of 5 M according to the manufacturer’s recommendation and incubated 
for 30 min to allow entrance of the dye into the cell. Subsequently, cells were washed twice 
with PBS and prepared for analysis. For confocal microscopy, cells in glass bottom dishes 
were treated with Hoechst33342 (5 M) to stain nuclear DNA and analyzed using a Leica 
TCS SP5 confocal microscope. MitoSOX™ Red staining was captured at a wave length of 
580 nm. For FACS analysis, cells were treated with poly (I:C), 3pRNA and CO4 for 6 h and 
48 h, respectively. As a positive control, cells were treated with 100 M antimycin A for 6 h. 
Subsequently, cells were transferred to FACS tubes and washed three times in 1 ml PBS. 
For the determination of mitochondrial superoxide by flow cytometry, the measurements 
were carried out using FAScalibur (BD Bioscience). MitoSOX Red was excited by laser at 
488 nm in the FL2 channel. 
 
2.6 Stable isotope labeling of amino acids in cell culture 
1205Lu cells were cultured in SILAC-DMEM medium supplemented with ciprofloxacin, L-
glutamine, dialyzed FCS and the light or heavy isotopes of lysine and arginine (Pierce 
Bioscience, Bonn, DE), respectively. Arginine was supplemented at concentrations of 48 
g/ml and 42 g/ml, respectively. Lysine was supplemented at 146 g/ml. Cells were allowed 
to incorporate the labeled amino acids for six passages and lysates from labeled cells were 
prepared, trypsin digested and analyzed by LC-MS to determine the incorporation efficiency 
of the isotopes. Raw files were processed using MaxQuant [157]. 
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2.6.1 SILAC sample preparation 
Cells of the 1205Lu line were cultivated in light and heavy medium and one part of the 
population was stimulated with 1 g/ml poly (I:C) for the indicated period of time. After 
stimulation the cells were harvested by trypsinization and washed twice in PBS. The cell 
number was determined with a Neubauer counting chamber and mitochondrial fractions were 
prepared according to the protocol described in 2.5.3.2. The protein concentration in 
mitochondrial fractions was determined by Bradford assay. Based on their protein 
concentration, samples derived from cells cultivated with light derivates of amino acids were 
pooled in a 1:1 ratio with samples derived from cells cultivated with heavy derivates of amino 
acids. Pooled mitochondrial samples were centrifuged at 13.000 x g and washed twice in 
100 l PBS supplemented with a protease inhibitor cocktail (Sigma Aldrich). After washing, 
samples were resuspended in 50 l PBS. Optionally, the outer mitochondrial membrane and 
surface proteins were extracted from pooled mitochondrial samples as described in 2.5.3.3 
and 2.5.3.4, respectively. 20 g of each sample was retained for western blot analysis before 
subsequent preparation for mass spectrometry analysis. 
 
2.6.2 Sample preparation for mass spectrometry 
The generic workflow of shotgun proteomics starts with the extraction of proteins from the 
biological sample. Proteins are degraded into peptides by site-specific endoproteases (e.g. 
trypsin and lys-C) cleaned, desalted and concentrated. To efficiently resolve and identify 
peptides contained in complex mixtures, a combination of ultrahigh-pressure liquid 
chromatography (UHPLC) and high-resolution mass spectrometry with very high sequencing 
speed have proven most successful. During the MS scan, mass to charge (m/z) ratio and 
relative intensities of co-eluting peptides are detected. In order to gain sequence information, 
peptides are subsequently collected and fragmented and m/z ratios and intensities of ionized 
fragments are collected (MS/MS). These MS/MS scans employ two stages of mass analysis 
in order to analyze the fragmentation of a specific ion in a complex mixture of ions. This 
information is matched to in-silico peptide and protein databases to assign the corresponding 
amino acid sequences to each peptide. Software tools, such as MaxQuant [157], enable 
automated mapping of peptides and matching to corresponding proteins [129]. 
Samples, prepared as described in 2.5.3, were subsequently denatured in 6 M Urea / 2 M 
thiourea (U/T) in 10 mM HEPES (pH 8.0) and sonicated for 10 min in an ultrasonication bath 
on ice. Lysates were centrifuged for 15 min (14,000 rcf/ RT) and supernatants were 
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transferred into a clean eppendorf tube. Protein concentration was determined by the 
Bradford assay (OD595). 100 l reduction buffer was added to the sample and incubated for 
30 min at RT. Alkylation was performed by addition of 55 mM iodoacetamide and incubation 
for 20 min at RT in the dark. Samples were subsequently digested with Lys C (1 g LysC 
solution/50 g protein solution) for at least 3h at RT. Samples were diluted 1:5 with 50 mM 
ammoniumbicarbonate in order to reduce the U/T concentration to  2 Urea / Thiourea (U/T). 
One g trypsin solution per 50 g protein was added and the sample was digested over night 
at RT. For storage, samples were shock frozen and stored at -80°C. 
Mass spectrometry analysis was performed on a LTQ-Orbitrap, coupled to a nanoLC system. 
 
2.6.3 Analysis and processing of quantitative mass spectrometry data 
Raw files, generated by mass spectrometry analysis for each experiment, were processed 
using the open source program MaxQuant (version 1.1.1.35) [157]. Each raw file was defined 
as a separate experiment in the experimental design file to obtain peptide ratios for each 
peptide detected in each experimental condition. The derived peak list was searched with 
Andromeda [158] against the human International Protein Index protein sequence database 
(ipi.HUMAN.v3.68.fasta; 87,083 entries) supplemented with 262 frequently observed 
contaminants such as human keratins, bovine serum proteins, and proteases and 
concatenated with the reversed copies of all sequences. Parent masses and fragment ions 
were searched with initial mass tolerances of 7 ppm and 0.5 Da, respectively. False 
discovery rates (FDRs) at the peptide and protein levels were fixed at 1%, including 
automatic filtering on peptide length, mass error precision estimates, and peptide scores of 
all forward and reversed peptide identifications. Reported protein groups had to be identified 
by at least one “unique peptide” (a peptide assigned to a single protein group) in order to be 
accepted as positively detected. Quantification was performed calculating the light-to-heavy 
(L/H) peptide ratios, considering unique and razor peptides (peptides assigned to multiple 
protein groups) and a minimum of two ratio counts as a requirement. Unequal protein loading 
was corrected by normalization of peptide ratios. Assuming that the majority of proteins show 
no differential regulation, the median of their logarithms was equalized to zero [157].  
The obtained data was further processed using the Perseus software 1.3.0.3 (Max Planck 
institute of biochemistry). L/H ratios were converted into log2 values. Ratios of reverse 
labeling experiments were inverted beforehand. Cutoffs for proteins deemed as differentially 
expressed were set to a L/H ratio larger than 1.5. For each data set, proteins with positive 
detection in both labeling conditions in at least one stimulation time point were considered as 
positive hits. The gene ontology database [159] was used for the annotation of proteins as 
mitochondrial, cytoplasmic or nuclear according to the cellular component categorization. 
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2.7 Bioluminescence resonance energy transfer assay 
Protein-protein interactions in living cells were analyzed using bioluminescence energy 
transfer (BRET). To carry out BRET analyses, two proteins of interest are genetically fused 
to an energy donor protein (the luciferase RLuc) or to an energy acceptor (the uorescent 
protein VENUS), respectively, constituting a BRET pair. If the proteins of interest interact with 
each other the BRET-tags come into close proximity and energy transfer can occur after 
oxidation of a luciferase substrate. The detection limit for positive BRET signals is below 100 
Å. The resulting acceptor energy emission can be detected and, in proportion to the donor 
luminescence, results in the BRET ratio [160].  
 
Figure 2-2  Bioluminescence resonance energy transfer assay (A) Overview depicting the 
interaction of two proteins of interest fused to Renilla luciferase (Rluc) as energy donor and the fluorophore 
VENUS as energy acceptor, respectively. Energy transfer results in luminescence (BRET signal) when the 
proteins come into close proximity (<100 Å), indicative for a positive PPI. (B) Time line indicating the basic 
protocol for BRET assays. Adapted from Gersting et al. [160]. 
 
Nucleofection of HEK293 cells was performed using the Cell Line Nucleofector® Kit (100 
RCT) (Lonza, Cologne, Germany), applied in 96-cuvette nucleofection plates. For 
transfection, 1 g of the BRET expression vectors (with suitable acceptor to donor plasmid 
concentrations for screening or saturations experiments as described below) was diluted in 
10 l electroporation buffer in 96-well sterile V-bottom plates. Cells were harvested by 
trypsinization, centrifuged at 600 x g for 5 min at 37°C and resuspended in prewarmed 
electroporation buffer to a concentration of 1.5 x 107 cells/ml. 16.6 l of the cell suspension 
(2.5 x 105 cells) were added to the prepared BRET expression vectors and mixed carefully by 
pipetting up and down. 20 l of the DNA-cell-solution mix was transferred to the 96-cuvette 
nucleofection plates and transfection was performed using the Nucleofector II Device in 
combination with the transfection program optimized for HEK293 cells (CM-130).  
After nucleofection, 80 l of pre-warmed DMEM without phenol red was added to each 
reaction and mixed thoroughly. A volume of 50 l was transferred to 96 well plates with clear 
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bottom, prepared in advance with 150 l DMEM per well. 24 h post transfection, 170 l of the 
supernatant were aspirated and 70 l of 30 M Coelenterazine were added per well. The 
reaction mix was incubated for 2 min and signals were detected at 485 nm (hRLuc) and 535 
nm (BRET signal) over 60 s with a total of 60 intervals. Two types of control experiments 
were performed in triplicates for every plate: a plasmid coding for a YFP–Rluc fusion protein 
served as a positive control. As a device-speci c negative control, a construct expressing the 
Rluc-tagged protein of interest with a VENUS-containing construct without fusion partner  
was co-transfected. The BRET ratio measured was used as correction factor (cf) and 
subtracted from every BRET pair. BRET ratios were calculated based on the following 
equation: 
 
Figure 2-3  Equation for calculation of BRET ratios. R as BRET ratio, IA as intensity of acceptor 
luminescence emission at 535 nm, ID as intensity of donor luminescence emission at 485 nm, cf as 
correction factor (BRETcontrol/ RLuccontrol) 
 
In order to allow data evaluation, the positive control, the VENUS–Rluc fusion protein, should 
result in BRET ratios of around R=1.0. A positive interaction of two investigated protein pairs 
was assumed at R > 0.1. For screening experiments, transfection was performed in 
nucleofection plates in duplicates for each sample and a total plasmid concentration of 1 
g/well with a ratio of 3:1 of acceptor (VENUS) to donor (hRLuc) constructs was used. For 
saturation experiments, ratios of acceptor to donor vectors were increased sequentially. 
Specific interactions result in a hyperbolic curve of BRET signals with saturation at high 
concentrations of acceptor-labeled protein (BRETmax). By contrast, nonspecific interactions 
result in BRET signals that increase in a linear fashion with increasing concentrations of 
acceptor-labeled protein, due to random collision of donor and acceptor [161]. Saturation 
experiments can also be exploited to monitor relative binding affinities of interaction partners. 
A relative binding index can be determined measuring the acceptor to donor ratio at half 
maximal BRET (BRET50) [160]. 
 
2.8 Determination of oxygen consumption rates 
In order to measure the O2 consumption rate of cells in cell culture a XF96 extracellular flux 
analyzer (Seahorse Bioscience) was used. This device measures the rate changes over time 
of dissolved O2 and pH in medium immediately surrounding adherent cells. For this type of 
analysis 1205Lu cells were plated in XF96 culture microplates V3-Pet at 3x104 cells per well 
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in 80 l XF assay medium (Seahorse Bioscience) and allowed to attach and equilibrate over 
night in an incubator. For stimulation per well, 0.1 l Lipofectamine RNAiMax and 10-100 
ng/ml poly (I:C) and 1 g/ml 3pRNA were diluted in 10 l Opti-MEM each and incubated for 5 
min. After pooling, the reagents were further incubated for 20 min and then transferred to the 
1205Lu cells-containing wells of a XF96 culture microplate. Stimulation was performed 1h or 
16h prior to measurements.  
Measurements of O2 and pH were continuously taken over 4 min and the oxygen 
consumption rates were calculated from the slopes of the concentration changes in these 
parameters over time. The average of eight replicates was used for data analysis. Baseline 
rates were measured at six time points before addition of stressors by pneumatic injection 
into the micro chamber.  
The following stressors were applied in the given order and concentrations: 
Stressor Concentration 
Oligomycin 2 M 
FCCP 5 M 
Rotenon 2.5 M 
Antimycin A 2.5 M 
 
2.9 Statistics 
All data are presented as mean +/- SEM and were analyzed by unpaired Student’s t-test or 
by unpaired, one-way analysis of variance (ANOVA) with the Newman-Keuls multiple 
comparison test, where appropriate. In all analyses P < 0.05 was defined as significant. All 
statistic calculations were done with Prism GraphPad. 
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3 Results 
 
3.1 Characterization of changes in the mitochondrial proteome upon 
stimulation of RIG-I-like receptor signaling 
Antiviral signaling upon stimulation of RIG-I-like receptors is a complex and highly 
regulated process. Due to its location in the outer mitochondrial membrane studies 
focusing on the RLR adaptor MAVS hypothesized that the surfaces of mitochondria act 
as signaling platforms for antiviral immune responses. Identifying the components and 
their spatiotemporal changes of these mitochondrial signaling platforms might help to 
further understand antiviral responses. The aim of the first part of this study was 
therefore to analyze changes in the mitochondrial proteome upon stimulation of the 
RLR signaling cascade.  
In order to do that we established cell fractionation protocols, that allowed the 
extraction of proteins from complete mitochondria, or specifically from the mitochondrial 
surface and the outer mitochondrial membrane, respectively, and analyzed the isolated 
protein samples via quantitative mass spectrometry. As the strategy to identify 
quantitative changes in sample composition upon RLR stimulation, we used SILAC 
(stable isotope labeling of amino acids in cell culture) a method that is described to 
very sensitively capture changes in two sets of protein samples. In order to achieve 
strong and synchronized stimulation pattern in our mitochondria samples, we decided 
to use high doses of poly (I:C), the synthetic ligand for MDA-5, rather than a virus 
infection model for stimulation. To capture transient changes in protein levels at early 
and later time points after activation of RLR-dependent signaling samples were 
collected at different time points after stimulation.  
 
3.1.1 Identification of a suitable cell culture model 
We aimed for a cell culture model matching the following criteria: 1.) Susceptibility to 
virus infection and RIG-I-like helicase stimulation 2.) Cultivation possible in medium 
suitable for SILAC analysis 3.) Fully functional antiviral responses 4.) Suitability for 
mitochondria purification and sub-fractionation.  
Since SILAC relies on metabolic incorporation of labeling, primary cells are not 
compatible with SILAC [162]. Even though, immortalized cell lines are generally well 
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suited for SILAC, they can exhibit alterations in RLR-signaling cascade and IFN 
responses (e.g. HEK293 cells). After screening a series of human cell lines of different 
tissue origins we identified the human melanoma cell 1205Lu as the most suitable 
candidate for our purpose while the other cell lines failed one or more criteria. The 
1205Lu cell line has been used in previous studies on RLR-mediated signaling [94] and 
was additionally found to be suitable for cultivation in SILAC medium and mitochondrial 
purification protocols in our experimental setup.  
In these screening experiments, 1205Lu cells were tested for their susceptibility to 
viruses and sensitivity to RLR stimulation. 1205Lu cells were infected with 1 MOI 
recombinant VSV, expressing the viral P-protein fused to GFP for 8 h. Using 
fluorescent microscopy and as well as electron microscopy we found 1205LU cells to 
be readily infected by VSV (Figure 3-1E). 24h after stimulation with Sendai virus, VSV 
as well as poly (I:C) and 3pRNA we detected elevated levels of IP10 and IL6 in the 
supernatant of cells (Figure 3-1A and B) demonstrating an intact and working RIG-I-like 
helicase signaling pathway in these cells. In addition, we measured mRNA levels of the 
IFN-inducible genes RIG-I and PKR and observed induction of expression levels after 
stimulation compared to unstimulated cells (Figure 3-1C and D).  
 
3    Results 
47 
 
 
Figure 3-1  Characterization of the RLR signaling cascade in the 1205Lu cell line. 
1205Lu cells were transfected with 1 g/ml 3pRNA and poly (I:C) complexed with lipofectamine as 
well as infected with 5 MOI VSV and 40 U/ml Sendai Virus. 24 h post stimulation mRNA expression 
levels for (A) RIG-I and (B) PKR were analyzed by qRT-PCR relative to the housekeeping gene 
HPRT and are depicted as fold induction compared to expression levels of unstimulated cells. 24 h 
post stimulation protein levels for (C) IP-10 and (D) IL6 in the supernatant were analyzed by ELISA. 
Data are shown as mean ± SEM of n=3 (E) Confocal microscopy image of 1205Lu cells infected by 
recombinant VSV-GFP virus for 8h. Nuclei were stained by Hoechst (blue) (F) Electron microscopy 
analysis of a 1205Lu cell 1.5h post VSV infection (1600x and 25000x magnification, respectively); 
white arrow marks a virus particle entering the cell  
 
The MAVS-mediated antiviral immune response is dependent on its localization to the 
outer mitochondrial membrane [49]. Mitochondria typically form a reticular network 
radiating from the nucleus and create an interconnected system, complexly 
coordinated by fission and fusion events. The distribution and morphology of 
mitochondria in 1205Lu cells was determined using confocal imaging and a 
mitochondria-specific staining (MitoTracker mxROS). Mitochondria were found to be 
evenly distributed throughout the cytoplasm of the cells, forming a network of tubular 
structures (Figure 3-2). MAVS could clearly be located to mitochondria, indicated via 
the co-staining with the mitochondrial stain. Taken together these results indicate a 
functional RLH signaling pathway in 1205Lu cells. 
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Figure 3-2 Confocal imaging of mitochondria and MAVS distribution in the 1205Lu cell 
line. Mitochondria were stained with MitoTracker (red), MAVS is visualized by -MAVS antibody 
(green), DNA of the nucleus is shown in blue by DAPI staining 
 
3.1.2 Establishing protocols for purification and subfractionation of 
mitochondria
3.1.2.1 Evaluation of protocols for purification of mitochondria 
In order to sensitively capture alterations in the proteins associated with mitochondria 
upon stimulation of the RLR signaling pathway we aimed for sub-cellular fractionation 
of the cells to enrich mitochondria and decrease sample complexity. Since it is 
hypothesized that regulation processes take place mainly at the organelle’s surface 
facing the cytoplasm, we established methods to isolate the outer mitochondrial 
membrane (OM) and to extract the surface proteins via proteolytic digestion. This was 
guided by the expectation that mitochondrial subfractionation will reduce the complexity 
of the sample significantly and therefore will allow a more sensitive detection of 
changes in proteome composition. 
In general, isolation approaches for mitochondria require cell homogenization followed 
by subsequent steps of purification, which is commonly performed by differential 
centrifugation. However, the protocols differ dramatically with respect to initial 
homogenization and usually require adaptations to distinct cell types or tissues. In 
collaboration with Dr. Hans Zischka (Helmholtz Zentrum München), we optimized the 
initial rupture of the outer cell membrane through application of a new device and 
integrated this step into efficient and rapid protocols for purification and 
subfractionation of mitochondria. We had first screened several rupturing strategies, 
such as cell homogenization by glass potter, nitrogen cavitation and chemical 
treatments, for their capability to selectively break the plasma membrane, but not the 
mitochondrial membranes of our cell culture model. However these strategies did not 
lead reliably to sufficient yield and quality of isolated organelles for subsequent 
quantitative MS analysis. Finally, we applied a so-called Balch homogenizer [163], an 
accurately carved metal apparatus for high-precision cell breakage, as a device for the 
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homogenization of the samples. When combined with a high-precision pump system, 
this resulted in an exactly tunable, operator-independent cell homogenization unit that 
we termed the “pump-controlled cell rupture system” (PCC) (Figure 3-3). The PCC 
proofed to be generally applicable to the isolation of mitochondria from primary rat liver 
cells as well as a wide range of cell lines, such as our cell culture model, human 
melanoma (1205Lu) but also rat hepatoma (McA 7777), human hepatoma (HepG2), 
human cervical carcinoma (HeLa), and mouse embryonic fibroblasts (MEF). The 
device was found to be highly efficient for a gentle but efficient lysis of the sample, 
leaving nuclei and mitochondria intact [164].  
 
Figure 3-3 The pump-controlled cell rupture system (PCC). A high-precision pump (1) 
ensures, via gas-tight syringes (2), the continuous sample delivery (3) in a constant rate to the 
Balch homogenizer (4). Cell breakage occurs on passage through a defined clearance (square), 
which is adjusted by selecting tungsten carbide balls of different diameters (5). The cell 
homogenate is collected in a second syringe (6) and can be re-subjected to the homogenizer, 
which is thermally equilibrated by a cooling plate (7). Adapted from [164]. 
 
In order to further increase purity of the mitochondrial preparation, we combined the 
initial cell rupturing protocol with positive selection of mitochondria using the magnetic 
activated cell sorting (MACS) technology. The quality of mitochondrial samples, 
generated with this strategy, was assessed by western blot analysis. The results, 
shown in Figure 3-4A, demonstrate that in mitochondrial fractions isolated via MACS 
technology mitochondrial marker proteins (TOM40 and cytochrome C) were highly 
enriched while the cytoplasmic marker actin and nuclear marker protein histone H3 
were decreased to levels near the limit of detection compared to complete cell lysates. 
Using MACS for mitochondria isolation resulted in a purer mitochondrial fraction than 
the use of a simple protocol of differential centrifugation and in a higher yield than the 
use of a gradient centrifugation protocol (Figure 3-4A and data not shown). 
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In order to selectively analyze proteins associated with the mitochondrial surface, a 
protocol for proteolytic cleavage and digestion of surface associated proteins by the 
endoprotease trypsin was established. Enzyme concentrations were titrated to achieve 
an optimal proteolytic digestion of surface proteins without affecting mitochondrial 
integrity. Effectiveness of the process was analyzed by western blotting (Figure 3-4B). 
We found 3 g of trypsin per mg of protein sample to sufficiently digest cytosolic 
fractions of integral outer membrane proteins with alpha-helical transmembrane 
domains (e.g. MAVS). The abundance of proteins with a beta-barrel structure, such as 
VDAC, was strongly reduced after trypsin treatment. Proteins localized inside of the 
organelle, such as cytochrome C and COX IV, were unaffected by the digestion 
process. Based on these results 20 g of trypsin per mg protein sample were chosen 
for subsequent experiments. 
 
 
 
Figure 3-4 Evaluation of mitochondria isolation and subfractionation protocols.  
(A) Comparison of mitochondria isolated via differential centrifugation to isolated by MACS 
technology by western blot (B) Evaluation of surface protein extraction by proteolytic digestion with 
increasing amounts of trypsin by western blot (C) Western blot analysis of outer mitochondrial 
membrane fractions in comparison to complete mitochondria extracted by MACS technology. 
Western blots are shown as representative results of three independent experiments. Equal 
amounts of protein (20 g/lane) were loaded per fraction. (D) Electron microscopy image of 
complete mitochondria and the outer mitochondrial membrane fraction isolated by MACS 
technology. 
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We also established a MACS technology-based protocol for the purification of the outer 
mitochondrial membranes from 1205Lu cells. After purification, mitochondria were 
subjected to hypo- and hypertonic buffers to induce organelle swelling and rupture of
the outer mitochondrial membrane. The outer membrane fraction was separated from 
the remaining organelle by mechanic shear forces and positively selected using the
magnetic activated cell sorting (MACS) technology. Quality of the protocol was 
assessed by western blot of marker proteins specific for mitochondrial compartments. 
We found TOM40, a marker protein for the outer mitochondrial membrane to be
present in samples of complete mitochondria as well as outer mitochondrial membrane. 
Proteins of the inter-membrane space (i.e. cytochrome C) and the mitochondrial matrix 
(i.e. Hsp60) decreased to a non-detectable level in the outer membrane fraction. 
Contamination with proteins from inner mitochondrial membranes (i.e. COXIV) was still 
present in the outer membrane fraction, however strongly decreased in compared to 
unfractionated mitochondria (Figure 3-4C). 
In addition, we assessed the purity of mitochondrial and outer membrane samples by 
electron microscopy (Figure 3-4D). While complete mitochondria revealed an intact 
outer membrane, surrounding the inner membrane and a densely packed matrix, outer 
mitochondrial membrane preparation featured loosely distributed membranes without 
characteristic tubular morphology. However, the circular structures observed in these 
samples point towards contamination with inner mitochondrial membrane, still attached
to the outer membranes, thereby further confirming the results of the western blot 
analysis.
3.1.2.2 Proteomic analysis of mitochondrial fractions
To further assess the quality of the mitochondrial preparations, the proteome of whole-
cell lysates, complete mitochondria, mitochondrial outer membrane, and proteins 
cleaved of the mitochondrial surface extracted from 1205Lu cells with our protocols 
were analyzed by LC/MS. The identified protein groups were matched to the GO 
database [159] to assess their cellular localization (Figure 3-5AC). This showed an
increase of mitochondrial annotated protein groups from 14% (whole cell lysates) by 
three-fold to 42% (complete mitochondria), by four-fold to 68% (mitochondrial outer 
membrane) as well as to 61% (mitochondrial surface). The ratio of cytosolic and 
nuclear annotated protein groups strongly decreased after mitochondria purification 
and sub-fractionation, further confirming the data obtained by western blot analysis.
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Figure 3-5 Analysis of the GO term enrichment of protein groups for cellular localization. 
Samples of cell lysate (A), complete mitochondria (B), mitochondrial outer membrane (C), and surface proteins 
(D) were analyzed by LC-MS. Results show percentage of protein groups with annotations for cellular 
localization in relation to total amount of protein groups detected. 
3.1.3 SILAC: A tool for quantitative shotgun analysis of changes in the 
mitochondrial proteome upon RIG-I-like receptor signaling
3.1.3.1 Validation of the purification strategy
Stable isotope labeling by amino acids in cell culture (SILAC) allows high-accuracy 
quantitative proteomics. For SILAC, the entire proteome is labeled by metabolic 
incorporation of isotypically stable derivates of amino acids, giving rise to two or more 
distinct populations which can be exposed to differential physiological conditions. The 
labeling allows simultaneous analysis by mass spectrometry, giving rise to quantitative 
data. The method allows the combination of samples at a very early time point, 
reducing the risk of quantitative errors during subsequent processing up to the 
proteomic analysis. [127].
In order to achieve metabolic labeling, cells were cultivated in DMEM-SILAC medium 
supplemented with the heavy isotopes [13C6,15N4]-arginine and [13C6,15N2]- lysine and 
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their light counterparts [12C6,14N4]-arginine and [12C6,14N2]-lysine, respectively. To 
validate the metabolic interconversion of arginine and proline, we tested arginine 
concentrations of 48 μg/ml and 42 μg/ml. After an adaptation phase of six cell 
passages, we analyzed lysates of the heavy-labeled cell population by LC-MS to 
determine the proportion of labeled peptides as well as arginine-proline conversion 
rate. As a result, the cell population supplemented with 48 μg/ml arginine showed 
93.4% amino acid incorporation for all peptides, with labeling efficiencies of 90.9% for 
arginine peptides and 93.6% for lysine peptides, respectively. In the cell population 
cultivated with 42 μg/ml arginine we observed 96.7% amino acid incorporation for all 
peptides, with labeling efficiencies of 96.4% for arginine peptides and 96.6% for lysine 
peptides, respectively (Figure 3-6A). 
Isotope-coded arginine can be metabolically converted into the amino acid proline. This 
conversion results in multiple satellite peaks for all proline-containing tryptic peptides in 
the heavy state, which in turn affects the accuracy of quantitation. Conversion can be 
circumvented by titration of arginine in order to achieve concentrations in the media
suitable for cell viability but without excess of the amino acid. We analyzed proline-
containing peptides and did not observe arginine-proline conversions, irrespective of 
the arginine concentration (Figure 3-6B). On the base of these results, cells were 
cultivated in SILAC-DMEM supplemented with 42 μg/ml of arginine for subsequent 
experiments. 
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Figure 3-6 SILAC efficiency in labeled 1205Lu cells. (A) Overall incorporation rates 
evaluated by assessment of peptide ratios between labeled and unlabeled peptides. Ratios for all 
peptides are depicted in black, ratios for arginine peptides in red, ratios for lysine peptides in green. 
(Peptide counts - 48 μg/ml: n=1645; 42 μg/ml: n=950) (B) Violin plot depicting the amount and 
distribution of incorporation rates as log2 ratios for arginine-containing and arginine/proline-
containing peptides in cells cultivated in medium containing 48 μg/ml and 42 μg/ml arginine. The 
median of each data set is indicated by the black square.
3.1.3.2 Validation of the pooling strategy
A crucial parameter in the setup of SILAC experiments is an accurate pooling strategy 
for heavy and light samples. Mixing the samples early in the proteomics workflow 
makes the quantification independent of variations that may be introduced during 
sample preparation or LC-MS analysis, ensuring optimal accuracy. In the presented 
experimental setting, pooling of cells before homogenization would have been the 
earliest suitable time point. A major disadvantage of this strategy however is that virus 
infection might change the cell status and consequently susceptibility of the cells for 
homogenization and mitochondria purification. We therefore chose to pool our samples
after purification of complete mitochondria based on protein contents of the samples 
and assessed the quality of this strategy by LC-MS analysis. 
By pooling equal amounts of protein, we found the majority of all ratios of labeled and 
unlabeled peptides of the same sequence to be distributed around a 1:1 ratio in a 
Gaussian distribution (Figure 3-7A). As a control for the sensitivity of the method we 
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pooled mitochondria of heavy and light populations in 3:1 and 1:3 ratios (Figure 3-7B
and Figure 3-7C). Even though we observed a Gaussian distribution, the disparate 
pooling of protein contents resulted in a 1.5-fold shift in the mean distribution of the 
ratios. The results indicated an accurate pooling strategy, sensitive enough to capture 
changes in SILAC ratios. Consequently, the pooling strategy was used for subsequent 
SILAC experiments. 
Figure 3-7 Validation of the pooling strategy. Mitochondria extracted from cell populations,
cultivated with heavy and light isotopes, were mixed in ratios of (heavy:light) 1:1 (A), 3:1 (B) and 1:3 (C) based 
on protein content and analyzed by LC-MS. Depicted is the number of peptide counts plotted against the log2
values of the ratios of peptides with identical sequence containing either heavy or light arginines and lysines.
3.1.3.3 Quantification of changes in the mitochondrial proteome induced by 
agonists of RIG-I-like helicases via SILAC analysis
In order to assess proteomic changes induced by activation of RLR signaling we 
stimulated the populations labeled with heavy amino acids with transfected poly (I:C),
while the second unlabeled/light population was transfected with non-stimulatory 
control RNA. To take the highly transient character of protein interactions into 
consideration, we performed stimulations for 6 h, 1.5 h and 0.5 h prior to mitochondria 
purification (Figure 3-8). Additionally, we repeated the experiment with crossed-over 
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treatment conditions (stimulating the unlabeled cells, while treating the cells labeled
with heavy amino acids with the control RNA) to exclude the possibility of differences 
arising from SILAC labeling and experimental variations. Following stimulation, 
samples of complete mitochondria, mitochondrial surface and mitochondrial outer 
membranes were generated, resulting in three sample sets.
Figure 3-8 Overview of the experimental set-up of the SILAC experiments. Cells were conditioned 
with light and heavy isotopes of arginine and lysine, respectively, and stimulated with poly (I:C). 6h, 1.5h and 
0.5h post-stimulation mitochondria were extracted and pooled according to protein concentrations. For further 
sub-fractionation, mitochondrial outer membrane was isolated or surface proteins were extracted by trypsin 
digestion. After partial proteolytic digestion by trypsin, samples were alkalized, reduced and proteolytically 
digested and then analysed by LC-MS.
Prior to LC-MS analysis we assessed the quality of the purification procedure by 
western blotting (Figure 3-9A). As a result of the proteolytic digestion, MAVS was not 
detectable in samples after trypsin treatment. However, COX IV as an inner 
mitochondrial marker was detectable in all analyzed samples (Figure 3-9B). TOM40 
was also found to be enriched in all samples of purified outer mitochondrial 
membranes, compared to cytochrome C and Hsp60. However, the relative abundances 
of these marker proteins differed between preparations, indicating considerable sample 
variations most likely due to the multi-step purification procedure (Figure 3-9C).
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Figure 3-9 Quality assessment of SILAC samples by western blot prior to their 
analysis by mass spectrometry. The poly (I:C) stimulation pattern in each fraction is indicated by 
+ (stimulated population) and - (unstimulated population). (A) 20 μg of every mitochondrial fraction 
was analyzed for the enrichment of the mitochondrial markers TOM40 and MAVS and compared to 
20 μg of control cell lysates. (B) 20 μg of mitochondrial samples were analyzed after trypsin 
treatment for reduced abundance of outer membrane marker protein MAVS in comparison to 
unchanged levels of inner membrane marker protein COX IV (C) 10 μg of outer membrane samples
(OM) were analyzed for shifted abundances marker proteins TOM40 (OM), cytochrome C (IMS) 
and Hsp60 (Matrix) compared to10 μg of mitochondrial fractions (M). 
3.1.3.4 Analysis of the proteomic data sets
In collaboration with Dr. Felix Meißner our samples were analyzed in the laboratory of 
Prof. Matthias Mann by LC/MS on an orbitrap mass spectrometry device. The detected 
peptides were analyzed by MSQuant [165] and matched to corresponding protein 
groups. In a second step, contaminating hits, protein groups which could not be 
matched to true, human protein sequences, were subtracted from the dataset. In order 
to extract quantitative data indicative for up- or down-regulation of a protein, protein 
groups labeled by heavy and light amino acids were matched to calculate ratios based 
on intensities. 
In each of the three data sets, we considered protein groups with positive detection in 
both labeling conditions in at least one stimulation time point. As a result of this 
analysis, we were able to identify 1947 protein groups in complete mitochondrial 
samples, 1943 protein groups in the mitochondrial surface samples and 1015 protein 
groups in samples of the outer mitochondrial membrane (Figure 3-10). By separate 
analysis of each stimulation time point, we found peptide ratios to cluster in a normal 
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distribution around a 1:1 ratio, indicating a correct labeling status of the samples. 
MAVS as a representative marker protein for the mitochondrial surface and RLR 
signaling cascade was quantified in all except one experimental condition. The protein 
was expected to be equally abundant in all labeling populations and can be used as a 
marker that the pooling strategy worked correctly. Indeed peptides derived from MAVS 
showed ratios of heavy-labeled and unlabeled peptides of around 1:1. 
Figure 3-10 Analysis of three SILAC datasets combined. (A) Venn diagram depicting the 
number of protein groups detected per SILAC experiment (all stimulation time points combined) and 
overlapping hits within measurements (B) Overview of marker proteins and their presence in each 
dataset with (+) indicating positive detection and (-) indicating lack of detection. 
To identify mitochondria-associated candidate proteins that potentially play a role in the 
response to RLR-stimulation we screened the data sets for protein groups with at least 
1.5 fold up- or down-regulation in both labeling conditions in a time point dependent 
manner. The analysis gave rise to 25 regulated protein groups for the complete 
mitochondrial proteome, of which 19 hits were down-regulated and 6 hits were up-
regulated. For the mitochondrial surface proteome 32 regulated protein groups were 
detected with 23 down-regulations and 9 up-regulations, respectively, and in the outer 
mitochondrial membrane proteome 98 regulated hits were detected with 96 down-
regulations and two up-regulations. A complete list of all regulated proteins identified 
with their respective ratios is indicated in 8.4.
Furthermore, the generated datasets were screened for known marker proteins of 
antiviral signaling (Figure 3-10B). We did not find any of the RLR receptors or any of 
the known downstream effector molecules besides MAVS in the datasets. However, we 
were able to detect PCBP2, a negative regulator of MAVS in samples of mitochondrial 
surface proteins [64]. It was found to be 1.9 fold up-regulated after 1.5 h and 2 fold 
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down-regulated again after 6h post-stimulation compared to the unstimulated condition. 
Additionally, protein kinase R (PKR) was present in datasets of complete mitochondria 
and mitochondrial surface. The protein was five-fold down-regulated in the proteome of 
complete mitochondria in 5 of 6 stimulated conditions and in 4 of 6 stimulated 
conditions for the mitochondrial surface proteome. PKR was the only hit to be 
reproducibly regulated over time and in more than two experimental settings.
3.1.3.5 Bioinformatic annotation of cellular compartments
In order to annotate the identified protein groups to their respective cellular 
compartment, the datasets were matched to the Gene Ontology database [159] and 
filtered for a mitochondrial, cytosolic and nuclear localization (Figure 3-11). As a result 
we found 30.2% mitochondrial annotations 28.5% nuclear and 77.1% cytoplasmic 
annotations in datasets of complete mitochondria (Figure 3-11A). Analysis of the 
dataset from mitochondrial surface revealed 24.5% mitochondrial, 38.8% nuclear and 
75.1% cytoplasmic annotated hits (Figure 3-11B). For the dataset derived from 
mitochondrial outer membrane sample we observed 31.1% mitochondrial, 25.5% 
nuclear and 78.6% cytoplasmic annotations (Figure 3-11C). 
Figure 3-11 Analysis of protein groups per mitochondrial fraction in regard to 
annotations to cellular compartments. Protein groups were matched to the gene ontology 
database for cellular compartments (all stimulation time points combined). Depicted is the 
percentage and overlap of protein groups annotated to cytoplasm (light green), mitochondria (dark 
green) and nucleus (blue) relative to the overall number of detected protein groups (grey).
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3.1.4 Functional validation of candidate proteins selected from the mass 
spectrometry data set
3.1.4.1 Selection of candidate proteins for further functional evaluation
We next attempted to validate the SILAC quantification results on a smaller subset of 
proteins. For further evaluation, we performed literature research on the regulated 
proteins and screened for potentially interesting implications in antiviral signaling. 
Based on this analysis we chose 12 of these proteins as candidates for further 
functional test. Nine of the candidates were found to be down-regulated two candidates 
were up-regulated at one or more time points during SILAC analysis. Interestingly, the 
candidate protein PCBP2 showed up-regulation as well as down-regulation in the data 
set of mitochondrial surface. 
Figure 3-12 Overview of candidate proteins picked for functional analysis. Based on 
literature research twelve proteins were selected for further evaluation. Down-regulations in the 
SILAC data sets are indicated in red, up-regulations in green, conflictive regulation patterns are 
shown in yellow.
3.1.4.2 Functional analysis of candidate proteins
Two diverging approaches were considered for further analysis of the chosen 
candidates: Firstly, a confirmation of SILAC results by western blotting as an 
independent experimental approach. Secondly, a functional characterization of the 
proteins in context of cellular antiviral responses. 
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Recapitulation of regulation levels of the proteins by western blotting posed the 
challenge of highly transient association and dissociation processes during antiviral 
signaling and different sensitivity levels of the two assays. The analysis of previously 
published literature revealed two candidate proteins, namely EIF2AK and PCBP2, with 
already described implications in antiviral signaling [64, 166]. Expansion of the 
literature analysis additionally showed potentially interesting characteristics for the ten 
remaining candidate proteins and possible direct or indirect impact on antiviral 
signaling. We consequently chose the functional characterization of candidates over 
western blot analysis for initial analysis.
In order to test the impact of our candidate proteins on RLR dependent signaling or the 
release of infectious particles, we chose to perform a small-scale loss-of-function assay 
of the respective candidate protein via siRNA knockdown. Since these knockdown 
assays are simple to control and do not require elaborated establishment of specific 
cell lines, we chose this method over a complete knock-out or over-expression assays.
We designed two siRNAs for each of the 12 candidates and tested their knockdown 
efficiencies in 1205Lu cells by qRT-PCR. 48 h after transfection, we observed reduced 
expression levels for all target mRNAs by 50-95% compared to expression levels of 
control cells (Figure 3-13A). Furthermore, a cell viability assay was performed to 
exclude the possibility of increased cell death due to abrogation of potentially essential 
mRNA levels. As a result, we did not see reduced viability compared to control 
transfected cells (Figure 3-13B). Taken together, the data suggests a positive 
knockdown efficiency for all designed siRNA without affecting cell viability, hence being 
suitable for further experiments. 
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Figure 3-13 Evaluation of knockdown effects in 1205Lu cells. (A) Knockdown efficiency of 
siRNA targeting 12 candidate as well as components of the RLR signaling cascade were analyzed 
by qRT-PCR. Results are shown as fold regulation normalized to respective expression levels of 
mRNA from control transfected cells (B) Cell viability, detected by cell titer blue assay, after two 
transfections of siRNA. Absorbance was detected at 570 nm.
In order to test the implication of candidates for antiviral responses, we stimulated 
MAVS-dependent signaling by transfection of 1 μg/ml poly (I:C) 48 h after knockdown 
of candidate mRNAs. 6 h post-transfection, mRNA levels were analyzed for IFN-ß
expression. Knockdown of MAVS and MDA5 as components of the RLR signaling 
cascade served as an internal control for the experimental setup. As expected, 
knockdown of these targets led to a significant decrease in IFN-ß expression levels. 
Interestingly, we observed significant increase of expression levels after knockdown of 
HNRNPL by four fold. Furthermore, stimulation after knockdown of DDX18 and SOD2 
led to significant decrease of IFN-ß expression by two fold and 10 fold, respectively. 
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Figure 3-14 Validation of the impact of candidate proteins on antiviral signaling in loss-
of-function experiments. (A) Changes of IFN-ß expression relative to HPRT as a reference on 
mRNA level were analyzed by rtPCR after knockdown of candidate mRNAs for 48 h and stimulation 
with 1μg/ml poly (I:C) for 6h, shown is the fold induction, normalized to the non-targeting control 
CO4. Depicted are results from four independent experiments ±SEM (***P < 0.001, P < 0.05, by 
unpaired t-test). (B) Cells were infected with VSV 10 fold dilutions 48 h after knockdown. Shown are 
representative results of two independent experiments with four replicates. ±SEM (**P < 0.005, by 
unpaired t-test).
In addition we aimed to investigate the role of candidates for virus replication/infection. 
We infected HEK293 cells with VSV 48 h after knockdown and analyzed the amount of 
infectious particles by median tissue culture infective dose (TCID50) assay (Figure 
3-13). As expected, virus load increased from 3.2x107 by 10 fold to 3.2x108 in cells 
after MAVS knockdown compared to control cells. Strikingly, we observed a drastic 
decrease in virus titers by five fold in SOD2 knockdown cells to 5.6x104. Virus infection 
is a process composed of several steps (attachment, membrane penetration, virus 
uncoating, transcription and translation as well as assembly and release) and SOD2 
might also have an implication in any one of these steps. The drastically reduced 
susceptibility of the cell towards virus infection after depletion of SOD2 might thus be 
independent of the effect of SOD2 on antiviral signaling. On the other hand, it has 
previously been shown that expression of IFN type I is necessary to establish 
expression of viral genes [167]. The strong decrease of IFN- in SOD2-depleted cells 
might possibly affect the virus replication cycle.
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These results suggest SOD2 has a possible functional role in the context of antiviral 
signaling and virus infection. Further studies will have to investigate in more detail the 
role of SOD2 and the other candidates in antiviral immune responses. 
3.2 The interplay between mitochondrial function and RIG-I-like receptor 
signaling
3.2.1 Respiration rate is decreased after stimulation of RIG-I-like receptor 
signaling
Mitochondria are an integral platform for antiviral signaling, apoptosis, ATP production 
as well as stress sensing and it has previously been shown that antiviral signaling is 
intimately linked to mitochondrial function [168]. In the following experiments we aimed 
to investigate if mitochondrial function is in return influenced by RLR and MAVS 
activation and specifically investigated if MAVS-dependent signaling alters the 
mitochondrial respiration rate.
In order to investigate the mitochondrial oxidative phosphorylation, we determined the 
oxygen consumption rate (OCR) using the label-free Seahorse XF96 assay. OCRs 
were analyzed in cells stimulated with transfected poly (I:C) and 3pRNA, both synthetic 
activators of RLH and MAVS-dependent signaling, as well as untransfected poly (I:C) 
and LPS, ligands for TLR3 and TLR4, respectively. 1 h and 16 h were selected as time 
points for the analysis to capture effects directly after pathway activation and effects 
taking place in the IFN type I feedback loop (Figure 3-15). 
1h after transfection of poly (I:C) or 3pRNA we found OCRs to be reduced by 10% 
compared to the OCR from control-transfected cells. This effect was increased over 
time, leading to a reduction of OCRs by 75% and 20% 16 h after RLH activation with 
poly (I:C) and 3pRNA respectively, in comparison to unstimulated control cells. Upon 
stimulation with untransfected poly (I:C), we did not observe significant changes of 
OCRs relative to unstimulated cells, regardless of the time points analyzed. Stimulation 
of cells with LPS led to a decrease of the cell’s respiratory rate by 22% after 1 h 
compared to control. Strikingly however, this effect of LPS was abolished 16h post 
stimulation.
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Figure 3-15 Analysis of basal OCR upon stimulation of innate immune signaling. 1205Lu 
cells were stimulated with transfected 100 ng/ml poly (I:C), 1 μg/ml 3pRNA and 100 ng/ml CO4 
RNA, as well as 5 μg/ml untransfected poly (I:C) and 10 ng/ml LPS. Basal OCRs were assessed 1h 
(A) and 16h (B) post stimulation. Depicted are representative results from three independent 
experiments performed as sextuplicates, respectively. Data is given as mean ± SEM of n=6. (***p <
0.001, **p < 0.01, *p < 0.05, by unpaired t-test.
We next aimed to investigate if there was a dose-dependency of the effect observed for 
poly (I:C) transfection. For this reason we transfected cells with two different 
concentrations of poly (I:C) and assessed the OCR 1 h later. We found, that already 
10-fold less concentrated poly (I:C) was sufficient to induce the same level of reduction 
of OCR in 1205Lu cells 1 h post transfection (Figure 3-16).
RLR activation is known to be able to induce apoptosis [94]. In order to exclude the 
possibility that changes in OCR are a result of differences in cell number due to cell 
death induction by poly (I:C) we measured protein concentration via bradford assay 
and looked for apoptosis and cell death using flow cytometry after annexin/PI staining 
in the cells that were assayed in the Seahorse XF96 analyser. According to these
assays we observed no significant changes in protein mass or viability after stimulation 
(Figure 3-17). 
3    Results
66
Figure 3-16 Analysis of OCR upon stimulation with different poly (I:C) concentrations. 
1205Lu cells were transfected with 10 ng/ml, 100 ng/ml poly (I:C) and 100 ng/ml CO4 RNA. Basal 
OCRs were assessed 1 h post stimulation. Depicted are representative results from three 
independent experiments performed as sextuplicates, respectively. Data is given as mean ± SEM 
of n=6. (***P < 0.001, **P < 0.01, *P < 0.05, by unpaired t-test).
Malignant transformation of cells (e.g. during tumor development) is also often 
characterized by increased aerobic glycolysis, leading to decreased oxygen 
consumption despite the presence of oxygen in the environment. This metabolic shift is 
known as the Warburg effect [169]. However, under physiological conditions non-
mitochondrial respiration represents only 10% of the oxygen consumption and 
oxidative phosphorylation is the main source for differentiated cells to generate ATP
[170]. The process of oxydative phosphorylation relies on a tightly controlled interplay 
between the membrane bound electron transport chain complexes I-V. Deregulation of 
one of these complexes can ultimately lead to alterations in mitochondrial respiratory 
capacities.
To address the question if stimulation of innate immune signaling leads to alteration of 
distinct parameters in mitochondrial respiration we performed a mitochondrial 
bioenergetic profile on cells transfected with poly (I:C), control-transfected cells and 
unstimulated cells using the XF96 Seahorse analyzer. In order to assess the specific 
aspects of mitochondrial respiration namely basal respiration, O2 used for ATP 
turnover, O2 spend by proton leakage, maximum respiration capacity and non-
mitochondrial respiration the cells were exposed to inhibitors of the electron transport 
chain at subsequent time points and the OCR was determined over a period of 2 h
(Figure 3-18A). The ATP synthase inhibitor oligomycin was applied to give information 
on the amount of oxygen specifically utilized for the generation of ATP. Subsequent 
addition of FCCP, a protonophore disrupting the membrane potential of the inner 
mitochondrial membrane and leading to accelerated electron transportation without the 
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production of ATP, was used to investigate maximal oxidative capacity of mitochondria. 
Finally, antimycin A and rotenone (inhibitors of complex III and complex I, respectively) 
were added to block mitochondrial respiration per se, giving information on 
mitochondria-independent oxygen consumption 
Figure 3-17 Assessment of viability upon stimulation of innate immune signaling. 
(A) Assessment of protein concentration via bradford assay was performed after every OCR 
analysis. Each data point represents average of 8 values ± SEM. p-values for poly (I:C) and 3pRNA 
transfected groups were calculated relative to CO4 control groups, p-values for untransfected poly 
(I:C) and LPS stimulated groups were calculated relative to unstimulated group. Depicted are 
representative results from six independent experiments (ns, by unpaired t-test). (B) 1205Lu cells 
were stained for propidium-iodide as a reference for cell death 16h after transfection of 100 ng/ml 
poly (I:C), 1 μg/ml 3pRNA and 100 ng/ml CO4 RNA, as well as 5 μg/ml untransfected poly (I:C) and 
10 ng/ml LPS. Shown are means of three independent experiments ± SEM, p-values for poly (I:C) 
and 3pRNA transfected groups were calculated relative to CO4 control groups, p-values for 
untransfected poly (I:C) and LPS stimulated groups were calculated relative to unstimulated group 
(ns, by unpaired t-test). 
In cells that have sufficiently active glycolysis to support metabolism while 
mitochondrial function is manipulated, all of the major aspects of mitochondrial coupling 
and respiratory control can be measured in a single experiment [171]. The sequential 
addition of the ATP synthase inhibitor oligomycin, the protonophoric uncoupler FCCP, 
and the electron transport inhibitors such as rotenone and antimycin A allows 
determination of basal respiration, ATP turnover, proton leak, coupling efficiency, 
maximum respiration rate, apparent respiratory control ratio, spare respiratory capacity 
and non-mitochondrial respiration (Figure 3-18 A). Basal respiration rates, usually 
strongly controlled by ATP turnover and partly by substrate oxidation and proton leak 
[172], were assessed before the addition of stressors (Figure 3-18 B. condition a). The
rate of oxygen consumption devoted to mitochondrial ATP synthesis was estimated 
from the decrease in respiration upon inhibition of the ATP synthase with oligomycin 
(Figure 3-18 B. condition c) and the respiration rate in the presence of oligomycin 
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(Figure 3-18 B, condition b) was taken as a direct measurement for proton leak across 
the mitochondrial membrane. Maximum respiration rates were assessed by addition of 
the uncoupler FCCP (Figure 3-18 B, condition d). The remaining oxygen consumption 
in the presence of rotenone and antimycin A allowed the determination of non-
mitochondrial respiration (Figure 3-18 B, condition e) and was subtracted from all other 
rates. 
As a result, we observed significant reduction of oxygen consumption devoted to ATP 
synthesis in poly (I:C)-stimulated cells compared to control cells, whereas oxygen 
consumption for maximal mitochondrial respiration and proton leak were unaltered 
(Figure 3-18 C). These results imply that the reduced oxygen consumption after poly 
(I:C)-dependent MAVS activation is caused by a specific down-regulation of 
mitochondria-mediated ATP synthesis.
Figure 3-18 Oxygen consumption rate upon transfection with poly (I:C) in the presence 
of stressors of the mitochondrial respiratory chain. (A) OCRs were assessed in 1205Lu cells 
1h after transfection of poly (I:C) (10 ng/ml and 100 ng/ml) and 100 ng/ml CO4 RNA. Oligomycin (1 
μM), FCCP (10 μM), antimycin A (1 μM), and rotenone (1 μM) were injected at subsequent time 
points as indicated. Shown are the results of one experiment representative of two with 8 replicates 
presented as mean ± SEM, p-values were calculated relative to CO4 control group (* p < 0.05, by 
unpaired t-test). (B) Schematic of a representative respiratory control experiment, indicating basal 
OCR (a), proton leak (b), ATP turnover respiration (c), maximal respiration (d) and non-
mitochondrial respiration (e). (C) Based on the data generated in (A), relative OCR level ± SEM
devoted for ATP consumption, maximal respiration rate and proton leak were calculated. p-values 
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were calculated by unpaired t-test for poly (I:C)-transfected experimental conditions relative to CO4 
control group and the CO4 group relative to the unstimulated condition.
3.2.2 No changes of components of the respiration chains upon stimulation
The regulation of mitochondrial respiration activity can be accomplished by several 
means. The simplest mechanism involves the feedback of substrates for an enzymatic 
reaction, such as ADP and Pi, for the ATP synthetic reaction. However, it has been 
shown in several systems, such as the heart, that large changes in mitochondrial 
synthetic rate are not associated with significant alterations in the substrates for ATP 
production or the net free energy in cytosolic ATP [173]. Altered respiratory rates can
furthermore result from uncoupling of the respiratory chain and from altered expression 
levels of components of the ETC complexes [174-176]. The major mechanism for 
modulating mitochondrial respiration rates however involves covalent posttranslational 
modifications (PTMs) to alter the activity of single respiratory chain complexes [177-
179]. Furthermore, PTMs have been shown to modulate the activity of mitochondrial 
respiratory chain complexes to allow metabolic homeostasis in the face of persistent 
and acute changes in energy demand [180].
To examine whether the reduced OCR upon stimulation of MAVS-dependent signaling 
might be caused by alterations in expression levels of ETC complexes, we performed 
western blotting with an OXPHOS antibody cocktail, recognizing subunit I-V of the 
ETC. 24 h after exposition to transfected poly (I:C) and 3pRNA, as well as
untransfected poly (I:C), the relative expression of components of the ETC was not 
altered in comparison to control cell lysates (Figure 3-19A). However, the stimulation of 
poly (I:C) and 3pRNA led to increased protein levels of IP-10 in the supernatant of the 
cells, indicating a robust activation of RLR signaling after stimulation with poly (I:C) and
3pRNA.
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Figure 3-19 Western Blot analysis of OXPHOS complexes I-V in lysates after 24h 
stimulation with RLH ligands. (A) Expression profile of complex I-subunit  NDUFB8, complex II-
30kDa, complex III-Core protein 2, complex IV-subunit I and complex V-alpha subunit of 1205Lu 
cells transfected with 100 ng/ml poly (I:C), 1 μg/ml 3pRNA and 5 μg/ml poly (I:C) (untransfected) to 
cells untreated and cells transfected with CO4 were compared. (B) Supernatants of the cells were 
analyzed for IP10 levels by ELISA. Data are shown as mean ± SEM of n=3. 
3.2.3 ROS levels are unaltered in response to RLR stimulation
Reactive oxygen species (ROS) have previously been shown to be implicated into 
modulation of MAVS-dependent signaling [150]. Given that alterations of the 
respiratory chain can cause elevated levels of ROS besides decreasing the OCR, we 
examined mitochondrial ROS levels in cells 6h and 48h post-transfection of poly (I:C) 
and 3pRNA. We used staining with MitoSox, a fluorescent dye activated by 
mitochondrial superoxide oxidation, followed by analysis with confocal microscopy and 
FACS to measure mitochondrial ROS production. As expected the MitoSox dye was
specifically targeted to mitochondrial structures, as shown in confocal microscopy 
(Figure 3-20A). Compared to a positive control consisting of treatment with the complex 
III inhibitor antimycin A no relevant induction of mitochondrial ROS was seen 6 h and 
48 h post stimulation with poly (I:C) and 3pRNA, (Figure 3-20B). Taken together, the 
data indicate that activation of MAVS-dependent signaling affects mitochondrial 
function leading to decreased respiratory O2-consumption, without excess generation 
of mitochondrial ROS.
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Figure 3-20 Analysis of mitochondrial ROS levels upon RLR stimulation. (A) Confocal 
microscopy analysis of 1205Lu cells stained with MitoRos. MitoROS stain is shown in red, nucleic 
DNA was stained by Hoechst, shown in blue. (B) FACS analysis of mitochondrial ROS levels by 
MitoSOX stain in 1205Lu cells stimulated with 100 ng/ml poly (I:C) and 1 μg/ml 3pRNA for 6 h and 
48 h and 1205Lu cells treated with 100 μm antimycin A for 6 h. Data are shown as mean ± SEM of 
n=3. 
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3.3 MAVS signaling depends on peroxisomal integrity
MAVS was initially described as a strictly mitochondrial protein, but was recently also 
detected at peroxisomal membranes. Peroxisomal MAVS has been shown to be 
important for an adequate antiviral response, establishing a transient anti-viral state in 
cells independent of IFN type I [50]. In order to get clues for the molecular basis of 
MAVS-mediated signaling on peroxisomes and the translocation of MAVS to 
peroxisomes a BRET assay was used in collaboration with the Molecular Pediatrics 
laboratory of Prof. A. Muntau at the Dr. von Hauner Childrens’ Hospital (LMU, Munich) 
to screen a library of peroxisomal proteins for interaction partners of MAVS. To study 
location-specific interactions of MAVS, we generated and implemented three differently 
targeted variants of MAVS into the screen with localization in both organelles 
(MAVSwt) or exclusively on mitochondria (MAVSmito) and peroxisomes (MAVSpex), 
respectively. The protein STING, previously described as interacting with MAVS [56],
was additionally included in the screen.
BRET is a powerful tool for the evaluation of protein-protein-interactions (PPIs). The
method provides enhanced sensitivity in living cells compared to other techniques, 
such as fluorescence resonance energy transfer (FRET) as it does not require an 
external excitation source, which often results in photo bleaching or auto-fluorescence.
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3.3.1Identification of interaction partners of MAVS in the peroxisomal proteome
3.3.1.1 Construction and validation of MAVS and Sting plasmids for BRET-
assays
BRET relies on the fact that the energy derived from a luciferase reaction can be used 
to excite a fluorescent protein if the latter is in close proximity to the luciferase enzyme.
In our setting BRET was used to test if luciferase-fused donor proteins interact with-
acceptor proteins fused with the YFP-variant Venus. However, the fusion of a protein to 
the Venus fluorescent protein or luciferase can alter its location, function and the 
capacity for interaction with other proteins. Whether this happens can depend on the 
location of the fusionprotein at the C or N-terminus. To increase our chances of 
functional interactions, we therefore used N-terminal as well as C-terminal tags for both 
interaction partners in our screen. This resulted in eight possible combinations of the 
differently fused variants for every tested protein pair. 
First, we cloned the cDNAs of STING and the MAVS variants into BRET vectors 
bearing the required tag combinations. To confirm different localization of the VENUS-
tagged MAVS proteins after over-expression, we used confocal imaging and co-
staining of mitochondria with a mitotracker dye. We could see an expected localization 
pattern for all N-terminally tagged proteins. STING-N-VENUS showed the expected
partial overlap with mitochondrial stain [56]. MAVSwt-N-VENUS also showed overlap 
with mitochondrial stain. However, next to this tubular pattern, also dotted structures 
were visible with no co-localization to mitochondria, resembling the distribution 
previously described by Dixit and colleagues [50]. MAVSpex-N-VENUS showed a 
distribution compatible with the expected peroxisomal localization and MAVSmito-N-
VENUS showed an exclusively mitochondrial localization. Due to interference of the 
fusion protein with the C-terminal transmembrane/localization sequence C-terminally 
tagged MAVS proteins were mislocalized to the cytoplasm. We therefore concluded 
that at least addition of N-terminal tags to MAVS variants and STING did not affect its 
localization and its capacity to interact with proteins in a physiological setting.
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Figure 3-21 Life cell imaging to localize VENUS-fusion variants of MAVS targeted to 
mitochondria and peroxisomes respectively. Hela cells were transfected with VENUS tagged 
MAVS constructs 24h prior to analysis (green). Mitochondria were stained by MitotrackerRed (red). 
Nuclei were stained by Hoechst (blue).
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To validate our BRET system we first tested the previously described interaction of 
MAVS and STING [56, 57] as binary interaction in our BRET set-up. A positive 
interaction between a protein pair was assumed if at least one out of eight tested tag 
combinations resulted in a BRET ratio above 0.1, which is a method-specific threshold. 
Co-transfection of both N-Luc-MAVS with N-Venus-STING and N-Luc-STING with N-
Venus-MAVS resulted in BRET ratios above the method-specific threshold for positive 
PPI (Figure 3-22B). Co-transfection of variants with C-terminal fusion-tags did not 
result in positive BRET ratios, most likely due to mislocalization of the proteins. 
Figure 3-22 Determination of binary protein interactions of MAVSwt and STING by BRET 
(A) Overview of N- and C-terminal fusion constructs for BRET donors (hRLuc) and acceptors 
(VENUS) using MAVSwt as an example. (B) MAVSwt and STING were co-expressed in HEK cells 
with varying hRLuc and VENUS fusion-tag combinations. BRET ratios above the threshold of 0.1 
indicated by the dashed line are considered positive.
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3.3.1.2 Screening for novel interaction partners
In order to screen for interaction partners within the peroxisomal proteome, a library of 
BRET vectors for 120 peroxisomal proteins was tested, established previously by the 
Molecular Pediatrics laboratory. We co-transfected all possible combination of the 120 
constructs with combinations of our MAVS- as well as STING-constructs and 
determined their BRET ratios.
As a result, positive interactions between MAVSwt and seven proteins, MAVSmito and 
nine proteins as well as MAVSpex and nine proteins were detected. Additionally, 
STING was found to interact with two proteins of the peroxisomal proteome (Figure 
3-23). Respective BRET ratios of the interaction partners are depicted in 8.5.
Based on gene ontology database analysis, we were able to assign several interaction 
partners to three functional entities, i.e. acyl-CoA hydrolysis, peroxisomal import and 
biogenesis as well as peroxisomal division. In conclusion, we were able to find 21 new 
interaction partners for MAVS in the peroxisomal proteome, suggesting links of MAVS 
to several peroxisomal functions. Additionally, two novel interaction partners for STING,
acyl-CoA synthetase long-chain family member 6 (ACSL6) and D-aspartate oxidase 
(DDO) were identified.
Figure 3-23 Network of positive binary protein interactions determined in a BRET-
screening assay. Depicted are 24 positive PPIs detected for MAVSwt, MAVSpex, MAVSmito and 
STING. Each line connecting two nodes represents a positive interaction of the respective protein.
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3.3.1.3 Validation of positive interactions by saturation experiments
In order to validate the results of the BRET-screen, we performed BRET saturation 
experiments. 11 of the previously obtained candidates were co-expressed with the
MAVS variants in HEK293 cells at increasing acceptor to donor ratios. BRET ratios 
were measured, followed by nonlinear regression analysis. R2 measurement for 
goodness of fit was performed and values of R2 > 0.8 were considered as positive 
interactions.
Consistent with the results of the screening assay, a strong positive interaction of 
MAVSwt, MAVSmito and MAVSpex with STING was observed in these saturation 
experiments. In addition, we confirmed the interaction of Pex11G with MAVSwt and 
MAVSpex. Interestingly, the saturation profile of Pex11B, an isoform of Pex11G, did 
not give positive results for interaction with any MAVS constructs. Specific interactions 
were also confirmed for Pex19 and Fis1 with MAVSwt and MAVSpex and for SOD1 
and ACOT1 with MAVSwt and MAVSpex, respectively. PMVK interacted with all MAVS 
variants, whereas positive interactions of MVK were only observed for MAVSpex. 
Positive interactions could not be confirmed for ACSL4 and ACSL6 (Figure 3-24A).
Figure 3-24 Characterization of protein interactions by saturation experiments. (A) 
Overview of binary interactions between MAVS localization variants and 11 candidates, tested by 
saturation experiments. Confirmed positive interactions based on R2 calculations are depicted in 
green, negative interactions are shown in red (B) Saturation curves extracted from binary 
interactions of MAVSwt, MAVSmito and MAVSpex with STING.
Furthermore, we used saturation assays to analyze structural characteristics of the 
interaction between STING and MAVS localization variants (Figure 3-24B). After 
sequential increase in the ratio of VENUS-tagged MAVS over hRLuc-tagged STING, 
BRET ratio showed a hyperbolic behavior, characteristic for positive interactions. The 
BRET signal at which the saturation curve plateaus (BRETmax) is a function of the 
distance and orientation between the donor and acceptor within oligomeric 
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conformation, whereas the concentration of acceptor giving 50% of BRETmax (BRET50)
is a reflection of the relative affinity between fusion proteins and BRET50 values 
inversely correlate with the strength of affinity [161]. The interaction of STING-MAVSwt 
occurred with a BRETmax value of (0.8997 SD±0.05076). Interestingly, this was almost 
two-fold higher compared to BRETmax values calculated for STING-MAVSmito (0.5262 
SD±0.1165) and STING-MAVSpex (0.5968 SD±0.04177), suggesting different 
structural conformations of the respective binding partners. Analysis of BRET50 values 
revealed similar binding affinities for STING to form heterodimers with MAVSwt 
(BRET50 5.465, SD±0.8223) and MAVSpex (BRET 50 6,339, SD±1,113) and a two-fold 
lower binding affinity for MAVSmito (BRET50 12.07, SD±5.215), indicating that STING 
appears to be far more likely to interact with MAVSwt and MAVSpex compared to
MAVSmito.
In conclusion, we confirmed an already described interaction of MAVS and STING via 
BRET saturation experiments. However, a previously performed BRET-based study on 
MAVS revealed that the transmembrane domain of the protein has a strong influence 
on the capacity for homo-oligomerization of MAVS, reflected by varying BRETmax
values. Since MAVS localization variants are equipped with differing transmembrane 
domains and it is not known to this point, if homo-oligomerization influences the 
capacity of MAVS to interact with STING, it seems difficult to conclude whether 
differences in BRETmax and BRET50 are caused by variations in binding affinities due to 
the localization or by variations e.g. in the ability to form multimers due to the method 
used to design the localization variants.
3.3.2Fibroblasts from patients with Zellweger syndrome show defects in RIG-I-
like receptor signaling
A finding obtained from the previous experiments was the interaction of MAVS with a 
variety of peroxins. We therefore reasoned a possible impact of this protein family in 
MAVS-mediated antiviral signaling. Given, that MAVSwt and MAVSpex specifically 
interacted with PEX19, we aimed to test the impact of this protein on innate immune 
signaling in a natural loss-of-function mutant. We used PEX19-deficient fibroblasts,
isolated from a patient with Zellweger syndrome and analyzed IFN-ß and ISG 
responses on mRNA level after stimulation with the synthetic ligands poly (I:C), dAdT, 
CpG DNA and IFN-ß for 24h compared to wild-type fibroblasts (Figure 3-25A). 
Strikingly, we found IFN-ß expression to be strongly reduced after poly (I:C) 
transfection in PEX19 deficient cells. Of note, we could exclude that this effect is due to 
an increased induction of cell death in PEX19-deficient cells bv poly (I:C). Transfection 
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of the synthetic DNA analog dAdT also resulted in diminished IFN type I responses in 
the absence of Pex19. Stimulation with the TLR9 ligand CpG DNA did not lead to 
activation of immune signaling in either of the two cell lines. This is most likely 
explained by the absence of functional TLR-9 in these fibroblast cell lines. Upon 
stimulation with IFN-ß, we could show elevated expression of the ISG RIG-I. However, 
this response was found to be equally strong in PEX19-deficient cells and wild-type 
cells, indicating that PEX19 deficient cells have no defect in the interferon-receptor 
mediated and JAK/STAT dependent antiviral signaling. These results implicate a direct 
or indirect role of PEX19 in the early antiviral signaling responses prior to the interferon 
receptor-mediated autocrine feed-back loop.
Figure 3-25 IFN type I responses of PEX19 deficient fibroblasts (A) PEX19 deficient 
fibroblasts and wild type fibroblasts were stimulated with 100 ng/ml poly (I:C), 1 μg/ml poly(dA:dT), 
10 μg/ml CpG DNA and 1000 U/ml IFN-ß 24h prior to mRNA extraction. Expression levels of IFN-
and RIG-I were determined by qRT-PCR and are shown as fold induction levels in relation to 
mRNA levels of unstimulated cells. Representative data from three independent experiments are 
shown. (B) Wild-type fibroblasts and PEX19-deficient fibroblasts were transfected with increasing 
concentrations of poly (I:C). After 24 h IFN-ß RNA expression levels relative to HPRT were 
determined by qRT-PCR and (C) living cells were determined by flow cytometry after staining with 
propidium iodide. Cells negative for propidiume iodide are depicted as % of living cells. Data in B 
and C are shown as mean + SEM of n = 3.
To test whether the defect in immune signaling was induced directly by PEX19 or 
rather by the lack of functional peroxisomes, we compared antiviral signaling 
responses of three human fibroblasts cell lines from different patients with Zellweger 
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syndrome, carrying mutations in either the PEX3, PEX19 or PEX26 gene. Just like 
PEX19, Pex26 is a protein crucial for early peroxisomal biogenesis. Mutations in the 
corresponding genes lead to empty and non-functional organelles. The PEX3 gene 
encodes for a peroxisomal membrane protein and its absence results in complete lack 
of peroxisomes. We characterized the PEX3 mutation phenotype again and confirmed 
that fibroblast bearing the mutation expressed very low levels of PEX3 mRNA 
compared to wild type fibroblasts (Figure 3-26A). Additionally, the peroxisomal marker 
protein catalase showed a cytoplasmic distribution rather than a vesicular pattern 
(Figure 3-26B) further indicating the absence of peroxisomes in these cells.
Figure 3-26 Characterization of the PEX3 mutation in human fibrobasts. (A) mRNA 
expression of PEX3 in PEX3-deficient fibroblasts and wild type fibroblasts was determined by qRT-
PCR (B) Analysis of catalase distribution in PEX3-deficient fibroblasts and wild-type fibroblasts by 
immunofluorescence. Catalase expression is depicted in green.
We next tested the ability of poly (I:C) to induce an immune response in the three cell 
lines with mutations in PEX3, PEX19 and PEX26, respectively, and analyzed IFN-ß
mRNA levels 24h post stimulation. As a result we observed a strong reduction of IFN-ß
expression in all three cell lines with peroxisomal defects relative to wild type cells 
(Figure 3-27). These results suggest an important role of peroxisomal integrity for an 
adequate induction of MAVS-dependent IFN type I responses. 
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Figure 3-27 Differences in IFN responses in PEX-deficient fibroblasts. Wild-type 
fibroblasts and fibroblasts deficient for PEX3, PEX19 and PEX26, respectively, were stimulated with 
100 ng/ml poly (I:C) 24h prior to mRNA extraction. Expression levels were determined by qRT-PCR 
and are shown as fold induction levels in relation to mRNA levels of unstimulated cells. 
Representative data from two independent experiments are shown.
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4 Discussion
MAVS is localized in the outer mitochondrial membrane as well as in the membrane of 
peroxisomes and MAVS-mediated RIG-I-like receptor signaling not only induces
antiviral and inflammatory pathways, but also triggers metabolic changes in activated 
cells and induces apoptosis. So far, the interplay of mitochondrial and peroxisomal 
organelle physiology and RIG-I-like receptor signaling processes are not fully 
elucidated. The aim of this work was to further analyze details of the interplay of 
MAVS-dependent antiviral signaling with both, mitochondria and peroxisomes. Taking 
different aspects of MAVS-mediated signaling into consideration, the study was divided 
in three parts and examined:
1) Changes in the proteome of mitochondria upon MAVS activation 
2) The impact of MAVS-dependent signaling on mitochondrial respiration
3) Interaction partners of MAVS within the peroxisomal proteome and how the loss 
of functional peroxisomes impacts on antiviral signaling
In order to characterize changes in the mitochondrial proteome induced by RIG-I-like 
receptor-dependent signaling, we first established methods for efficient purification of 
mitochondria, for mitochondria subfractionation and for extraction of mitochondrial 
surface proteins in a cell culture model, the melanoma cell line 1205Lu. Using SILAC 
we performed quantitative proteomic analysis of three mitochondrial fractions: whole 
mitochondria, the isolated outer mitochondrial membrane and the proteins that can be 
cleaved of intact mitochondria by trypsin. In these fractions we found alterations in 155 
proteins in response to stimulation with the synthetic RIG-I-like receptor ligand poly 
(I:C). Among these candidates, we picked 12 proteins for further evaluation of their role 
in antiviral signaling. Using siRNA, we performed a small-scale loss-of-function assay 
and found three proteins, i.e. SOD2, DDX18 and HNRNPL, to significantly alter MAVS-
dependent signaling. Knock-down of HNRNPL resulted in enhanced, whereas knock-
down of DDX18 and SOD2 led to decreased IFN-ß mRNA expression upon RIG-I-like 
receptor activation. Depletion of SOD2 additionally resulted in a decrease of the 
infection rate of vesicular stomatitis virus.
The mitochondrial respiration rate was assessed by determining the oxygen 
consumption rate (OCR) using the label-free Seahorse XF96 assay. Transfection of 
poly (I:C) and 3pRNA resulted in a significant decrease of OCR after 1 h and 16 h
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compared to control conditions. The decrease in OCR was thereby found to be linked 
to a decrease in O2 consumption used for ATP generation but was not associated with 
changes in the capacity for maximal respiration, proton leakage and ROS production, 
MAVS-independent stimulation with untransfected poly (I:C) did not alter OCR levels 
and stimulation with LPS resulted in a significant decrease of OCRs after 1 h, but had 
no effect after 16 h. MAVS activation did not lead to increased apoptosis levels nor 
deregulation of respiratory chain components in our setting.
In order to identify molecular mechanisms underlying MAVS-mediated responses on 
peroxisomes, a large scale BRET-based screen was done to determine protein-protein 
interactions (PPIs) between MAVS and peroxisomal proteins. We found 25 novel 
putative interaction partners of MAVS in the peroxisomal proteome, of which we could 
confirm eight in independent saturation experiments. Three fibroblast cell lines from 
patients with Zellweger syndrome, carrying mutations in the genes of PEX3, PEX19 
and PEX27, respectively, were used as a model system to study MAVS signaling in the 
absence of functional peroxisomes. All cell lines displayed a highly reduced capacity to 
induce IFN-ß expression in response to poly (I:C) stimulation compared to wild-type 
fibroblasts. The PEX19-deficient cell line additionally showed reduced IFN-ß responses 
upon dAdT stimulation. Stimulation with recombinant IFN-ß resulted in the induction of 
comparable RIG-I expression levels in wild-type and PEX19-deficient fibroblasts.
4.1 Characterization of changes in the mitochondrial proteome upon
stimulation of RIG-I-like receptor signaling
MAVS-mediated signaling is a highly dynamic and transient process, which relies on 
protein-protein interactions and post-translational modifications of effector proteins 
which initiate immune and inflammatory responses. Previous studies revealed that 
MAVS activation is accompanied and influenced by changes in many mitochondrial 
functions and that mitochondrial localization of MAVS is crucial for the ability to induce 
antiviral responses via RLRs. These studies were performed using classical 
biochemical approaches with the focus on one particular protein at a time, rather than 
the whole mitochondrial proteome. In our study, we aimed for a comprehensive and 
unbiased analysis of the complete mitochondrial proteome in context of antiviral 
signaling through RLR activation, which had so far not been performed yet. Due to 
cellular heterogeneity and plasticity, the elucidation of the subcellular distribution of 
proteins under different conditions is a major challenge in cell biology [181]. However, 
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mitochondrial proteomic profiles have been generated previously in context of diseases 
using several animal models [182, 183].
For identification of stimulation-induced changes in the mitochondrial proteome, we 
chose quantitative high-resolution proteomics in combination with subcellular 
fractionation in an untargeted and unbiased manner using SILAC as the basis for 
quantification. In order to perform cellular fractionation, we established a simple and 
rapid method for the isolation of functionally active and structurally intact mitochondria 
from small tissue samples and cultured cells in collaboration with Dr. Hans Zischka 
[164]. In order to reduce complexity and to enrich for lower abundance components 
while depleting the most abundant ones, we combined the mitochondria isolation 
protocol with an additional MACS-based purification step and established methods to 
enrich for the outer mitochondrial membrane (OM) and proteins associated with or part 
of the mitochondrial surface via proteolytic digestion.
4.2 SILAC- based quantitative proteomic analysis
Up to now, a variety of quantitative proteomic approaches have been published to 
study whole cells in context of immune signaling [184]. A label-free quantitative 
proteomics analysis compared three conventional dendritic cell subsets of the mouse in 
context of innate immune signaling and revealed expression changes of over 5000 
proteins. Furthermore, Luber et al. could show that components of PRR signaling 
pathways were differentially expressed and highlighted a not yet appreciated difference 
in RLR-mediated antiviral response between cDC subsets [185]. Label-free quantitative 
proteomics was also applied to investigate difference in surface markers between 
macrophage and DCs and between DCs subsets [186, 187]. Furthermore, a 
combination of 2-dimensional gel electrophoresis and ICAT-based quantitative analysis 
was performed to analyze cellular response to severe acute respiratory syndrome-
associated coronavirus (SARS-CoV) infection in the Vero E6 cell line [188]. These 
approaches focused on changes of protein expression levels within complete cells. 
However, signaling cascades are usually activated and regulated by transient binding 
of effector molecules rather than immediate changes of expression patterns. With 
proteomic analyses on subcellular fractions it is possible to capture these 
spatiotemporal changes. To date, only few approaches have been taken to analyze 
protein translocation between cellular compartments in context of immune signaling. In 
this context, an iTRAQ-based quantitative proteomic approach was used to analyze the 
macrophage nuclear proteome and secretome after influenza A virus infection. This 
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study allowed the identification of several novel host factors contributing to innate 
immune responses during influenza A virus infection [189]. Furthermore, SILAC 
analyses have been performed quantifying changes within the nucleolar proteome of 
cells infected with influenza A virus [138], corona infectious bronchitis virus[190, 191]
and human respiratory syncytial virus [192].
By combining mitochondria purification and subfractionation strategies with SILAC-
based shotgun proteomics, the major achievement of this study is the first 
comprehensive quantitative analysis of mitochondria in context of RLR signaling. To 
date, only very few study combined SILAC as a proteomic quantification strategy with 
mitochondria purification to gain information on proteomic changes in response to 
cellular stimulation patterns. A recent report by Chen et al. performed SILAC of 
mitochondria after glucotoxicity in -cells [193]. Two studies 
have been performed in context of Parkinson’s disease. Jinghua et al. investigated 
mitochondrial dysfunction induced by rotenone in Parkinson’s disease [194]. Chan et 
al. analyzed parkin-induced proteasomal degradation of components of the 
mitochondrial proteome [195]. Wu et al. relied on 2D-electrophoresis to analyze 
changes in the mitochondrial proteome of A549 cells infected by swine influenza virus
[196].
Our approach identified an average of 1.700 proteins per analysis and a total of more 
than 5000 protein groups in three independent experiments. For comparison, the study 
of Chen et al., which also included three independent analyses on complete 
mitochondria and resulted in the detection of only 1,000 protein groups [193]. The 
report by Jin et al. showed similar detection levels with 1722 identified proteins [194]
whereas Chan et al. were able to detect 2979 proteins, indicating a higher sensitivity  
[195]. In contrast, a 2D-electrophoresis-based study on purified mitochondria detected 
only approximately 500-700 proteins per experimental condition. These results show 
that SILAC in principle leads to a drastically increased sensitivity of detection levels per
se. 
Besides a high sensitivity of detection however, it is as well crucial to maximize 
specificity levels by highly pure mitochondrial fractions. Different mitochondria 
purification strategies in combination with differing cell culture models can be an 
explanation for substantial variation in the detection level for proteins between studies.
Mitochondria were purified by nycodenz [193], sucrose [194] and percoll gradient [195],
whereas we pursued a MACS-based purification protocol. It is consequently possible 
that we extracted higher amounts of proteins per se due to different purification 
strategies. A second explanation could be a higher sensitivity in the LC-MS/MS 
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analysis in our study. Detection levels highly depend on e.g. the initial chromatography 
quality, ionization efficiency, and measurement times and can thus cause major 
variations [154, 197-199]. In addition, different quantification strategies were applied. 
High sensitivity of the measurements additionally enhances the detection level for 
proteins of low-abundance. Even though we can consider our detection method as 
sensitive, we were not able to detect proteins involved in antiviral signaling which have 
been reported to transfer to the mitochondrial surface upon stimulation of MAVS, e.g.
MDA-5 or TRAF2 and TRAF3 [19, 24, 27, 46]. Taking into consideration that these 
translocation processes are transient, we integrated a time course into the 
experimental approach, thereby increasing the possibility to detect these effector 
molecules of antiviral signaling. The lack of detection might be due to the fact that 
mitochondria are highly complex organelles bearing up to 4000 proteins [69] and only a 
certain percentage of mitochondria per cell might get involved in the RLH signaling 
cascade. Binding of single proteins to only some organelles might consequently be 
below the detection threshold, even after mitochondrial fractionation. In addition, it is 
possible to lose transiently attached proteins during the purification process. The 
mapping of all detected proteins for their cellular compartment localization at least 
according to the gene ontology database revealed an enrichment of mitochondrial 
proteins from 20% in complete cell lysates to 50-60% in mitochondrial fractions. 
However, the results also indicated an average of 70% cytoplasmic and 30% nuclear 
proteins. Several reasons are likely to be responsible for this distribution. Firstly, up to 
now databases do not represent the full mitochondrial proteome yet. Secondly, even 
though mitochondria purification protocols have been optimized to limit the amount of 
proteins of other cellular compartments, it is not possible to exclude these potentially 
contaminating factors to 100 %. Additionally, the high sensitivity of LC-MS analysis also 
lowers the threshold of detection level for non-mitochondrial proteins. The SILAC-
based studies of Jin et al. and Chan et al. reported 50 % [194] and approximately 35 % 
[195] mitochondrial-associated proteins after cell fractionation, indicating similar 
enrichment levels. However, Chen et al. reported only 7.5 % of the proteins to be 
associated with other cellular compartments [194]. While the sucrose gradient 
ultracentrifugation technique used for organelle isolation in their report is recognized to 
yield in high purity of mitochondria [200], their annotation strategy was based on a 
different protein data base, potentially causing differences in the calculation [194]. Low 
levels of contaminating proteins might be advantageous in order to decrease sample 
complexity and increase the detection of low-abundance proteins. However, it has to 
be taken into consideration that the decrease of proteins from other compartments 
might also reduce the possibility to detect proteins transiently translocated to the 
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mitochondria after stimulation. Optimally, the purification strategy should be harsh 
enough to diminish the contamination level of all non-associated proteins while 
retaining transiently associated proteins from the cytoplasm.
We considered a candidate to be regulated if 1.5-fold higher or lower intensity 
compared to the unstimulated condition were detected. Additionally, each experimental 
condition was performed twice with identical stimulation protocol but reversed SILAC 
conditions. We thereby provide evidence that the expression and/or subcellular 
localization of 155 host proteins is affected at the early phases of MAVS-dependent 
signaling. The cut-off level of 1.5 fold is in accordance with other studies, in which 
ratios of 1.3–2.5-fold have been used as cut-offs for both statistical and biological 
significance [131, 132, 135, 138, 139, 162, 190, 191, 193-195, 201].
However, quantification strategies are only one factor affecting the quality of 
measurements. Mitochondria are the most complex organelles of eukaryotic cells [38] 
and abundance and morphology of the organelles are highly tissue and cell type 
specific. Large-scale proteomic analyses have provided information on differing 
abundances of mitochondria between tissues, indicating that heart tissue contains 
more than twice the mitochondrial mass than tissue from brain regions [202]. In 
addition, studies have shown that morphologies, such as length and cristae 
composition differ substantially in mitochondria isolated from varying tissues [52]. 
These reports are in line with our observation on highly diverse mitochondrial 
ultrastructure between isolated mitochondria from primary hepatocytes and cell culture 
models, such as e.g. 1205Lu, HEK293 and HeLa [22]. Given such widely varying 
morphologies it is reasonable to expect that the protein composition of these organelles 
may vary significantly between tissues and cell types. One study revealed substantial 
differences in proteomic composition of mitochondria isolated from rat liver, skeletal 
and heart tissue [203]. Several additional proteomic studies on rat mitochondria 
showed only half of mitochondrial proteins to be core components found in all tissues, 
whereas the remaining half are distributed in a tissue-specific manner [202]. It is thus 
difficult to compare results from quantitative proteomic analyses on different cell types 
or tissues, even if they were generated utilizing similar experimental approaches.
Several strategies can be considered to further optimize the presented experimental 
approach. Even though SILAC can be applied in animals such as mice, it is usually 
limited to cell culture models, since labeling of complete animals is time and cost 
consuming [204, 205]. However, SILAC has recently been expanded to tissue analysis 
by using a mix of five SILAC labeled cell lines as internal standards for tissue proteome 
quantification (Super-SILAC) [136, 201]. This strategy would allow the integration of 
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animal models into the study, which would in turn be suited for different mitochondria 
isolation protocols. Super-SILAC in combination with mitochondria purification has 
recently been applied to distinguish differences between mitochondria isolated from 
synaptic and non-synaptic mice brains [206].
Secondly, application of different targeting strategies could be integrated into the study. 
Although mitochondria have been extensively characterized by MS proteomics, most 
previous studies have used mitochondrial purification, which is potentially associated 
with sample loss and contamination. An alternative approach was taken by Rhee et al. 
in 2013 [207]. The authors established a method for proteomic mapping of 
mitochondrial matrix and inner membrane proteins in living cells via an ascorbate 
peroxidase enzymatic tag (APEX), directed to the mitochondrial matrix. Upon addition 
of biotin-phenol and H2O2, APEX oxidizes phenol which in turn covalently reacts with 
electron-rich amino acids such as Tyr, Trp, His, and Cys, resulting in biotinylation of the 
corresponding proteins. The endogenous proteins were purified using streptavidin 
beads, digested to peptides, and identified by tandem MS. As an additional control, the 
authors used stable isotope labeling of experimental and control samples to distinguish 
between biotinylated proteins and nonspecific binders. Using this approach they were 
able to detect already described matrix proteins without detecting proteins from other 
mitochondrial compartments like the outer membrane. In addition, they could assign 
new proteins to the mitochondrial matrix [207]. By directing APEX specifically to the 
mitochondrial outer membrane, this strategy might also be considered as an approach 
independent of mitochondria purification.
In conclusion, the achievement of this study is a comprehensive survey of 
mitochondrial proteins and the quantification of regulated protein abundances in 
context of RLR-dependent signaling. While previous experimental approaches have 
mostly tested one hypothesis at a time, this study gives an example how the field of 
proteomics offers great potential for the global identification and characterization of
mitochondrial proteins involved in innate immune signaling in a nonbiased manner. The 
study however also illustrates sensitivity limits of the current protocol and shows that 
further improvements of the method are required to consistently resolve the postulated 
mitochondria-associated signaling complexes by mass spectrometry.
4.2.1 Functional analysis of candidates
The most straightforward approach to investigate the function of a gene is to 
characterize the phenotypic changes associated with its inactivation or loss. As loss-of-
function assays for the functional characterization in context of RLR-signaling and virus 
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infection, we chose the transient depletion of the respective candidate mRNAs by 
siRNA. 
As type I IFNs are known to be directly induced by MAVS-signaling [35, 49, 62, 95] we 
evaluated the effect of knocking-down our candidates on IFN– mRNA expression
levels and included the determination of VSV titer after VSV infection as a more global 
screening assay of antiviral activity. 
The biological importance of HNRNPL, DDX18 and SOD2 for MAVS signaling or viral 
infection is unknown. As the only candidate, knockdown of HNRNPL led to a significant 
increase of IFN-ß mRNA expression after poly (I:C) stimulation and consequently 
suggests an inhibitory role on RLR signaling. Previous studies on HNRNPL show a 
stable association with nuclear hnRNP, a complex involved in pre-mRNA processing, 
mRNA translocation from the nucleus to the cytoplasm, and translation [208, 209].
HNRNPL and other HNRP proteins have been identified in the cytoplasm in addition to 
their nuclear localization, being involved in the transportation of mRNA. HNRNPL has 
never been described with a mitochondrial localization. However HNRNPK, also a 
member of the HNRNP family, was reported to bind mitochondria-associated satellite 
RNA within mitochondria [210].
HNRNPL has been shown to bind to the internal ribosome entry site (IRES) of the 
hepatitis C virus (HCV) genomic RNA and binding of the protein correlated with the 
translational efficiencies of the corresponding mRNAs [211]. Interaction of HCV RNA 
was additionally described for HNRNPK [212]. In a second study the interaction of 
HNRNPL with the N-terminal region of Norwalk virus (NV) RNA was shown and the 
authors described a potential role in viral translation or replication processes [213]. No
direct link to innate immune signaling cascades has been reported yet. However, one 
study provided evidence for interaction of HNRNPL and PCBP2 (also known as 
HNRNP E2) [209], another previously described regulator of RLR signaling [64].
Antiviral functions were however reported for HNRNPA2/B1, also a member of the 
HNRNP family. The protein interacts with the influenza A virus protein NS1 and inhibits 
viral replication. Knockdown of HNRNPA2/B1 was shown to promote transport of NS1 
mRNA from the nucleus to the cytoplasm in infected cells [214]. A similar implication in 
antiviral signaling might be possible for HNRNPL. Due to its implication for packaging 
of mRNA [215], it seems possible that HNRNPL binds to cytoplasmic, potentially 
immuno-stimulatory RNA and shields it from detection by MDA5. 
Knockdown of DDX18 led to a significant decrease of IFN- production upon RLR 
activation, while it had no effect on virus replication. According to literature, DDX18 is a 
nucleolar protein specifically up-regulated in highly proliferating cells like embryonic 
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stem cells [216] with a putative role in cell cycle regulation and/or apoptosis control due 
to interaction with c-myc [217]. Interestingly, DDX18 also belongs to the same family of 
dead box helicases like RLRs, pointing towards RNA binding capacity. However, 
DDX18 was never described as a protein implicated in immune signaling responses. 
Since knock-down of DDX18 did not lead to changes in the viability of the cells, the 
effect on IFN-ß expression is likely to be independent from its putative implication in 
apoptosis and cell proliferation. The decreased expression of IFN-ß after knockdown of 
the protein and poly (I:C) stimulation indicates a potentially beneficial role for RLR 
signaling. Due to a possible implication in RNA binding, it could be speculated, that 
DDX18 binds to immuno-stimulatory RNA in the cytoplasm and enhances RLR-
mediated antiviral signaling responses.
SOD2 was found to have a strong impact on IFN-ß mRNA expression as well as on 
viral replication. The enzyme is described as a mitochondrial matrix protein that 
efficiently converts superoxide to the less reactive hydrogen peroxide (H2O2) [218].
Loss of SOD2 activity can result in numerous pathological phenotypes in metabolically 
active tissues, particularly within the central nervous system [219]. In several previous 
studies a link between SOD2 and virus infection has already been reported. Even 
though SOD2 is not inducible by type I IFNs, the non-structural protein 1 (NS1) of 
human respiratory syncytial virus was found to suppress the induction of SOD2
expression in response to infection [220]. Furthermore, down-regulation of the protein 
led to inhibited HBV replication, accompanied by ROS generation and mitochondrial 
dysfunction [221] and HIV-1 Tat was also able to attenuate basal SOD2 expression 
[222]. Rakkola et al. were able to show the up-regulation of SOD2 after toll-like 
receptor activation in a proteomic screening approach of human macrophages [223].
Additionally, SOD2 has been found to be transported from mitochondria to the 
cytoplasm in apoptotic neuronal cells in the context of chronic prion infection. This 
mislocalization led to proteasomal degradation of the enzyme [224]. ROS signaling has 
been shown to play an important role in MAVS dependent signaling [91, 93, 150, 225,
226] and increase of intracellular ROS concentrations have been reported to enhance 
RLR signaling [93]. SOD2 transforms superoxide into the long-lived ROS H2O2 and, 
based on previous reports, it can be speculated that depletion of SOD2 leads to locally 
increased superoxide but decreased H2O2 levels [227-229]. It might consequently be 
speculated that mitochondrial H2O2 is required or beneficial for RLR signaling. 
However, if the inhibitory effect of SOD2 knock-down on IFN-ß expression in our 
experimental setup is linked to ROS production remains to be determined. 
Additionally, knock-down of SOD2 resulted in decreased VSV infection rates. Virus 
infection is a process composed of several steps (attachment, membrane penetration, 
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virus uncoating, transcription and translation as well as assembly and release) and 
SOD2 might also have an implication in one of these steps. The drastically reduced 
susceptibility of the cell towards virus infection after depletion of SOD2 might thus be 
independent of the effect of SOD2 on antiviral signaling. 
Taken together, we were able to observe an effect on RLR signaling for three 
candidates and on virus infection for one out of 12 candidate proteins. However, further 
studies are necessary to dissect the underlying mechanisms for these observations. 
Ultimately, changes in abundance detected in the initial LC-MS analysis can have 
multiple explanations that need to be taken into consideration. It might be possible for 
the abundance of a protein to change on a cellular level (e.g. due to increase or 
decrease in degradation of the protein or transcriptional regulation). On the other hand, 
the abundance might not be altered on a cellular level, but instead the localization of 
the respective protein e.g. through shuttling of a protein to or from the mitochondrion. In
this regard it will be interesting in future studies to analysze changes in the expression 
levels of the candidate proteins on RNA as well as protein levels after poly (I:C) 
stimulation in whole cell lysates. Another reason for altered intensities during LC-MS 
analysis can be changes in post-translational modification (PTM) patterns, such as 
phosphorylation. Protein phosphorylation is one of the most prevalent intracellular 
protein modifications and thus of pivotal importance in signaling pathways. 
Interestingly, phosphopeptides have been reported to potentially have lower ionization 
and detection efficiencies during MS analysis as compared with their unmodified 
counterparts [230]. Changes in peptide intensities in MS measurements that are 
misinterpreted as changes in protein abundance can in some cases be caused by 
changes of phosphorylation patterns of proteins instead. It might therefore be useful in 
the future to analyze phosphorylation patterns of the respective candidate proteins in 
context of RLR signaling and to perform LC-MS analysis again on the mitochondrial 
phosphoproteome. 
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4.3 Decrease of mitochondrial respiration rate after stimulation of RIG-I-like
receptor signaling
In this study we have shown that transfection of poly (I:C) and 3pRNA leads to a 
significant decrease in basal oxygen consumption rate. Since protein levels, as a mean 
for cell concentration, and cell viability were unaltered after stimulation, these results 
suggest reduced mitochondrial respiration after activation of RLR signaling. While 
previous publications already described a strong contribution of mitochondrial integrity 
and morphology to MAVS-mediated signaling [49, 59, 86, 88, 89, 91, 93, 150, 225], we 
were now able to show that RLR signaling in turn also affects mitochondrial function.  
A possible reason for the decreased oxygen consumption through mitochondrial 
respiration might be a reduced capability of mitochondria for oxidative phosphorylation
in these cells. On the other hand it is possible that antiviral signaling changes the 
reduction of ATP production through oxidative phosphorylation in favor for energy 
generation through glycolysis. 
Oxidative phosphorylation is characterized by a highly regulated interplay between the 
complexes of the electron transport chain (ETC). The ETC is the main producer of 
ROS in non-phagocytic cells [231] and several reports describe a positive impact of 
increased ROS levels on MAVS signaling [91, 93, 150, 225, 226]. Deregulation of the 
respiratory chain would likely result in impaired electron transfer from complex I and 
complex III, leading to the formation of ROS [77]. However, we did not observe 
significant increase of mitochondrial ROS levels upon stimulation of RLR signaling in 
our study, indicating that the interplay of components of the ETC might not be 
deregulated as a reason for the seen decreased mitochondrial respiration. In 
accordance with this hypothesis, we did not find deregulated protein expression levels 
of components of the respiratory chain. It seems to be likely that the decrease of 
mitochondrial oxygen consumption is not caused by the deregulation of the oxidative 
phosphorylation components. 
Taking into consideration that the mitochondr m) is defined
by the electrochemical gradient that forms along the mitochondrial membrane and is 
maintained by calcium uptake m is also coupled to mitochondrial respiration [232]
and reduced membrane potential might thus be a reason for lower respiration rates. 
Prior work by Koshiba et al. has shown that RLR signaling is strongly dependent on an 
m, as depolarization or hyperpolarization of the inner mitochondrial membrane
results in decreased antiviral responses. This effect was described to be at the level of 
MAVS and MAVS-dependent, since the signaling steps down-stream of MAVS, such 
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m
[86]. Another study by Lei et al. has shown that MAVS activation on the other side 
m. However, the authors argue that this reduction is caused 
by the onset of MAVS-induced apoptosis [233]. This link is in contrast to our finding, 
that reduced respiration was a very early event independent of reduced cell viability. 
Altered respiratory rates could also be due to post-translational modifications (PTMs) of 
components of the ETC, such as oxidation of cysteines, [174]. However, no reports on 
altered PTM profiles of components of ETC are published in context of RLR signaling 
and this aspect thus needs further investigation. 
Another explanation for reduced mitochondrial respiration might be that ATP production 
through oxidative phosphorylation is reduced after RLR activation in favor for energy 
generation through glycolysis. In favor of this hypothesis, a recent study by Pantel et al. 
showed, that dendritic cells (DCs) exhibited strongly reduced basal OCRs after 
activation of the innate immune system in mice with uncomplexed poly (I:C) in 
comparison to DCs of control mice [234]. Additionally, they were able to show a 
drastically reduced maximal mitochondrial respiration rate in their study. Analysis of 
extracellular acidification rates as an indicator for lactate production and glycolysis 
indicated a metabolic switch from oxidative phosphorylation to glycolysis after 
stimulation with poly (I:C). Using IFN type I knockout-cells, 
respectively, they could furthermore show, that this effect is IFN-dependent and 
coordinated by the transcription factor H
immune stimulation via poly (I:C) led to activation of DCs together with a metabolic 
switch from oxidative phosphorylation to glycolysis [234]. In accordance with these 
results another study also reported reduced (maximal) mitochondrial respiration in a 
HepG2 cell culture model upon stimulation of TLR3 with poly (I:C) [235].
While uncomplexed poly (I:C) is internalized by endocytosis and recognized by TLR3 
[236], transfected poly (I:C) in the cytosplasm of the cell activates the innate immune 
system via MDA-5 [237]. In our experimental setup, we were able to see a strong 
decrease of basal OCRs in cells after poly (I:C) transfection, correlating with a strong 
induction of the IFN-stimulated gene IP10. But in contrast to the previous reports, 
stimulation with uncomplexed poly (I:C) did not affect mitochondrial respiration at any 
time point. However together with the fact that stimulation of 1205Lu cells with 
uncomplexed poly (I:C) did not result in increased expression of the IFN-stimulated 
IP10, these results suggest that the cells do not express TLR3 and therefore do not
induce interferon upon stimulation with uncomplexed poly (I:C). Taken together, our 
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data might be in favor for a metabolic switch in cells upon MAVS activation, leading to 
reduced oxidative phosphorylation in favor for ATP generation through glycolysis. 
Interestingly, we observed significantly reduced respiration rates upon LPS stimulation 
for 1 h, which was reversed 16 h post stimulation. A possible explanation might be that 
LPS is a potent inducer of nitric oxide (NO). NO can modulate mitochondrial respiration 
and oxygen consumption through reversible binding and inhibition at complex IV, 
leading to the accumulation of NADH [238]. Transient induction of NO within the cell 
might therefore lead to alteration in basal levels of mitochondrial respiration.
MAVS-dependent signaling is activated in vivo after viral infection. Interestingly, several 
reports in the last decades have also associated virus infection with dysfunction in 
mitochondrial respiration and increased glucose demand. For example the
mitochondrial respiratory capacity was found to be decreased in neuronal cells infected 
with Sindbis virus. Additionally, this modulation in mitochondrial respiration was 
followed by a significant increase in both the uptake and utilization of glucose 
molecules through the glycolytic pathway [239]. By using cell lines inducibly expressing 
different HCV constructs, a second study showed that HCV protein expression led to 
severe impairment of mitochondrial oxidative phosphorylation and to a switch to non-
oxidative glucose metabolism
involved in this process [240]. Glucose uptake was furthermore found to be stimulated 
in cells infected with VSV and SFV [241], as well as influenza virus [242], representing 
viruses that are also able to induce MAVS-dependent signaling. Taken together, the
results from these studies suggest that virus infection might manipulate the cellular 
state to match increased energy needs for expression of viral proteins. Our results 
however indicate that activation of MAVS-dependent signaling itself might already 
induce modulations in mitochondrial respiration. Activation of signal transduction and 
increased gene expression leads to a rapid demand in cellular energy production. 
Transient metabolic reprogramming of the cell might consequently not only be 
advantageous for the virus to ensure efficient replication, it might also be a suitable 
mechanism for the infected cell to adjust to increased expression of antiviral molecules. 
This switch might be similar to the Warburg effect described for cancer cells [169].
Taken together, the findings indicate an impact of RLR signaling on mitochondrial 
respiration which is not due to alterations in the respiratory chain. The novel 
contribution of the presented work is to reveal the impact of MAVS signaling on 
mitochondrial respiration, which has not been shown previously.
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Further studies however are needed to evaluate how immune signaling via MAVS 
leads to the metabolic switch.
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4.4 MAVS signaling depends on peroxisomal integrity
4.4.1 MAVS specifically interacts with a set of peroxisomal proteins
Several studies have proposed that peroxisomes are involved in viral infection based
on the fact that viral proteins were targeted to peroxisomes, such as the Nef protein
[124, 125] and the nonstructural influenza virus A protein 1 (NS1) [126]. Another report 
provided evidence for a direct link to innate immune responses by showing that the 
pestivirus protein Npro targets peroxisomes as well as mitochondria in order to bind and 
inactivate IRF3 [243]. A recent report by Dixit et al. has shown a role of peroxisomes in 
the host responses to viral infection due to the localization of the antiviral adaptor 
protein MAVS on the peroxisomal membrane [50]. Even though many studies on 
MAVS-dependent signaling via mitochondria have been conducted, up to now no 
further reports on the molecular basis of MAVS signaling on peroxisomes have been 
published. Our study now represents a comprehensive analysis of interaction partners 
of MAVS in the peroxisomal proteome. 
Just like mitochondria, peroxisomes are dynamic organelles which multiply by fission 
processes. Peroxisomal fission is partly mediated by DRP1 and FIS1, both 
representing GTPases also involved in mitochondrial fission [101, 108, 109]. RLR 
signaling via mitochondria has been shown to be strongly influenced by mitochondrial 
dynamics, since MAVS activation is enhanced by mitochondrial elongation through the 
mitochondrial fusion proteins MFN1 and OPA1, whereas mitochondrial fragmentation 
via DRP1 and FIS1 reduced MAVS-signaling [88, 90]. In addition, two studies provided
evidence for direct interactions of MAVS with components of the fission and fusion 
machinery. MFN2 was found to interact with the C-terminus of MAVS, providing a 
mechanism of negative regulation of MAVS signaling [59]. A second study analyzed 
physical interactions of MAVS with MFN1/MFN2, FIS1, OPA1 and DRP1. The authors 
uniquely found positive interactions between MAVS and MFN1 and proposed MAVS to 
be a negative regulator for the protein, inhibiting MFN1-mediated mitochondrial 
elongation [90]. In contrast to the second report, we observed interactions of MAVSwt 
and MAVSpex with FIS1. We could furthermore confirm interactions of PEX11G with 
MAVSwt and MAVSpex as another component of the peroxisomal fission and fusion 
machinery. However, if the positive interaction profiles of these proteins are of
functional relevance for peroxisomal morphology needs to be further analyzed. 
Supporting the model that peroxisomal dynamics are involved in RLR signaling, Dixit et 
al. showed in their initial report on peroxisomal targeting of MAVS, an elongation of 
peroxisomes in more than 90% of MAVSpex-expressing cells infected with reovirus 
T3D [50].
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Figure 4-1 Illustrations of RLR signaling via mitochondria and peroxisomes.
Upon activation of RIG-I/MDA5 by viral RNA, the receptors undergo conformational changes 
and bind to MAVS both on mitochondria and peroxisomes. Mitochondrial MAVS initiates 
antiviral signaling via activation of the transcription factor IRF3, leading to a sustained 
antiviral response with expression of type I IFNs and subsequent induction of ISGs via 
JAK/STAT signaling. Peroxisomal MAVS induces ISGs in an IFN-independent manner, 
induced by activation of IRF3/IRF1 heterodimers. Activation of peroxisomal MAVS results in 
an early and transient antiviral response, supplementing the mitochondrial antiviral 
response. Additionally, it might contribute to morphological changes through fusion and 
fission via interaction with FIS1.
Several reports characterized the peroxisomal membrane targeting sequence (mPTS) 
directing proteins to the peroxisomal membrane as a region bearing one or more 
transmembrane domains in conjunction with a short sequence, with either a cluster of 
basic residues or a mixture of basic and hydrophobic amino acids [244-248]. The 
import of peroxisomal membrane proteins is dependent on the cytosolic shuttling 
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protein PEX19 [249, 250]. A recent study showed PEX19 to bind to a sequence of 11
amino acids within the mPTS, which is characterized by conserved hydrophobic and 
positively charged amino acids [121]. The results of our screening approach gave the 
first hint for a positive interaction of MAVS with PEX19. After performing saturation 
experiments, we could reconfirm the interaction of MAVSpex and MAVSwt with PEX19. 
However, we were not able to detect a PEX19 binding motive in the wild-type MAVS 
sequence. We were not able to find this motive in FIS1 either, another protein with 
described localization for peroxisomes and mitochondria [108, 251]. Previous reports 
solely describe PEX19 as a cytosolic chaperone and import factor for peroxisomal 
membrane proteins [121, 122, 250, 252, 253]. The reconfirmed interaction of MAVSpex 
and MAVSwt with PEX19 gives now raise to a mechanistic model on how MAVS is 
integrated into the peroxisomal membrane. It further supports the initial finding of Dixit 
et al., that MAVS is specifically targeted to peroxisomes and does not get their via 
membrane fusion with other cellular organelles [50].
Figure 4-2 Hypothesized import mechanism for MAVS into peroxisomal membranes. 
Based on the results of our study, we hypothesize that MAVS is integrated into the peroxisomal 
membrane in a PEX19-dependent mechanism. MAVS binds to cytosolic PEX19 and might be 
integrated into the peroxisomal membrane in a PEX3/PEX16-dependent process. After membrane 
integration, PEX19 might be released again from the protein to restart the shuttling process. 
However, a mPTS motive in MAVS with a binding site for PEX19 has not been determined yet.
The third functional group of MAVS interacting peroxisomal proteins we detected in the 
initial screening approach were proteins involved in acylCoA hydrolysis. However, we 
could not confirm the interactions in subsequent saturation experiments. Since initial 
interactions were exclusively found between these proteins and the mitochondrial 
localization variant of MAVS, it might be possible that positive BRET signals were due 
to localization artifacts. 
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In order to genetically separate the putative mitochondrial and peroxisomal functions of
the protein Dixit et al. replaced the previously defined C-terminal localization motif [49]
downstream of amino acid (aa) 500 with domains that instead direct the protein to a 
single compartment. Using the 26 aa long localization motif of the peroxin PEX13 [252],
a protein called peroxisomal protein (MAVSpex) was created. By fusion of the 98 aa 
long localization sequence of FIS1 [108] to the truncated C-terminus of the protein, a 
mitochondrial construct (MAVSmito) was generated. We took advantage of the already 
characterized fusion proteins and the constructs used in this study were based on the 
sequences used by Dixit et al. [50]. Previous studies have shown however, that 
interaction with several effector molecules occurs downstream of the MAVS amino acid 
500 [63, 64, 254, 255]. Consequently, it has to be taken into consideration that 
interactions of proteins with the localization variants of MAVS might not occur at 
endogenous regions of MAVS, but might also take place at the C-terminal targeting 
sequences of PEX13 and FIS1, respectively. Additionally, fusion of these targeting 
sequences might also lead to different conformational characteristics of the protein, 
potentially altering interaction profiles. However, all proteins showing interactions with 
either MAVSpex or MAVSmito additionally showed a positive interaction profile with 
MAVSwt in saturation experiments, indicating that at least these tested interactions are 
mediated by MAVS-specific interactions. Another aspects for consideration is that the 
C-terminal targeting sequence of FIS1, which was used to locate MAVS to the 
peroxisome, is described to be necessary for both peroxisomal as well as mitochondrial 
targeting [101, 108, 251]. This is in contrast to the observation of Dixt et al., who see a 
purely peroxisomal localization of the MAVSpex fusion construct.  
In conclusion, we were able to find 21 putative interaction partners for MAVS in the
peroxisomal proteome by a BRET-based screening approach and were able to confirm 
8 interactions in independent BRET saturation experiments. Our results give rise to a 
model how MAVS is integrated into the peroxisomal membrane and links MAVS to 
peroxisomal dynamics. In further studies it will be of high interest to evaluate how these 
interaction dynamics change in the context of acute antiviral responses.
4.4.2 Fibroblasts from patients with Zellweger syndrome show defects in RIG-I-
like receptor signaling
Using fibroblasts from Zellweger syndrome patients as a system to study antiviral 
signaling in the absence of functional peroxisomes, we found impaired RLR signaling in 
these cells. For interpreting these results however, it has to be taken into consideration 
that peroxisomes are required for biochemical processes that are also connected to
mitochondria [256]. Cells with peroxisomal impairment might consequently also display
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defects in mitochondrial function and overall cell status. Given that PEX19-deficient 
fibroblasts are able to induce RIG-I expression comparable to wild-type cells upon 
stimulation with recombinant IFN-ß, these cells are nevertheless capable of normal 
signaling downstream of the IFN type I receptor and the induction of interferon 
inducible genes though the JAK/STAT pathway. However, the impact of PEX-
deficiency on mitochondrial function is needed to be tested in more detail before the 
reduced IFN- induction upon RLR stimulation can be really attributed to the missing 
peroxisomes and the peroxisomal branch of the RLR signaling.
The report of Dixit at al. implied that localization of MAVS on both peroxisomes and 
mitochondria is necessary to induce complete antiviral immunity. Furthermore, they 
proposed that full ISG and IFN expression requires signaling from both organelles, 
indicating that crosstalk exists between peroxisomes and mitochondria to allow the two 
pathways to be properly integrated [50]. In another recent study it was found that 
peroxisomes and mitochondria interact with one another at the MAM in hepatocytes 
upon viral infection. These contact sites have been proposed to form an innate immune 
signaling synapse, which coordinates the signaling functions of MAVS on peroxisomes 
and mitochondria [151].
Up to now, no studies have been performed on innate immune signaling in context of 
Zellweger syndrome and it is not known whether patients are more prone to viral 
infections. Descriptions of viral infection in context of Zellweger syndrome are missing 
in the literature. However, this might also be due to the very low life expectancy of 
these patients [115]. Furthermore, it remains unclear if RLR signaling is the only innate 
immune pathway that exploits peroxisomes as a signaling platform, or if other receptors 
signal via these organelles. Interestingly in this context, we could show that PEX19-
deficient cells expressed less IFN upon stimulation with dAdT compared to wild-type 
cells. Cytosolic dAdT can induce IFN via two distinct pathways. Firstly, the AT-rich DNA 
strand can be transcribed into double-stranded RNA (dsRNA) by RNA polymerase III 
containing a 5'-triphosphate moiety. Activation of RIG-I by this dsRNA induces 
production of IFN in a MAVS-dependent pathway [34]. On the other hand, dAdT binds 
to and activates cyclic GMP-AMP (cGAMP) synthase (cGAS), which produces the 
second messenger cGAMP. cGAMP is recognized by the adaptor protein STING. Sting 
activation leads to the induction of a MAVS-independent signaling cascade and 
expression of IFN [257-260]. The possibility that peroxisomes are additionally involved 
in STING-dependent immune signaling can consequently not be excluded. Stimulation 
experiments with the second messenger cGAMP will be useful in the future to clarify 
this question.
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In summary, using a cell culture model system deficient of functional peroxisomes we 
could show by that intact organelles are crucial for the induction of comprehensive 
MAVS-dependent signaling. Together with the finding of the BRET-based screening 
approach for interaction partners within the peroxisomal proteome, we hypothesize, 
that MAVS is integrated into the peroxisomal membrane in a PEX19-dependent 
mechanism in order to mediate antiviral signaling on these organelles. 
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5 Summary 
Up to now, diseases caused by viral infections remain a challenging global health 
issue. Innate immunity is the first line of defense against viral infections. A hallmark of 
antiviral innate immune responses is the production of type I IFN and pro-inflammatory 
cytokines. These molecules not only rapidly contain viral infection by inhibiting viral 
replication and assembly but also play a crucial role in activating the adaptive immune 
system to eradicate the virus. The RIG-I-like receptors (RLRs) are essential for the 
detection of cytoplasmic viral RNA of many human pathogenic viruses, such as 
hepatitis C virus, influenza A virus, noro virus or dengue virus. The adaptor protein 
MAVS coordinates the signals from activated RLRs and is crucial for the initiation of the 
antiviral signaling cascade. Due to its location in the outer mitochondrial membrane as 
well as in the membrane of peroxisomes studies focusing on MAVS hypothesized that 
the surfaces of mitochondria and peroxisomes act as signaling platforms for antiviral 
immune responses and postulated an intricate bi-directional interplay between 
mitochondrial and peroxisomal organelle-function and antiviral signaling. In the 
literature, many details of the interplay between organelle function and MAVS mediated 
signaling have already been elucidated. [50, 59, 88, 90, 91, 150, 151, 225]. However, 
many aspects of the interplay between mitochondria, peroxisomes and antiviral 
signaling are still unknown or a matter of debate. The presented dissertation therefore 
focused on the identification of new players and aspects in the interplay of RLR 
signaling and mitochondria and peroxisomes.
In a quantitative shotgun proteomic approach, we identified 155 proteins, whose 
abundance changes in mitochondrial fractions in response to RLR stimulation. Using a 
small-scale loss-of-function analysis on 12 of these proteins, we found three 
candidates, i.e. SOD2, DDX18 and HNRNPL, that significantly altered MAVS-
dependent IFN responses. Depletion of SOD2 additionally resulted in reduced virus 
titers after infection with vesicular stomatitis virus. 
Secondly, we showed that mitochondrial respiration was significantly reduced after 
activation of MAVS signaling. The decrease was associated with a reduced O2
consumption rate used for ATP production and not associated with an increase in 
mitochondrial ROS production. These results suggest that RLR signaling induces a 
metabolic switch in cells away from oxidative phosphorylation towards increased 
glycolysis.
An in-vivo BRET-based screening for protein-protein interactions resulted in the 
identification of 25 putative binding partners of MAVS in the peroxisomal proteome and 
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eight of these interactions could be confirmed in independent experiments leading to a 
model of Pex19-dependent integration of MAVS into the peroxisomal membrane.
Using three cell lines isolated from Zellweger syndrome patients with defects in Pex19, 
Pex3 and Pex27, we studied MAVS–mediated signaling in the absence of functional 
peroxisomes. The cells of all three patients showed drastically impaired IFN type I
responses upon RLR activation, indicating that intact peroxisomes are crucial for the 
induction of comprehensive MAVS-dependent signaling. 
In conclusion, this study identifies new proteins and aspects relevant for mitochondria 
and peroxisomes as signaling platforms in MAVS-mediated antiviral signaling.
Furthermore it provides the first evidence for the influence of RLR signaling on the 
metabolic status of the cell. A better understanding of the function and activity of the 
signaling cascade might eventually lead to the development of novel therapeutic 
approaches for the management of viral diseases. 
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6 Zusammenfassung
Bis heute stellen virale Erkrankungen weltweit eine gravierende Herausforderung für 
die Gesundheit dar. Das angeborene Immunsystem und das durch dieses induzierte 
Typ-I Interferon sowie pro-inflammatorische Zytokine stellen hierbei den primären
Verteidigungsmechanismus gegen virale Infektionen dar. Induktion dieser antiviralen 
Moleküle hat nicht nur die Inhibition der Virusreplikation und Virusassemblierung zur 
Folge, sie bewirkt im Folgenden auch die Aktivierung des adaptiven Immunsystems.
Die Familie der RIG-I-like Rezeptoren (RLRs) ist hierbei von essentieller Bedeutung für 
die Detektion von zytoplasmatischer RNA einer Vielzahl humanpathogener Viren, unter 
anderem des Hepatitis C Virus, Influenza A Virus, Noro Virus und Dengue Virus. Nach 
Aktivierung der RLRs wird eine antivirale Signalkaskade durch das Adapterprotein
MAVS weitergeleitet. MAVS konnte auf der äußeren mitochondrialen Membran sowie 
der peroxisomalen Membran lokalisiert werden. Durch frühere Studien manifestierte 
sich die Hypothese, dass die Oberflächen von Mitochondrien und Peroxisomen
Signalplattformen für antivirales Signaling darstellen und in zahlreichen Arbeiten 
konnten bereits Hinweise für ein komplexes, wechselseitiges Zusammenspiel 
antiviraler Immunantworten mit der jeweiligen Organellfunktion gefunden werden [50,
59, 88, 90, 91, 150, 151, 225]. Nichts desto trotz sind viele Aspekte der Beziehung von 
Mitochondrien, Peroxisomen und antiviraler Signalvermittlung bisher unbekannt oder 
nicht vollständig aufgeklärt. Aus diesem Grund fokussiert die vorliegende Dissertation 
auf die weitere Charakterisierung des Zusammenspiel der RLR Signalkaskade mit 
Mitochondrien und Peroxisomen.
In einer quantitativen massenspektrometrischen Proteomanalyse wurden 155 Proteine
identifiziert, die nach Stimulierung von RLRs Veränderungen ihrer Häufigkeit in 
mitochondrialen Fraktionen zeigten. In einer weiterführenden loss-of-function Analyse
mittels siRNA von zwölf der identifizierten Proteine zeigten drei Kandidaten (SOD2, 
DDX18 und HNRNPL) signifikante, MAVS abhängige Veränderungen in der IFN 
Expression. Der knock-down von SOD2 resultierte zusätzlich in vermindertem Virustiter 
nach Infektion mit vesikulärem Stomatitis Virus. Wir konnten somit Proteine mit Einfluss 
auf MAVS-abhängige antivirale Signalkaskaden neu identifizieren.
Des Weiteren zeigten wir eine signifikante Reduktion der mitochondrialen Atmung nach 
Aktivierung der MAVS-Signalkaskade. Dieser Effekt konnte auf verminderten 
Sauerstoffverbrauch in Zusammenhang mit ATP Produktion zurückgeführt werden und 
war nicht mit erhöhter Produktion von mitochondrialen ROS assoziiert. Diese 
Ergebnisse deuten darauf hin, dass es durch Aktivierung von RLRs zu einer 
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Umstellung des zellulären Metabolismus von oxidativer Phosphorylierung zu Gunsten 
der Glykolyse kommt.
Eine BRET-basierte in-vivo Analyse von Protein-Protein Interaktionen führte zur 
Identifizierung von 25 Interaktionspartnern von MAVS innerhalb des peroxisomalen 
Proteoms. Acht dieser Verbindungen konnten in unabhängigen Experimenten bestätigt 
werden und die Ergebnisse führten zu der Entwicklung der Hypothese, dass MAVS in 
einem PEX19-abhängigen Prozess in die peroxisomale Membran integriert wird.
Mittels drei Zelllinien von Patienten mit Zellweger Syndrom mit Mutationen in PEX19, 
PEX3 oder PEX27 analysierten wir MAVS-abhängiges Signaling in Abwesenheit von 
funktionellen Peroxisomen. Die Zellen aller Patienten zeigten drastisch verminderte 
Typ I Interferon Antworten nach RLR Stimulierung. Dies lässt vermuten, dass intakte 
Peroxisomen eine essentielle Voraussetzung für die vollständige Aktivierung der 
MAVS-abhängigen Signalkaskade darstellen. 
Zusammenfassend wurden in der vorliegenden Arbeit neuartige Proteine identifiziert, 
die relevant für Mitochondrien und Peroxisomen als Signalplattformen in der 
MAVS-abhängigen Signalkette sind. Des Weiteren konnte gezeigt werden, dass die 
RLR Signalkaskade den zellulären Metabolismus beeinflusst. Das neugewonnene 
Verständnis bezüglich Funktion und Aktivität dieser Signalkaskade könnte zur
Entwicklung von neuen Therapieansätzen für Virusinfektionen genutzt werden.
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8 Appendices
8.1 List of PCR primers 
All primers were obtained from Metabion (Planegg, Germany).
Target Gene Primer Sequence (5’        3’)
HPRT
forward tgaccttgatttattttgcatacc
reverse cgagcaagacgttcagtcct
IFN-ß
forward cgacactgttcgtgttgtca
reverse gaggcacaacaggagagcaa
MAVS
forward tgtctgccagcacagtcc
reverse gagctgctggggtctcct
RIG-I
forward tggaccctacctacatcctga
reverse ggcccttgttgtttttctca
MDA5
forward aggcaccatgggaagtgat
reverse ggtaaggcctgagctggag
NLRX1
forward gcctggtactgggcatca
reverse gcccaaacactcgtggaa
EIF2AK
forward tttggacaaagcttccaacc
reverse cggtatgtattaagttcctccatga
HNRNPL 
forward agcggctcaagactgacaa
reverse gtgcgggtcatcgtagttct
DDX18 
forward gcctcccttcgttgatctg
reverse ctttcttggttttctggtagcc
SERPINA3 
forward actccagacagacggctttg
reverse attctctccattctcaactctgc
ACIN1 
forward cctgctgcctcctgacttt
reverse ttcagaaattgaggagctttttc
ILF3
forward tgacatcccctgttgtcaga
reverse tctgcctgtccagaacgtc
EDC4 
forward aagagcctggccttccac
reverse cacctcatcatcatggtcactt
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PCBP2 
forward tgccatctttaaggctttcg
reverse ttggtcatggagctgttgat
SOD2 
forward aagtaccaggaggcgttgg
reverse tgaacttcagtgcaggctga
SND1 
forward gggtaccatccttcatccaa
reverse acagcgtgcgaaaccttc
STAU1 
forward atggtatcggcaaggatgtg
reverse tggtccaactcagacagcaa
IGFBP2
forward aagggtggcaagcatcac
reverse ctggtccagttcctgttgg
PEX3
forward ggctgagttctttcgacc
reverse tccaatagtaaacggacag
8.2 List of quantitative real-time PCR primers
All primers were obtained from Metabion (Planegg, Germany). Primers and probes 
were designed by using the online Roche Assay Design Center
Target Gene Primer Sequence (5’        3’)
HPRT
forward tgaccttgatttattttgcatacc
reverse cgagcaagacgttcagtcct
IFN-ß
forward cgacactgttcgtgttgtca
reverse gaggcacaacaggagagcaa
MAVS
forward tgtctgccagcacagtcc
reverse gagctgctggggtctcct
RIG-I
forward tggaccctacctacatcctga
reverse ggcccttgttgtttttctca
MDA5
forward aggcaccatgggaagtgat
reverse ggtaaggcctgagctggag
NLRX1
forward gcctggtactgggcatca
reverse gcccaaacactcgtggaa
EIF2AK
forward tttggacaaagcttccaacc
reverse cggtatgtattaagttcctccatga
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HNRNPL 
forward agcggctcaagactgacaa
reverse gtgcgggtcatcgtagttct
DDX18 
forward gcctcccttcgttgatctg
reverse ctttcttggttttctggtagcc
SERPINA3 
forward actccagacagacggctttg
reverse attctctccattctcaactctgc
ACIN1 
forward cctgctgcctcctgacttt
reverse ttcagaaattgaggagctttttc
ILF3
forward tgacatcccctgttgtcaga
reverse tctgcctgtccagaacgtc
EDC4 
forward aagagcctggccttccac
reverse cacctcatcatcatggtcactt
PCBP2 
forward tgccatctttaaggctttcg
reverse ttggtcatggagctgttgat
SOD2 
forward aagtaccaggaggcgttgg
reverse tgaacttcagtgcaggctga
SND1 
forward gggtaccatccttcatccaa
reverse acagcgtgcgaaaccttc
STAU1 
forward atggtatcggcaaggatgtg
reverse tggtccaactcagacagcaa
IGFBP2
forward aagggtggcaagcatcac
reverse ctggtccagttcctgttgg
PEX3
forward ggctgagttctttcgacc
reverse tccaatagtaaacggacag
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8.3 Small interfering RNA sequences
All small interfering RNAs were designed via the WI siRNA selection program [261] and
purchased from Eurofins MWG (Ebersberg, Germany).
Target siRNA Sequence (5’        3’)
RIG-I
1 aucacggauuagcgacaaatt
2 ccuuaacaaucuacugaaatt
MDA5 1 guaucguguuauuggauuatt
MAVS
1 cagaggagaaugaguauaatt
2 ccaccuugaugccugugaatt
HNRNPL
1 guccauacccuuacacucu
2 uaagaugaacugugaccga
EIF2AK2
1 gcagggaguaguacuuaaaua
2 ggcaguuaguccuuuauua 
DDX18
1 cgaugaaacuccugcguaa
2 agggaaaucugaagaagaa
SERPINA3
1 gccuguacaagcaguuagu
2 acuauaaccugaacgacau
ACIN1
1 cccacagguuccacuuuau
2 gccagaucguucagaaaga
ILF3
1 gagcuccugugugagaaau
2 guacgaaauacugcaaucu
EDC4
1 ggauggagaucggcauaau
2 gauaucuucagcucaguga
PCBP2
1 atacgagagagtacagggg
2 ggacagtatgccattccac
SOD2
1 guuccuuugacaaguuuaa
2 gguggucauaucaaucaua
SND1
1 cagcaaaggtctagccaca
2 ccggcuuucagaaugugaa
STAU1
1 cucccacaguuguauaaau
2 gcugcgcugaacaucuuaa
IGFBP2
1 cagugcaagaugucucuga
2 aaccucaaacagugcaagaug
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NLRX1
1 gacccuuacaagcaucuau
2 ccuugucucagcucuuuaa
CO4 1 gcgcuauccagcuuacgua
8.4 List of candidate proteins identified by SILAC screening
Overview of proteins regulated by >1.5 fold detected in three SILAC datasets. 
SILAC ratios are depicted as log2 values, with (A) and (B) indicating reversed labeling 
conditions at each stimulation time point.
Complete mitochondria
30min
SILAC 
ratio (A)
SILAC ratio 
(B)
protein name gene name
-0,7808346
-0,716683 Actin-related protein 2/3 complex subunit 4 ARPC4-TTLL3;ARPC4
-3,029146 -0,836893 Chromodomain-helicase-DNA-binding protein 4 CHD4
-0,735908 -0,785508 Actin-related protein 2/3 complex subunit 3 ARPC3
-3,167604 -0,7201909 Heterogeneous nuclear ribonucleoprotein L HNRNPL
-3,348177 -0,7936878 Histone H1,2 HIST1H1C
-2,337302 -2,1431 Interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2
-0,7403359 -0,8946044 Src substrate cortactin CTTN
-1,354686 -0,6100385 UGP2
-3,010541 -0,8117998 ATP-dependent RNA helicase DDX18 DDX18
90min
SILAC 
ratio (A)
SILAC ratio 
(B)
protein name gene name
0,8225262 1,927304 Homeobox protein cut-like 1 CUX1
0,7481177 0,8406808 Lamina-associated polypeptide 2, isoform alpha;Thymopoietin;Thymopentin TMPO
360min
SILAC 
ratio (A)
SILAC ratio 
(B)
protein name gene name
-0,6241543 -0,7812338 Ankycorbin RAI14
0,9138755 0,6236651 Tenascin TNC
-0,6599962 -0,8747576 Myosin-10 MYH10
-0,8291519 -1,427928 Myosin light polypeptide 6 MYL6
0,8399596 1,082561 Alpha-1-antichymotrypsin;Alpha-1-antichymotrypsin His-Pro-less SERPINA3
0,9981233 0,6973358 Amyloid beta A4 protein; APP
-1,081583 -1,137962 Myosin light chain 3;Myosin light chain 1/3, skeletal muscle isoform MYL3;MYL1
8    Appendices
132
1,282796 1,312187 SPARC SPARC
-1,076645 -1,337654 Myosin regulatory light chain 12A MYL12A
-2,247765 -3,199013 Interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2
-0,8568678 -1,351515 Myosin-9 MYH9
-0,6473997 -1,136585 F-actin-capping protein subunit beta CAPZB
-0,8357544 -0,9974008 F-actin-capping protein subunit alpha-1 CAPZA1
-0,6964472 -0,6655747 Unconventional myosin-Ie MYO1E
Mitochondrial surface
30min
SILAC 
ratio (A)
SILAC 
ratio (B)
protein name gene name
-0,745672 -0,822934 Src substrate cortactin CTTN
-1,984617 -0,946281 Apoptotic chromatin condensation inducer in the nucleus ACIN1
-2,905521 -0,815165 Thyroid hormone receptor-associated protein 3 THRAP3
90min
SILAC 
ratio (A)
SILAC 
ratio (B)
protein name gene name
-1,60621 -1,48011 Gelsolin GSN
-1,214542 -1,275663 CLIP-associating protein 1 CLASP1
-1,256425 -1,353154 Interleukin enhancer-binding factor 3 ILF3
-0,9347034 -0,811553 Supervillin SVIL
-0,7315417 -0,790772 Galectin-1 LGALS1
-0,8571553 -0,951289 Peptidyl-prolyl cis-trans isomerase FKBP2;Peptidyl-prolyl cis-trans isomerase FKBP2
-1,35487 -1,0202 Enhancer of mRNA-decapping protein 4 EDC4
-0,6213775 -1,144895 60S acidic ribosomal protein P2 RPLP2
0,7918558 1,10036 Poly(rC)-binding protein 2 PCBP2
0,6331987 0,8712316 Trifunctional enzyme subunit alpha, mitochondrial;Long-chain enoyl-CoA hydratase HADHA
-0,6286977 -1,582556 Emerin EMD
-0,6028323 -1,15043 Syntaxin-12 STX12
-1,273831 -0,909965 Protein disulfide-isomerase A3 PDIA3
0,7024803 0,9201066 Matrix-remodeling-associated protein 7 MXRA7
-1,096591 -0,918233 Superoxide dismutase [Mn], mitochondrial;Superoxide dismutase SOD2
-0,8277941 -1,104605 Splicing factor 3A subunit 1 SF3A1
-0,7900352 -1,014784 Staphylococcal nuclease domain-containing protein 1 SND1
0,9611788 0,660589 Thioredoxin, mitochondrial TXN2
-0,9648547 -0,767654 Sideroflexin-1 SFXN1
-1,055411 -0,641915 Tropomodulin-3 TMOD3
-0,9222921 -0,724126 LIM domain and actin-binding protein 1 LIMA1
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360min
SILAC 
ratio (A)
SILAC 
ratio (B)
protein name gene name
-0,6870096 -1,180339 Poly(rC)-binding protein 2 PCBP2
0,9017261 0,6250663 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial NDUFS1
-0,7927569 -1,418784 Apoptotic chromatin condensation inducer in the nucleus ACIN1
-0,7076895 -0,862669 Double-stranded RNA-binding protein Staufen homolog 1 STAU1
1,252416 0,8108397 Insulin-like growth factor-binding protein 2 IGFBP2
0,913033 0,6750743 Cytochrome b-c1 complex subunit 2, mitochondrial UQCRC2
0,6793337 0,6761111 Beta-sarcoglycan SGCB
-0,9239882 -0,950916 Pinin PNN
Mitochondrial surface
30 min
SILAC 
ratio (A)
SILAC 
ratio (B)
protein name gene name
-0,7664287 -1,575992 Pre-mRNA-processing factor 19 PRPF19
-1,380524 -1,375542 Serine/arginine repetitive matrix protein 2 SRRM2
-0,7727277 -1,482090 RuvB-like 1 RUVBL1
-0,6743401 -1,819746 Chromatin target of PRMT1 protein CHTOP
-0,7664287 -1,575992 Pre-mRNA-processing factor 19 PRPF19
-1,380524 -1,375542 Serine/arginine repetitive matrix protein 2 SRRM2
-0,7727277 -1,482090 RuvB-like 1 RUVBL1
-0,6743401 -1,819746 Chromatin target of PRMT1 protein CHTOP
-0,6551143 -1,955916 Putative rRNA methyltransferase 3 FTSJ3
-0,7451819 -1,413265 Proline-, glutamic acid- and leucine-rich protein 1 PELP1
-0,6952621 -1,260397 ATP-dependent RNA helicase DDX51 DDX51
-0,725674 -1,567245 Exosome complex component RRP43 EXOSC8;DKFZp564C0482
-0,6316303 -1,811052 Probable ATP-dependent RNA helicase DDX27 DDX27
-0,614184 -1,798142 Probable rRNA-processing protein EBP2 EBNA1BP2
-0,623026 -0,879434 Extended synaptotagmin-1 ESYT1
-0,6710679 -1,980204 Guanine nucleotide-binding protein-like 3 GNL3
-0,6829718 -1,333524 Transcription intermediary factor 1-beta TRIM28
-0,7398723 -1,347425 Splicing factor 3B subunit 2 SF3B2
-0,7187547 -1,236379 Ribosome biogenesis protein BOP1 BOP1;KM-PA-2
-0,7995152 -1,842765 Nucleolar and coiled-body phosphoprotein 1 NOLC1
-0,6050752 -1,187210 Ribosome biogenesis regulatory protein homolog RRS1
-0,7753842 -1,484477 WD repeat-containing protein 43 WDR43
-0,7363559 -1,465772 Splicing factor 3B subunit 3 SF3B3
-0,7068248 -1,682907 Splicing factor 3A subunit 1 SF3A1
-0,678685 -1,550847 RNA-binding protein Raly RALY
-0,6697434 -1,665895 CCAAT/enhancer-binding protein zeta CEBPZ
-0,6581228 -1,553122 Heterogeneous nuclear ribonucleoprotein A1; HNRNPA1;HNRNPA1L2
8    Appendices
134
-0,9677635 -1,631108 ATP-dependent RNA helicase DDX24 DDX24
-0,6447377 -1,640880 Pre-mRNA 3-end-processing factor FIP1 FIP1L1
-0,862618 -1,354821 U4/U6,U5 tri-snRNP-associated protein 1 SART1
-0,6300152 -1,621943 U3 small nucleolar RNA-interacting protein 2 RRP9
-0,6700964 -1,357427 Splicing factor 3B subunit 1 SF3B1
-0,8962162 -1,711642 U5 small nuclear ribonucleoprotein 200 kDa helicase SNRNP200
-0,6306507 -1,403469 Surfeit locus protein 6 SURF6
-0,6435758 -1,799927 Ribosomal L1 domain-containing protein 1 RSL1D1
-0,6571951 -1,331697 Metastasis-associated protein MTA2 MTA2;DKFZp686F2281
-0,7729932 -1,996672 Ribosome biogenesis protein NSA2 homolog NSA2
-0,6044677 -0,697453 Fructose-bisphosphate aldolase A ALDOA
-1,1647584 -0,886173 Non-histone chromosomal protein HMG-17; HMGN2;HMGN3
-0,751781 -1,461518 Histone H1,0 H1F0
-0,6965562 -0,670355 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial ACADM
-0,6425188 -1,512651 Splicing factor U2AF 65 kDa subunit U2AF2
-0,7085825 -0,639079 Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial SUCLG1
-0,601249 -1,581076 Eukaryotic translation initiation factor 6 EIF6
-0,8474847 -1,098876 Small nuclear ribonucleoprotein Sm D1 SNRPD1
-0,6732426 -1,277867 60S ribosomal protein L10a RPL10A
-0,8628803 -1,564602 Heterogeneous nuclear ribonucleoprotein U HNRNPU
-0,6542583 -0,983989 60S ribosomal protein L18 RPL18
-0,6028322 -1,460264 ATP-dependent RNA helicase A DHX9
-0,66701 -1,674355 Transducin beta-like protein 3 TBL3
-0,7604202 -1,262125 Interleukin enhancer-binding factor 2 ILF2
-0,8980346 -1,424109 Heterogeneous nuclear ribonucleoproteins C1/C2 HNRNPC
-0,6579127 -1,486613 U3 small nucleolar RNA-associated protein 18 homolog UTP18
-0,6448938 -1,702057 116 kDa U5 small nuclear ribonucleoprotein component EFTUD2
-0,9710223 -2,277061 RNA-binding protein FUS FUS
-0,7883955 -1,491449 Heterogeneous nuclear ribonucleoprotein D0 HNRNPD
-0,7574159 -1,689842 Nucleolar GTP-binding protein 1 GTPBP4
-0,8028021 -1,627687 DNA topoisomerase 2-alpha;DNA topoisomerase 2 TOP2A
-0,7956579 -1,823847 Probable ATP-dependent RNA helicase DDX56 DDX56
-0,652391 -1,203987 H/ACA ribonucleoprotein complex subunit 2 NHP2
-0,7827339 -1,185289 Double-stranded RNA-specific adenosine deaminase ADAR
-0,7169661 -0,823066 Transmembrane protein 109 TMEM109
-0,7195036 -1,435553 THO complex subunit 4 ALYREF
-0,7892582 -1,439969 RRP12-like protein RRP12
-0,6376251 -1,556490 U3 small nucleolar RNA-associated protein 14 homolog A UTP14A
-0,6697434 -1,665895 CCAAT/enhancer-binding protein zeta CEBPZ
-0,6581228 -1,553122 Heterogeneous nuclear ribonucleoprotein A1 HNRNPA1;HNRNPA1L2
-0,9677635 -1,631108 ATP-dependent RNA helicase DDX24 DDX24
-0,6447377 -1,640880 Pre-mRNA 3-end-processing factor FIP1 FIP1L1
-0,862618 -1,354821 U4/U6,U5 tri-snRNP-associated protein 1 SART1
-0,6300152 -1,621943 U3 small nucleolar RNA-interacting protein 2 RRP9
-0,6700964 -1,357427 Splicing factor 3B subunit 1 SF3B1
-0,8962162 -1,711642 U5 small nuclear ribonucleoprotein 200 kDa helicase SNRNP200
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-0,6306507 -1,403469 Surfeit locus protein 6 SURF6
-0,6435758 -1,799927 Ribosomal L1 domain-containing protein 1 RSL1D1
-0,6571951 -1,331697 Metastasis-associated protein MTA2 MTA2;DKFZp686F2281
-0,7729932 -1,996672 Ribosome biogenesis protein NSA2 homolog NSA2
-0,6044677 -0,697453 Fructose-bisphosphate aldolase A ALDOA
-1,1647584 -0,886173 Non-histone chromosomal protein HMG-17 HMGN2;HMGN3
-0,751781 -1,461518 Histone H1,0 H1F0
-0,6965562 -0,670355 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial ACADM
-0,6425188 -1,512651 Splicing factor U2AF 65 kDa subunit U2AF2
-0,7085825 -0,639079 Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial SUCLG1
-0,601249 -1,581076 Eukaryotic translation initiation factor 6 EIF6
-0,8474847 -1,098876 Small nuclear ribonucleoprotein Sm D1 SNRPD1
-0,6732426 -1,277867 60S ribosomal protein L10a RPL10A
-0,8628803 -1,564602 Heterogeneous nuclear ribonucleoprotein U HNRNPU
-0,6542583 -0,983989 60S ribosomal protein L18 RPL18
-0,6028322 -1,460264 ATP-dependent RNA helicase A DHX9
-0,66701 -1,674355 Transducin beta-like protein 3 TBL3
-0,7604202 -1,262125 Interleukin enhancer-binding factor 2 ILF2
90 min
SILAC 
ratio (A)
SILAC 
ratio (B)
protein name gene name
0,99964 0,786973 Nucleoporin p54 NUP54
3,070634 0,6773325 Epididymal secretory protein E1 NPC2
360min
SILAC 
ratio (A)
SILAC 
ratio (B)
protein name gene name
0,99964 0,786973 Nucleoporin p54 NUP54
-0,950141 -1,580105 Zinc finger CCCH-type antiviral protein 1 ZC3HAV1
-1,212292 -1,572638 Heat shock protein beta-1 HSPB1
-0,620465 -0,892330 Aspartate--tRNA ligase, cytoplasmic DARS;DKFZp781B11202
-0,967615 -0,769541 Metalloproteinase inhibitor 3 TIMP3
-0,6791706 -0,751765 Cytoplasmic dynein 1 heavy chain 1 DYNC1H1
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8.5 List of protein interactions detected by BRET screening
Overview of luciferase and VENUS signals detected in BRET screening assay
Protein1 Protein2 Luc1 Luc2 Venus1 Venus2 BRETmean
MAVS PEX5d 23010 25540 7500 8655 0.0404
MAVS PEX19 9281 10326 3084 3542 0.0466
MAVS PEX5b 14900 13558 4927 4521 0.0447
MAVSpex PEX5b 10546 12275 3477 4092 0.0458
MAVS STING 10441 14643 7293 9516 0.3869
MAVSmito STING 12401 15157 4519 5737 0.0797
MAVS SOD1 22669 14578 7684 4905 0.0457
MAVSpex DECR2 6219 6771 2133 2223 0.044
MAVSpex MVK 11731 11211 3725 3687 0.0403
MAVSpex PEX11B 8508 10256 2907 3366 0.0464
MAVSpex ACOX2 8349 7926 2675 2822 0.0526
STING DDO 8758 9119 2922 2720 0.0272
MAVS PEX19 12874 18192 4521 6252 0.0623
MAVSmito PEX5d 9143 8187 3328 2868 0.0675
MAVSmito ACSL4 7788 8272 2369 2687 0.0323
MAVS ACAA1A 15865 17551 4844 5678 0.0301
MAVSmito HCAL1 14516 14015 4539 4670 0.0352
MAVSpex PECI 19890 22383 6277 6852 0.0326
STING ACSL6 4690 4503 1417 1591 0.0488
MAVSpex FIS1 14438 17994 4775 6175 0.0363
MAVSpex ALDH3A2 18586 24483 6097 7332 0.036
MAVSpex PEX11G 17309 19034 5716 6058 0.0354
MAVSmito RHOC 8389 5715 2652 1940 0.0509
MAVSmito CAT 7235 8907 2377 2772 0.0345
MAVSmito ACOT1 16558 19768 4949 6163 0.0401
MAVS PMVK 23239 25848 7138 7928 0.0417
MAVSmito TMEM135 13443 14959 3865 4700 0.0356
MAVSmito ACOT4 13009 11003 4089 3654 0.0369
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8.6 Abbreviations
ACIN1 Apoptotic Chromatin Condensation Inducer 1
APEX ascorbate peroxidase enzymatic tag
BRET Bioluminescence resonance transfer
BSA Bovine serum albumin
CARD Caspase activation and recruitment domain
Cardif CARD adapter inducing interferon-beta
Cat Catalase
CpG Oligonucleotide with cytosine-(phosphate)-guanine motifs
CytC Cytochrome C
DAPI 4’,6-Diamidin-2’-phenylindoldihydrochlorid
DDX18 DEAD box protein-18
DMEM Dulbecco‘s modified Eagle‘s medium 
DMSO Dimethyl sulfoxid
DNA Deoxyribonucleic acid
ds Double-stranded
e.g. exempli gratia
EDC4 Enhancer of mRNA decapping 4
EIF2AK eIF2alpha kinase
ELISA Enzyme-linkedimmunosorbent assay
FACS Fluorescent activated cell sorting
FCCP Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
FCS Fetal calf serum
FITC Fluorescine 
HCV Hepatitis C virus 
HNRNPL Heterogeneous ribonucleoprotein-L
HSP60 Heat shock protein 60
Huh-7 Human hepatoma cell line-7
i.e. id est
IFN Interferon
IGFBP2 Insulin-like growth factor binding protein 2
IL6 Interleukine 6
ILF3 Interleukin enhancer binding factor 3
IP10 Interferon-gamma induced protein 10 kDa
IPS-1 Interferon-beta promoter stimulator 1
IRF3 IFN regulatory factor 3
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ISG Interferon-stimulated gene
JAK Janus kinase
kDa Kilo Dalton
LAMP Lysosome associated membrane protein
LGP2 Laboratory of genetics and physiology-2
LPS Lipopolysaccharide
MACS Magnetic-activated cell sorting
MAM Mitochondria-associated membrane
MAVS Mitochondrial antiviral signaling protein
MDA5 Melanoma differentiation-associated gene 5
min Minute
MOI Multiplicity of infection
mRNA Messenger RNA
nd Not determined
Nuclear factor kappa B
NLRX1 NOD-like receptor family member X1
ns Not significant
NV Norwalk virus
OCR Oxygen consumption rate
OM Outer mitochondrial membrane
p.i. Post-infection
PAMP Pathogen-associated molecular pattern
PBCP2 Poly(rC)-binding protein 2
PBS Phosphate-buffered saline
PCR Polymerase chain reaction
PEX Peroxin
PI Propidium iodide
PMP70 Peroxisome marker protein 70
PRR Pattern recognition receptor
PTPC Permeability transition pore complex
qRT-PCR Quantitative real-time polymerase chain reaction
RIG-I Retinoic acid-inducible gene I
RLR RIG-I-like receptor
RNA Ribonucleic acid
RT Room temperature
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
sec Second
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SERPINA3 Serpin peptidase inhibitor clade A, member 3
SILAC Stable isotope labeling of amino acids in cell culture
SOD2 Super oxide dismutase-2
ss Single-stranded
STAT Signal transducer and activator of transcription
STAU1 Staufen homolog 1
STN1 Staphylococcal nuclease and tudor domain containing 1
TBK1 TANK-binding kinase 1
TCID50 50% tissue culture infective dose
TLR Toll-like receptor
TOM40 Translocase of the outer membrane 40
TRAF Tumor necrosis factor receptor-associated factor
VISA Virus-induced signaling adapter
VSV Vesicular stomatitis virus
wt Wild-type
m Mitochondria inner membrane potential
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